<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">100569</article-id><article-id pub-id-type="doi">10.7554/eLife.100569</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.100569.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>β-1,6-Glucan plays a central role in the structure and remodeling of the bilaminate fungal cell wall</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bekirian</surname><given-names>Clara</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0004-9300-949X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Valsecchi</surname><given-names>Isabel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bachellier-Bassi</surname><given-names>Sophie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Scandola</surname><given-names>Cyril</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5305-9095</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Guijarro</surname><given-names>J Inaki</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chauvel</surname><given-names>Murielle</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Mourer</surname><given-names>Thierry</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Gow</surname><given-names>Neil AR</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Aimanianda</surname><given-names>Vishu Kumar</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5813-7497</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>d'Enfert</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Fontaine</surname><given-names>Thierry</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8184-789X</contrib-id><email>thierry.fontaine@pasteur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/003vg9w96</institution-id><institution>Institut Pasteur, Université Paris Cité, INRAE, USC2019, Unité Biologie et Pathogénicité Fongiques</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04k031t90</institution-id><institution>EA DYNAMYC 7380, Faculté de Santé, Université Paris-Est Créteil (UPEC), École Nationale Vétérinaire d'Alfort (EnvA), USC Anses</institution></institution-wrap><addr-line><named-content content-type="city">Créteil</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Université Paris Cité, Ultrastructural Bioimaging Unit</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Université Paris Cité, CNRS UMR3528, Biological NMR and HDX-MS Technological Platform</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Advanced Molecular Virology Group</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00vbzva31</institution-id><institution>Medical Research Council Centre for Medical Mycology, University of Exeter</institution></institution-wrap><addr-line><named-content content-type="city">Exeter</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Université Paris Cité, Immunobiology of Aspergillus Group</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brakhage</surname><given-names>Axel A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/055s37c97</institution-id><institution>Hans Knöll Institute</institution></institution-wrap><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Soldati-Favre</surname><given-names>Dominique</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01swzsf04</institution-id><institution>University of Geneva</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>05</day><month>12</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP100569</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-06-30"><day>30</day><month>06</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-07-01"><day>01</day><month>07</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.06.30.601427"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-09-02"><day>02</day><month>09</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100569.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-11-06"><day>06</day><month>11</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100569.2"/></event></pub-history><permissions><copyright-statement>© 2024, Bekirian et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Bekirian et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-100569-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-100569-figures-v1.pdf"/><abstract><p>The cell wall of human fungal pathogens plays critical roles as an architectural scaffold and as a target and modulator of the host immune response. Although the cell wall of the pathogenic yeast <italic>Candida albicans</italic> is intensively studied, one of the major fibrillar components in its cell wall, β-1,6-glucan, has been largely neglected. Here, we show that β-1,6-glucan is essential for bilayered cell wall organization, cell wall integrity, and filamentous growth. For the first time, we show that β-1,6-glucan production compensates the defect in mannan elongation in the outer layer of the cell wall. In addition, β-1,6-glucan dynamics are also coordinated by host environmental stimuli and stresses with wall remodeling, where the regulation of β-1,6-glucan structure and chain length is a crucial process. As we point out that β-1,6-glucan is exposed at the yeast surface and modulate immune response, β-1,6-glucan must be considered a key factor in host–pathogen interactions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>β-1,6-Glucan</kwd><kwd>cell wall</kwd><kwd><italic>Candida albicans</italic></kwd><kwd>KRE6</kwd><kwd>immune response</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases</institution></institution-wrap></funding-source><award-id>ANR-10-LABX-62-IBEID</award-id><principal-award-recipient><name><surname>Bekirian</surname><given-names>Clara</given-names></name><name><surname>Bachellier-Bassi</surname><given-names>Sophie</given-names></name><name><surname>Chauvel</surname><given-names>Murielle</given-names></name><name><surname>d'Enfert</surname><given-names>Christophe</given-names></name><name><surname>Fontaine</surname><given-names>Thierry</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-21-CE17-0032-01</award-id><principal-award-recipient><name><surname>Aimanianda</surname><given-names>Vishu Kumar</given-names></name><name><surname>Fontaine</surname><given-names>Thierry</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/101873</award-id><principal-award-recipient><name><surname>Gow</surname><given-names>Neil AR</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/200208</award-id><principal-award-recipient><name><surname>Gow</surname><given-names>Neil AR</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/215599</award-id><principal-award-recipient><name><surname>Gow</surname><given-names>Neil AR</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/224323</award-id><principal-award-recipient><name><surname>Gow</surname><given-names>Neil AR</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100019690</institution-id><institution>MRC Centre for Medical Mycology</institution></institution-wrap></funding-source><award-id>MR/N006364/2</award-id><principal-award-recipient><name><surname>Gow</surname><given-names>Neil AR</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>Region Ile de France</institution></institution-wrap></funding-source><award-id>SESAME 2014 NMRCHR grant no 4014526</award-id><principal-award-recipient><name><surname>Guijarro</surname><given-names>J Inaki</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>French Government Programme Investissements d'Avenir France BioImaging</institution></institution-wrap></funding-source><award-id>ANR-10-INSB-04-01</award-id><principal-award-recipient><name><surname>Scandola</surname><given-names>Cyril</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007155</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/M026663/2</award-id><principal-award-recipient><name><surname>Gow</surname><given-names>Neil AR</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100023300</institution-id><institution>Institut Pasteur</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>d'Enfert</surname><given-names>Christophe</given-names></name><name><surname>Fontaine</surname><given-names>Thierry</given-names></name><name><surname>Guijarro</surname><given-names>J Inaki</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health and Care Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gow</surname><given-names>Neil AR</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>β-1,6-Glucan is crucial for <italic>Candida albicans</italic> cell wall structure and integrity, adapting dynamically to environmental stresses and compensating for mannan deficiencies in cell wall organization.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Pathogenic fungi are a significant burden to public health, recently estimated to cause 2.5 million annually attributable deaths worldwide (<xref ref-type="bibr" rid="bib35">Denning, 2024</xref>). Among these, <italic>Candida</italic> species are responsible for more than 100 million mucosal infections and 1.5 million systemic infections, representing the fourth most frequent cause of bloodstream infection in hospitalized patients (<xref ref-type="bibr" rid="bib35">Denning, 2024</xref>; <xref ref-type="bibr" rid="bib15">Brown et al., 2012</xref>; <xref ref-type="bibr" rid="bib110">Sharma and Chakrabarti, 2023</xref>). <italic>Candida albicans</italic> is the most common opportunistic species, which in healthy individuals often colonizes mucosal surfaces (oral cavity, gastrointestinal tract, as well as genital tract) (<xref ref-type="bibr" rid="bib34">d’Enfert et al., 2021</xref>), but leads to invasive infection, post trauma or when immune system of the host is compromised. <italic>C. albicans</italic> is classified in the critical priority group of the WHO list of fungal pathogens (<xref ref-type="bibr" rid="bib124">WHO, 2022</xref>).</p><p>Fungal cells are enveloped by a cell wall, which is essential for protection, integrity, and to maintain cell morphology. During commensalism with human hosts, the cell wall enables fungi to survive host defenses, whereas during pathogenic interactions the cell wall also plays a central role in the polarized growth of invasive hyphae, thereby facilitating host tissue invasion (<xref ref-type="bibr" rid="bib57">Hall, 2015</xref>; <xref ref-type="bibr" rid="bib87">Mishra et al., 2022</xref>). The cell wall architecture is dynamic and therefore critical in modulating the host immune responses (<xref ref-type="bibr" rid="bib14">Brown, 2011</xref>; <xref ref-type="bibr" rid="bib93">Netea et al., 2015</xref>), which are driven by host immune receptors (pattern recognition receptors [PRRs]) (<xref ref-type="bibr" rid="bib92">Netea et al., 2006</xref>; <xref ref-type="bibr" rid="bib40">Erwig and Gow, 2016</xref>; <xref ref-type="bibr" rid="bib31">Dambuza et al., 2017</xref>). Recognition of fungal pathogen-associated molecular patterns (PAMPs) by host PRRs triggers an array of antifungal responses, including phagocytosis, the production of reactive oxygen/nitrogen species (ROS/RNS), neutrophil extracellular traps, and the release of cytokines and chemokines that recruit immune cells to the site of infection and activate adaptive immunity (<xref ref-type="bibr" rid="bib31">Dambuza et al., 2017</xref>; <xref ref-type="bibr" rid="bib79">Lionakis and Levitz, 2018</xref>; <xref ref-type="bibr" rid="bib117">Urban et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Gow et al., 2011</xref>). Being extracellular, thereby first to interact with the host immune system, fungal cell wall components function as the major PAMPs.</p><p>The cell wall of <italic>C. albicans</italic> is a complex structure with a fibrillar outer layer of mannoproteins and an inner polysaccharide layer composed of chitin, β-1,3-glucan and β-1,6-glucan, which are not present in mammalian cells (<xref ref-type="bibr" rid="bib50">Gow and Hube, 2012</xref>). Dectin-1, a C-type lectin receptor that recognizes fungal cell wall β-1,3-glucan, has been demonstrated to play a dominant pro-inflammatory role in antifungal immunity (<xref ref-type="bibr" rid="bib12">Brown et al., 2002</xref>; <xref ref-type="bibr" rid="bib13">Brown and Gordon, 2003</xref>; <xref ref-type="bibr" rid="bib114">Taylor et al., 2007</xref>; <xref ref-type="bibr" rid="bib41">Ferwerda et al., 2009</xref>; <xref ref-type="bibr" rid="bib82">Marakalala et al., 2013</xref>). Chitin particles derived from the <italic>C. albicans</italic> cell wall lead to the selective secretion of the anti-inflammatory cytokine IL-10 (<xref ref-type="bibr" rid="bib122">Wagener et al., 2014</xref>). Mannans from <italic>C. albicans</italic> are recognized by multiple receptors expressed on different immune cells (Mannose receptor, DC-SIGN, TLR4, Dectin-2, Dectin-3), which are involved in yeast phagocytosis and appear to play a critical role in the induction of Th17 responses (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>; <xref ref-type="bibr" rid="bib29">Choudhury et al., 2023</xref>). <italic>C. albicans</italic> has developed strategies to sense environmental signals encountered within the host and to regulate the exposure of its cell wall PAMPs. For example, low levels of β-1,3-glucan exposure by <italic>C. albicans</italic> correlate with enhanced colonization of the gastrointestinal tract (<xref ref-type="bibr" rid="bib108">Sem et al., 2016</xref>; <xref ref-type="bibr" rid="bib61">Hopke et al., 2018</xref>) and β-1,3-glucan is mainly hidden from immune recognition by the outer layer of mannan fibrils (<xref ref-type="bibr" rid="bib40">Erwig and Gow, 2016</xref>; <xref ref-type="bibr" rid="bib76">Lenardon et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Graus et al., 2018</xref>). Although these <italic>C. albicans</italic> cell wall polysaccharide PAMPs have been investigated in the context of host–fungal interaction, the immunomodulatory potentials of β-1,6-glucan, another major constituent of the <italic>C. albicans</italic> cell wall, remains under-investigated.</p><p>The composition and organization of the fungal cell wall result from an equilibrium between syntheses and remodeling of the constituent polysaccharides (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>; <xref ref-type="bibr" rid="bib51">Gow et al., 2017</xref>). β-Glucans and chitin, which account for about 60% and 2–10% (depending on the morphotype), respectively, are cross-linked to form the skeletal armor of the <italic>C. albicans</italic> cell wall (<xref ref-type="bibr" rid="bib49">Gow et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Klis et al., 2009</xref>). Mannoproteins, which are predominantly glycosylphosphatidylinositol (GPI)-modified and covalently linked to the skeletal polysaccharides via β-1,6-glucan bridges (<xref ref-type="bibr" rid="bib67">Klis et al., 2009</xref>; <xref ref-type="bibr" rid="bib80">Liu et al., 2016</xref>), account for 30–40% of the cell wall. β-1,6-Glucan is composed of a linear chain of β-1,6-linked glucose residues with few short side chains of β-1,3-glucoside or laminaribioside residues (<xref ref-type="bibr" rid="bib64">Iorio et al., 2008</xref>; <xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>). According to analytical methods, the β-1,6-glucan content is highly variable, from 15 to 50% (<xref ref-type="bibr" rid="bib86">Mio et al., 1997</xref>; <xref ref-type="bibr" rid="bib60">Herrero et al., 2004</xref>; <xref ref-type="bibr" rid="bib44">Free, 2013</xref>; <xref ref-type="bibr" rid="bib107">Schiavone et al., 2014</xref>). Although β-1,6-glucan plays a crucial structural role in the <italic>C. albicans</italic> cell wall, the dynamics of this cell wall polysaccharide as a function of growth or stress conditions remains underexplored.</p><p>Genes required for the full β-1,6-glucan production have been identified in model yeast, <italic>Saccharomyces cerevisiae</italic> (<xref ref-type="bibr" rid="bib11">Brown et al., 1993</xref>). Among them, <italic>KRE5</italic> codes a putative α-glucosyltransferase (<xref ref-type="bibr" rid="bib19">CAZy, 2024a</xref>) (GT-24) localized in the endoplasmic reticulum (ER); its deletion results in the absence of β-1,6-glucan in <italic>S. cerevisiae</italic> and about 80% reduction in cell wall β-1,6-glucan content in <italic>C. albicans</italic> (<xref ref-type="bibr" rid="bib60">Herrero et al., 2004</xref>; <xref ref-type="bibr" rid="bib78">Levinson et al., 2002</xref>). Functions of Kre1, Kre6, Kre9 and the related homologs are unclear. Their localization in the ER, Golgi, plasma membrane, or extracellular culture medium suggests an intracellularly initiating biosynthetic pathway of β-1,6-glucan (<xref ref-type="bibr" rid="bib77">Lesage and Bussey, 2006</xref>; <xref ref-type="bibr" rid="bib88">Montijn et al., 1999</xref>). <italic>KRE6</italic> and its functional homolog <italic>SKN1</italic> share 66% identity and both encode transmembrane proteins containing a glycosyl-hydrolase domain (GH-16). <italic>KRE6</italic> deletion in <italic>S. cerevisiae</italic> results in a 70% decrease in the cell wall β-1,6-glucan content (<xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>). In <italic>C. albicans,</italic> the double deletion of <italic>KRE6</italic> and <italic>SKN1</italic> leads to a slow growth, cell wall abnormalities, cell separation failure, and reduced virulence (<xref ref-type="bibr" rid="bib58">Han et al., 2019a</xref>; <xref ref-type="bibr" rid="bib59">Han et al., 2019b</xref>). Two more <italic>KRE6</italic> homologs (<italic>KRE62</italic> and <italic>SKN2</italic>) have been identified in <italic>C. albicans</italic> (<xref ref-type="bibr" rid="bib21">CGD, 2024</xref>) but their function has not yet been investigated, and the <italic>C. albicans</italic> cell wall β-1,6-glucan biosynthetic pathway, namely the β-1,6-glucosyltransferase involved in β-1,6-glucan polymerization and other enzymes involved in β-1,6-glucan remodeling (elongation, branching, or cross-linking with β-1,3-glucan), remains to be identified.</p><p>We standardized biochemical approaches to quantify as well as to characterize β-1,6-glucan of <italic>C. albicans</italic>, which allowed us to perform comparative analysis and to study the dynamic of this cell wall polysaccharide in response to stress conditions and to antifungal treatments. β-1,6-Glucan biosynthesis appears to be a compensatory reaction when mannan elongation is defective, whereas the absence of β-1,6-glucan results in a significantly sick growth phenotype and complete cell wall reorganization. Moreover, β-1,6-glucan showed a distinct immunomodulatory response compared to other cell wall polysaccharides. Together, our study establishes overarching and critical roles for β-1,6-glucans in the organization, structure, biosynthesis, and immunomodulatory properties of the cell wall.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>β-1,6-Glucan: A critical polysaccharide of <italic>C. albicans</italic> cell wall</title><p>Despite numerous studies (<xref ref-type="bibr" rid="bib86">Mio et al., 1997</xref>; <xref ref-type="bibr" rid="bib60">Herrero et al., 2004</xref>; <xref ref-type="bibr" rid="bib44">Free, 2013</xref>; <xref ref-type="bibr" rid="bib107">Schiavone et al., 2014</xref>), the composition and organization of <italic>C. albicans</italic> cell wall β-1,6-glucan remain unclear. To better understand the composition and organization of the cell wall β-1,6-glucan, we have fractionated cell wall and applied new biochemical strategies to quantify and characterize them. The <italic>C. albicans</italic> cell wall was separated into three fractions according to polymer properties and reticulations, namely sodium-dodecyl-sulfate-β-mercaptoethanol (SDS-β-ME) extract, alkali-insoluble (AI), and alkali-soluble (AS) fractions (see ‘Materials and methods’). In synthetic dextrose (SD) medium at 37°C, the SDS-β-ME fraction was the smallest (18% of total cell wall) and mainly composed of mannoproteins (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). The AI fraction was the major one (46%) and was exclusively composed of glucose and glucosamine, the monosaccharide building blocks of β-glucans and chitin, respectively. The AS fraction (36% of total cell wall) was characterized by a high amount of mannose residues (54% of the fraction) resulting from the release of covalently cell wall-anchored mannoproteins (<xref ref-type="fig" rid="fig1">Figure 1a</xref>), and this fraction also contained glucose residues originating from β-glucans. Overall, we found that the <italic>C. albicans</italic> cell wall is composed of 3% of chitin, 43% of proteins/mannoproteins (27% of mannans), and 54% of β-glucans, which was in agreement with earlier studies and validated our analytic approach (<xref ref-type="fig" rid="fig1">Figure 1a and b</xref>; <xref ref-type="bibr" rid="bib22">Chaffin et al., 1998</xref>; <xref ref-type="bibr" rid="bib45">Garcia-Rubio et al., 2020</xref>; <xref ref-type="bibr" rid="bib104">Ruiz-Herrera et al., 2006</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Analysis of <italic>C</italic>. <italic>albicans</italic> cell wall β-1,6-glucans.</title><p>(<bold>a</bold>) Percentages of cell wall polymers on total cell wall, distributed by fractions: sodium-dodecyl-sulfate-β-mercaptoethanol (SDS-β-ME), alkali-insoluble (AI), and alkali-soluble (AS). Cells were grown in synthetic dextrose (SD) medium at 37°C. Means and standard deviations were calculated from three independent experiments. (<bold>b</bold>) Table of the mean percentages of each polymer in the cell wall from three independent experiments. (<bold>c</bold>) Diagram of β-1,6-glucan structure. In blue are represented glucose residues linked in β-1,6 and in green glucose residues linked in β-1,3. According to nuclear magnetic resonance (NMR) analysis and high-performance anion exchange chromatography (HPAEC) after endo-β-1,6-glucanase digestion (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), based on three independent experiments, an average of 6.4% (± 0.5%) of glucose units of the main chain are substituted by a single glucose residue (88–90%) or a laminaribiose (10–12%). (<bold>d</bold>) Gel filtration analysis on a Superdex 200 column of β-1,6-glucan released by endo-β-1,3-glucanase digestion. The column was calibrated with dextrans (Tx: × kDa). (<bold>e</bold>) HPAEC analysis of the digestion products of the AI fraction treated with an endo-β-1,6-glucanase. Chromatographs in (d) and (e) are representative of three independent experiments. PED, pulsed electrochemical detector; nC, nanocoulombs; RI, refractive index; mV, millivolt; DP, degree of polymerization; Glc, glucose.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw data for panels a and b.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><sup>1</sup>H and <sup>13</sup>C NMR resonance assignments, <sup>3</sup>J<sub>H1/H2</sub> and <sup>1</sup>J<sub>H1/C1</sub> coupling constants of the monosaccharide residues of cell wall β-1,6-glucan purified from the alkali-insoluble (AI) fraction.</title><p>Chemical shifts are expressed in ppm and coupling constants in Hz.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Cell disruption is essential to eliminate glycogen in alkali-insoluble (AI) and alkali-soluble (AS) fractions.</title><p>High-performance anion exchange chromatography (HPAEC) analysis of oligosaccharides released by α-amylase enzymatic digestion of AI and AS fractions. (<bold>a</bold>) Control: glycogen, (<bold>b</bold>) AI fraction obtained after biomass cell disruption, (<bold>c</bold>) AI fraction from biomass with no cell disruption, (<bold>d</bold>) AS fraction obtained after biomass cell disruption, and (<bold>e</bold>) AS fraction from biomass with no cell disruption. PED, pulsed electrochemical detector; nC, nanocoulomb.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Quantification methods of β-1,6-glucans in alkali-insoluble (AI) fractions.</title><p>(<bold>a</bold>) The specific oxidation of β-1,6-glucans of the AI fraction by periodate was used for quantification. Briefly, IO<sub>4</sub>Na splits bonds between vivinal carbons bearing hydroxyl groups (only present in β-1,6-glucoside), which leads to the formation of aldehydes, which can react with 4-hydroxybenzhydrazide (PAHBAH) to form a yellow compound measurable by absorbance at OD = 405 nm. (<bold>b</bold>) Specificity of the periodate oxidation method for β-1,6-glucans (pustulan). The method is specific for β-1,6-glucans (pustulan and AI fraction) and inactive on β-1,3-glucans (curdlan). (<bold>c</bold>) Linearity of β-1,6-glucan assay after periodate oxidation. We showed that the response of the method described in (<bold>a</bold>) is proportional from 0 to 20 µg of pustulan.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig1-figsupp3-v1.tif"/></fig></fig-group><p>To differentiate β-1,3-glucans and β-1,6-glucans, we developed two methods, one for the AI fraction and other for the AS fraction (see ‘Materials and methods’ and <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>) as β-glucan was found in both fractions. β-1,6-Glucan corresponded to 23% of the total cell wall and was mainly found in the AI fraction (<xref ref-type="fig" rid="fig1">Figure 1a and b</xref>). β-1,6-Glucan in the AI fraction could be solubilized by digesting β-1,3-glucan using an endo-β-1,3-glucanase, confirming that it is covalently linked to the cell wall β-1,3-glucan as previously shown in <italic>S. cerevisiae</italic> (<xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>; <xref ref-type="bibr" rid="bib68">Kollár et al., 1997</xref>). Further, gel filtration chromatography showed that the solubilized β-1,6-glucan was eluted in a single symmetric peak with Gaussian shape showing a homogeneous polymer with an apparent molecular weight range of 18–112 kDa (<xref ref-type="fig" rid="fig1">Figure 1d</xref>), and the average molecular weight was estimated to be 58 kDa. The structure of purified β-1,6-glucan was analyzed by <sup>1</sup>H and <sup>13</sup>C-NMR (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) and by high-performance anion exchange chromatography (HPAEC) after endo-β-1,6-glucanase digestion (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). The nuclear magnetic resonance (NMR) chemical shifts and coupling constants as well as the HPAEC profile of the digested products were highly comparable to those we described for <italic>S. cerevisiae</italic> (<xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>), showing a similar structure: a main chain of β-1,6-glucosyl residues with side chains of β-1,3-glucosyl or β-1,3-laminaribiosyl residues. The relative intensity of the anomeric proton in NMR and HPAEC analysis after endo-β-1,6-glucanase digestion indicated that an average of 6.4% of glucose units of the main chain is substituted and that 88–90% of the side chains is composed of a single glucose residue (<xref ref-type="fig" rid="fig1">Figure 1c and e</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Altogether, our data showed that β-1,6-glucan is a major cell wall polymer in <italic>C. albicans,</italic> representing 40% of the cell wall β-glucans.</p></sec><sec id="s2-2"><title>Environmental regulation of β-1,6-glucan synthesis</title><p>The composition and surface exposure of fungal cell wall polymers are dependent on environmental growth conditions (<xref ref-type="bibr" rid="bib61">Hopke et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Gow et al., 2017</xref>). We applied chemical assays and our biochemical approaches to enable comparative analyses of cell wall robustness in relation to β-1,6-glucan dynamics in <italic>C. albicans</italic>.</p><p>First, we analyzed the cell wall composition in relation to cell morphotype and growth phase (exponential vs. stationary phase, yeast vs. hyphae, planktonic vs. biofilm). No significant difference was observed between cell wall β-1,6-glucan and other polymers produced during the exponential (control) and stationary phases in yeast cells (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In biofilms, only a slight increase in mannan content (26% vs. 20%), but no change in relative β-glucan content, was observed. In contrast, the cell wall isolated from <italic>C. albicans</italic> hyphae was characterized by an increase in chitin content (10% vs. 3%) as previously shown (<xref ref-type="bibr" rid="bib51">Gow et al., 2017</xref>; <xref ref-type="bibr" rid="bib104">Ruiz-Herrera et al., 2006</xref>; <xref ref-type="bibr" rid="bib8">Braun and Calderone, 1978</xref>), as well as a reduction in β-1,6-glucan (18% vs. 23%) and mannan contents (13% vs. 20%) compared to the yeast form. The decrease in β-1,6-glucan content was reflected in a reduction in the β-1,6-glucan size (43 vs. 58 kDa), demonstrating that both content and structure of β-1,6-glucan are regulated during growth and cellular morphogenesis. In addition, a higher branching rate of β-1,3-glucan of the hyphal cell wall was also observed in the AI fraction (7.3% vs. 5.3%) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Comparative analyses of cell wall β-1,6-glucans produced in various environmental conditions.</title><p>(<bold>a</bold>) Percentages of cell wall polymers (alkali-insoluble [AI] + alkali-soluble [AS] fractions) on total cell wall. Cells were grown in liquid synthetic medium at 37°C under different conditions, as specified in ‘Materials and methods’. (<bold>b</bold>) β-1,6-Glucan mean molecular weight (MW). Average molecular weight was estimated by gel filtration chromatography on a Superdex 200 column. (<bold>c</bold>) Branching rate of β-1,6-glucans. Branching rate was determined by high-performance anion exchange chromatography (HPAEC) after digestion of the AI fraction by an endo-β-1,6-glucanase (% expressed as number of glucose units of the main chain that are substituted by a side chain). For (a–c), means and standard deviations from three independent replicate experiments are shown. All data were compared to the control conditions and were analyzed by one-way ANOVA with Dunnett’s multiple comparisons test: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw data for panels a, b and c.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Global cell wall composition produced by <italic>C</italic>. <italic>albicans</italic> in different environmental conditions.</title><p>Results are represented as the percentage of each polymer on total cell wall in alkali-insoluble (AI) fraction (<bold>a</bold>), alkali-soluble (AS) fraction (<bold>b</bold>), and sodium-dodecyl-sulfate-β-mercaptoethanol (SDS-β-ME) fraction (<bold>c</bold>). Means and standard deviations were obtained from three independent replicate experiments. All data were compared to the control conditions and were analyzed using one-way ANOVA with Dunnett’s multiple comparisons test: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Raw data for panels a, b and c.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Branching rates of β-1,6-glucans and β-1,3-glucans produced by <italic>C</italic>. <italic>albicans</italic> under various environmental conditions.</title><p>(<bold>a</bold>) Branching rate of β-1,6-glucans from alkali-insoluble (AI) fraction. The branching rate was estimated by high-performance anion exchange chromatography (HPAEC) after digestion by an endo-β-1,6-glucanase. (<bold>b</bold>) Branching rate of β-1,3-glucans from AI fraction, The branching rate was estimated by HPAEC after digestion by an endo-β-1,3-glucanase. Means and standard deviations from three independent replicate experiments are shown. All data were compared to the control conditions and were analyzed using one-way ANOVA with Dunnett’s multiple comparisons test: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Raw data for panels a and b.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig2-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig2-figsupp2-v1.tif"/></fig></fig-group><p>We further investigated the effect on cell wall composition of environmental growth conditions, such as temperature, pH, carbon source, and hypoxia, on cell wall composition (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Hypoxic condition (1% O<sub>2</sub>, 5% CO<sub>2</sub>) resulted in a slow growth but did not lead to a significant alteration of the cell wall composition. In contrast, all other tested conditions led to a modification of cell wall composition including the proportion of β-1,6-glucan. For example, growth at 30°C or in 1 M NaCl led to a decrease in the cell wall β-1,6-glucan content and a decrease in β-1,6-glucan chain length. However, these decreases at low temperature were compensated by a higher content of less-branched β-1,3-glucan, whereas high salt led to an increased branching rate of both β-1,6-glucan and β-1,3-glucan (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Buffered culture medium at pH 4 or 7.5 led to a slight decrease in the β-1,6-glucan molecular weight and an increase in its branching frequency in comparison to buffered medium at pH 5.4. However, the most pronounced alteration of the cell wall was observed in lactate containing medium, with a steep reduction in polysaccharides from the structural core, chitin (–43%), β-1,3-glucan (–48%), and mainly β-1,6-glucan (–72%), in agreement with the decrease in thickness of the inner cell wall layer previously described (<xref ref-type="bibr" rid="bib38">Ene et al., 2012</xref>). Lactate medium also led to a strong reduction in the average β-1,6-glucan molecular weight (19 vs. 58 kDa), a decrease in β-1,6-glucan branching (4.9 vs. 6.4%), and an increase in β-1,3-glucan branching (7.4 vs. 5.3%, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p><p>The presence in the medium of short-chain fatty acids (acetate, propionate, or butyrate) at physiological gut concentrations resulted in a growth defect but did not alter the global cell wall composition. The main difference was an increase in β-1,6-glucan molecular weight (64–68 kDa vs. 58 kDa) (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). Oxidative stress and drugs targeting the cell wall did not induce any major alterations (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Cell wall chitin content was reduced in the presence of nikkomycin, a chitin synthesis inhibitor, and increased in the presence of the cell wall-damaging agents Congo Red or caspofungin, as previously observed (<xref ref-type="bibr" rid="bib23">Chapman et al., 1992</xref>; <xref ref-type="bibr" rid="bib101">Roncero and Durán, 1985</xref>; <xref ref-type="bibr" rid="bib123">Walker et al., 2013</xref>), but with no impact on β-1,3-glucan and β-1,6-glucan contents. The major stress effect we observed was in the presence of caspofungin, which caused an increase in the average molecular weight of β-1,6-glucan (70 vs. 58 kDa).</p><p>These data demonstrate that the content, size, and branching of β-1,6-glucan in the <italic>C. albicans</italic> cell wall are regulated by numerous environmental growth and stress conditions.</p></sec><sec id="s2-3"><title>β-1,6-Glucan dynamics responds to alterations in inner cell wall synthesis</title><p>We investigated the dynamics of β-1,6-glucan in <italic>C. albicans</italic> mutants in which the genes involved in the biosynthesis or remodeling of chitin and β-1,3-glucan were deleted. Four chitin synthases, located at the plasma membrane, have been described in <italic>C. albicans,</italic> and we have analyzed three deletion mutants. Chs1 is involved in primary septum formation and is essential for vegetative growth. We therefore analyzed the conditional P<italic><sub>MRP1</sub>-CHS1/chs1</italic>Δ mutant under repressive condition. Chs2 is a nonessential class II enzyme and represents the major chitin synthase activity measured in cell membrane preparations (<xref ref-type="bibr" rid="bib48">Gow et al., 1994</xref>). Chitin synthase 3 (Chs3) is responsible for most of the cell wall chitin production and chitin ring formation at sites of cell division (<xref ref-type="bibr" rid="bib97">Preechasuth et al., 2015</xref>) but it is not essential for growth and viability. Our comparative analyses did not show any alteration in the chitin content in the P<italic><sub>MRP1</sub>-CHS1/chs1</italic>Δ and <italic>chs2</italic>Δ/Δ mutants, but a strong reduction was observed in the <italic>chs3</italic>Δ/Δ mutant (–92.3%) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) in accordance with previous data (<xref ref-type="bibr" rid="bib89">Munro et al., 1998</xref>; <xref ref-type="bibr" rid="bib85">Mio et al., 1996</xref>). In the P<italic><sub>MRP1</sub>-CHS1/chs1</italic>Δ mutant, the cell wall had a 45.7% decrease in mannan content in the AS fraction and a 50% increase in β-1,6-glucan in the AI fraction (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, <xref ref-type="fig" rid="fig3">Figure 3a</xref>). In the <italic>chs3</italic>Δ/Δ mutant, the low proportion of chitin led to an increase in both β-1,3-glucan (×1.6) and β-1,6-glucan (×1.6) in the AS fraction (<xref ref-type="fig" rid="fig3">Figure 3a</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), suggesting a defect in β-glucans cross-linking in the cell wall polysaccharide core. No significant change in β-1,6-glucan structure was noticed for these two mutants (<xref ref-type="fig" rid="fig3">Figure 3b and c</xref>). Strikingly, no significant effect of the <italic>CHS2</italic> deletion was observed on cell wall chitin content or overall wall composition.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Comparative analysis of β-1,6-glucan content and structure produced by cell wall mutants.</title><p>(<bold>a, d, g</bold>) Percentages of cell wall β-1,6-glucans (alkali-insoluble [AI] and alkali-soluble [AS] fractions) on total cell wall. (<bold>b, e, h</bold>) β-1,6-Glucans mean molecular weight (MW). (<bold>c, f, i</bold>) Branching rate of β-1,6-glucans. Cells were grown in liquid synthetic dextrose (SD) medium at 30°C. Means and standard deviations from three independent replicate experiments are shown. All data were compared to the control conditions and were analyzed by one-way ANOVA with Dunnett’s multiple comparisons test: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001; ns, nonsignificant; NA, nonapplicable.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data for panels a to i.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Cell wall composition of <italic>C</italic>. <italic>albicans</italic> mutants.</title><p>Results are represented as the percentage of each polymer on total cell wall in alkali-insoluble (AI) fraction (<bold>a</bold>), alkali-soluble (AS) fraction (<bold>b</bold>), and sodium-dodecyl-sulfate-β-mercaptoethanol (SDS-β-ME) fraction (<bold>c</bold>). Means and standard deviations were obtained from three independent replicate experiments. All data were compared to the parental strain SC5314 and were analyzed using one-way ANOVA with Dunnett’s multiple comparisons test: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Raw data for panels a, b and c.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Branching rates of β-1,6-glucans and β-1,3-glucans produced by different cell wall mutants of <italic>C. albicans</italic>.</title><p>(<bold>a</bold>) Branching rate of β-1,6-glucans from alkali-insoluble (AI) fraction. The branching rate was estimated by high-performance anion exchange chromatography (HPAEC) after digestion by an endo-β-1,6-glucanase. (<bold>b</bold>) Branching rate of β-1,3-glucans from AI fraction. The branching rate was estimated by HPAEC after digestion by an endo-β-1,3-glucanase. Means and standard deviations from three independent replicate experiments are shown. All data were compared to the control conditions and were analyzed using one-way ANOVA with Dunnett’s multiple comparisons test: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001; NA, nonapplicable.</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Raw data for panels a and b.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig3-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Absence of β-1,6-glucans in the cell wall of the quadruple <italic>kre6/kre62/skn2/skn1</italic>Δ/Δ mutant.</title><p>High-performance anion exchange chromatography (HPAEC) analysis of oligosaccharides released by the endo-β-(1,6)-glucanase digestions of alkali-insoluble (AI) fraction of WT (<bold>a</bold>), AI fraction of <italic>kre6/kre62/skn2/skn1</italic>Δ/Δ (<bold>b</bold>), alkali-soluble (AS) fraction of WT (<bold>c</bold>), AS fraction of <italic>kre6/kre62/skn2/skn1</italic>Δ/Δ (<bold>d</bold>), and water (<bold>e</bold>). Experiments were performed in triplicates. PED, pulsed electrochemical detector; nC, nanocoulomb.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig3-figsupp3-v1.tif"/></fig></fig-group><p><italic>FKS1</italic>, <italic>FKS2,</italic> and <italic>FKS3</italic> encode β-1,3-glucan synthases in <italic>C. albicans</italic> (<xref ref-type="bibr" rid="bib104">Ruiz-Herrera et al., 2006</xref>; <xref ref-type="bibr" rid="bib113">Suwunnakorn et al., 2018</xref>). As <italic>FKS1</italic> is essential for vegetative growth (<xref ref-type="bibr" rid="bib113">Suwunnakorn et al., 2018</xref>), we used the heterozygous <italic>fks1</italic>Δ mutant, which displays a haplo-insufficiency phenotype (<xref ref-type="bibr" rid="bib74">Lee et al., 2018</xref>). Only a decrease (–58.7%) in β-1,3-glucan content in the AS fraction (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) was observed, without any other significant changes. Moreover, essentiality of <italic>FKS1</italic> prevented analysis of β-1,6-glucan dynamics in a β-1,3-glucan-deficient mutant. <italic>PHR1</italic> and <italic>PHR2</italic> encode β-1,3-glucanosyltransferases of the GH-72 family involved in β-1,3-glucan elongation and branching at the extracellular cell wall level (<xref ref-type="bibr" rid="bib43">Fonzi, 1999</xref>; <xref ref-type="bibr" rid="bib3">Aimanianda et al., 2017</xref>). In <italic>C. albicans,</italic> their expression is strongly pH dependent: in vitro, <italic>PHR1</italic> is expressed above pH 5.5, while <italic>PHR2 is</italic> expressed below pH 5.5 (<xref ref-type="bibr" rid="bib33">De Bernardis et al., 1998</xref>). The <italic>phr1</italic>Δ/Δ mutant was thus grown at pH 7.5 and <italic>phr2</italic>Δ/Δ at pH 5.5. As expected for both mutants, defects in GH-72 β-1,3-glucan remodelase led to a decrease in β-1,3-glucan branching (–67.3% for <italic>phr1</italic>Δ/Δ, –31.5% for <italic>phr2</italic>Δ/Δ) (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>) and a compensatory increase in the cell wall chitin content (1.5× for <italic>phr1</italic>Δ/Δ and 3.7× for <italic>phr2</italic>Δ/Δ) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). No change in the cell wall β-1,3-glucan content was observed in the <italic>phr1</italic>Δ/Δ mutant (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). In contrast, deletion of <italic>PHR2</italic> led to an increase in β-1,3-glucan content and a cross-linking defect (–31.5% estimated on the ratio β-1,3-glucan content in AS and AI fractions). Concomitantly, deletion of <italic>PHR2</italic> led to a reduction in cell wall β-1,6-glucan content in both AI (–58.7%) and AS (–51.3%) fractions and to a reduction in molecular weight and branching of the β-1,6-glucan chains (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). In the <italic>phr1</italic>Δ/Δ mutant, only a significant increase in the molecular weight of β-1,6-glucan chain was observed (60 vs. 50 kDa) (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>Taken together, these data showed that mutational disruption of chitin-synthase or β-1,3-glucan-synthase genes did not significantly alter the cell wall β-1,6-glucan structure. However, defects in chitin content led to a decrease in the cross-linking of β-glucans in the inner wall (i.e., AI fraction) that corresponds to the effect of nikkomycin-treated <italic>C. albicans</italic> phenotype (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>); conversely, an increase in chitin content led to more cross-linking of β-glucans as observed in the <italic>FKS1</italic> mutant or in the presence of caspofungin (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). In contrast, disruption of cell wall β-1,3-glucan remodeling had a pH-dependent effect on β-1,6-glucan structure (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>).</p></sec><sec id="s2-4"><title>A β-1,6-glucan mannan compensatory pathway links the regulation of the inner and outer cell wall layers</title><p>In <italic>C. albicans</italic>, mannosylation of cell wall proteins is required for the organization of the fibrillar outer layer of the cell wall that is composed of <italic>N</italic>-linked mannans (<xref ref-type="bibr" rid="bib76">Lenardon et al., 2020</xref>; <xref ref-type="bibr" rid="bib53">Gow and Lenardon, 2023</xref>). This fibrillar layer is anchored to the polysaccharide core composed of β-1,3-glucan and chitin, via β-1,6-glucan bridges (<xref ref-type="bibr" rid="bib67">Klis et al., 2009</xref>). We analyzed mutants deficient in Golgi α-mannosyltransferases involved in <italic>O</italic>- and <italic>N</italic>-mannosylation. Mnt1 and Mnt2 are α-1,2-mannosyltransferases involved in catalyzing consecutive reactions in <italic>O</italic>-mannan elongation (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>; <xref ref-type="bibr" rid="bib91">Munro et al., 2005</xref>). As predicted, the cell wall of the <italic>mnt1/mnt2</italic>Δ/Δ mutant showed minor changes in overall mannan content (<xref ref-type="fig" rid="fig3">Figure 3d</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib91">Munro et al., 2005</xref>). However, deletion of <italic>MNT1</italic> and <italic>MNT2</italic> genes led to a strong reduction in β-1,6-glucan molecular weight (18 vs. 43 kDa) and an increased branching of β-1,6-glucan chains (8.6 vs. 5.3%) (<xref ref-type="fig" rid="fig3">Figure 3e and f</xref>). A slight increase in the β-1,3-glucan branching was also observed in the <italic>mnt1/mnt2</italic>Δ/Δ double mutant (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Overall, these data suggested that β-1,6-glucan and mannan syntheses may be coupled.</p><p><italic>N</italic>-mannan elongation requires the activity of a set α-1,6-mannosyltransferases in the Mannan Polymerase I and II complexes for the formation of α-1,6-mannan backbone that is subsequently modified with α-1,2- and α-1,3-mannosyltransferases that assemble the <italic>N</italic>-mannan side chains (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>). Och1 activity is responsible for the initial addition of α-1,6‐mannose onto the relatively well conserved <italic>N</italic>-glycan triantennary complex of glycoproteins, and Mnn9 activity is essential for the polymerization of the α-1,6‐mannose backbone. Mnn2, Mnn21, Mnn22, Mnn23, Mnn24, and Mnn26 activities are essential to the synthesis of side chains (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>). Single <italic>och1</italic>Δ/Δ and <italic>mnn9</italic>Δ/Δ mutants and the sextuple <italic>mnn2/21/22/23/24/26</italic>Δ/Δ mutant resulted in a major decrease in mannan content in the AS fraction (–90.4% for <italic>och1</italic>Δ/Δ, –88.9% for <italic>mnn9</italic>Δ/Δ, and –87.1% for <italic>mnn2/21/22/23/24/26</italic>Δ/Δ) and a compensatory increase in chitin content (×3.1 for <italic>och1</italic>Δ/Δ, ×2.5 for <italic>mnn9</italic>Δ/Δ, and ×2.5 for <italic>mnn2/21/22/23/24/26</italic>Δ/Δ) in the AI fraction (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), as previously described (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>). A significant increase in cell wall β-1,3-glucan content was observed in the <italic>mnn9</italic>Δ/Δ and <italic>mnn2/21/22/23/24/26</italic>Δ/Δ mutants. There was also a significant increase in the β-1,6-glucan content (×3.2 for <italic>och1</italic>Δ/Δ, ×2.4 for <italic>mnn9</italic>Δ/Δ, and ×2.4 for <italic>mnn2/21/22/23/24/26</italic>Δ/Δ, respectively) concomitant with the elongation of β-1,6-glucan chains, and consequential increase in its molecular weight (<xref ref-type="fig" rid="fig3">Figure 3d and e</xref>).</p><p>Overall, these data suggest that the β-1,6-glucan biosynthesis is stimulated via a compensatory pathway when there is a defect in <italic>O</italic>- and <italic>N</italic>-linked cell wall mannan biosynthesis. This novel compensatory response occurs by increasing the β-1,6-glucan content in <italic>N</italic>-mannan elongation-deficient mutants and increasing branching of shorter β-1,6-glucan chains in <italic>O</italic>-mannan-deficient mutants.</p></sec><sec id="s2-5"><title><italic>KRE6-</italic>family-members-dependent β-1,6-glucan biosynthesis</title><p>Genes encoding proteins essential for β-1,6-glucan biosynthesis were first identified in <italic>S. cerevisiae</italic> as mutants resistant to Killer Toxin K1 (<italic>KRE</italic>) (<xref ref-type="bibr" rid="bib11">Brown et al., 1993</xref>; <xref ref-type="bibr" rid="bib109">Shahinian and Bussey, 2000</xref>). In addition, a range of proteins in the endoplasmic reticulum and Golgi (Cwh41, Rot2, Kre5, Kre6, Skn1) are critical for the assembly of this polymer (<xref ref-type="bibr" rid="bib109">Shahinian and Bussey, 2000</xref>). We analyzed homologs of <italic>CWH41</italic>, <italic>ROT2</italic>, <italic>KRE5</italic> in <italic>C. albicans</italic>. These three calnexin cycle proteins involved in glucosylation/deglucosylation of <italic>N</italic>-glycan in the ER (<xref ref-type="bibr" rid="bib1">Aebi et al., 2010</xref>) had a reduced amount of cell wall mannan (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Strong cell wall phenotypes were observed for <italic>kre5</italic>Δ/Δ and <italic>rot2</italic>Δ/Δ mutants, which exhibited significant increases in the highly branched β-1,3-glucan (×1.8 for <italic>rot2</italic>Δ/Δ<italic>,</italic> ×2.2 for <italic>kre5</italic>Δ/Δ) (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), chitin (×4.2 for <italic>rot2</italic>Δ/Δ, ×5.2 for <italic>kre5</italic>Δ/Δ) and a strong decrease in β-1,6-glucan in the <italic>rot2</italic>Δ/Δ (–68.7%) and <italic>kre5</italic>Δ/Δ mutants (–81.5%) (<xref ref-type="fig" rid="fig3">Figure 3g</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). In addition, the β-1,6-glucan structure was also altered in both mutants, with a decrease in the average molecular weight (15–16 kDa instead of 43 kDa for the parental strain) and a reduction in the side chain branching (–54.2% for <italic>rot2</italic>Δ/Δ and –76.5% for <italic>kre5</italic>Δ/Δ) (<xref ref-type="fig" rid="fig3">Figure 3h and i</xref>). <italic>KRE1</italic> encodes a plasma membrane protein whose function is not yet clear (<xref ref-type="bibr" rid="bib9">Breinig et al., 2002</xref>; <xref ref-type="bibr" rid="bib10">Breinig et al., 2004</xref>). The <italic>kre1</italic>Δ/Δ <italic>C. albicans</italic> mutant exhibited a reduced molecular weight of β-1,6-glucan chains (20 kDa instead of 43 kDa in the parental strain) (<xref ref-type="fig" rid="fig3">Figure 3h</xref>) but was not affected in overall cell wall composition (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><p>In <italic>C. albicans,</italic> the <italic>KRE6</italic> family is composed of four homologs: <italic>KRE6</italic>, <italic>SKN1</italic>, <italic>KRE62,</italic> and <italic>SKN2</italic>. These genes encode putative trans-β-glycosylases of the GH-16 family for which no biochemical activity has been described to date (<xref ref-type="bibr" rid="bib20">CAZy, 2024b</xref>). To analyze the function of these four proteins in <italic>C. albicans</italic>, we used a transient CRISPR/Cas9 protocol to build the four single-knockout mutants, the double <italic>kre6/skn1</italic>Δ/Δ, and the quadruple <italic>kre6</italic>Δ/Δ<italic>/kre62/skn2/skn1</italic>Δ/Δ mutants. Among the single mutants, only <italic>kre6</italic>Δ/Δ exhibited a marked alteration in the cell wall composition (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), with significantly lower β-1,6-glucan (–46.8%) (<xref ref-type="fig" rid="fig3">Figure 3g</xref>) and mannan content (–42.8%) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), and higher β-1,3-glucan (×1.9) and chitin (×3.9) content. In addition, the β-1,6-glucan chain length was shorter (–50.5%) and more branched (×1.7) than in the parental strain (<xref ref-type="fig" rid="fig3">Figure 3h and i</xref>) and β-1,3-glucan was also hyperbranched (×1.8) (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). The <italic>kre6/skn1</italic>Δ/Δ mutant phenotype, β-1,6-glucan content, and structure were similar to the single <italic>kre6</italic>Δ/Δ mutant (<xref ref-type="fig" rid="fig3">Figure 3g–i</xref>). The quadruple <italic>kre6/kre62/skn2/skn1</italic>Δ/Δ mutant did not produce any measurable β-1,6-glucan (<xref ref-type="fig" rid="fig3">Figure 3g</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), which was confirmed by endo-β-1,6-glucanase digestion of the AI and AS fractions (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). The absence of β-1,6-glucan was associated with an increased chitin content (9.5% vs. 2.5%), and highly branched β-1,3-glucan (48% vs. 20% in the parental strain) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplements 1 and 2</xref>). Reintegration of <italic>KRE6</italic> under the control of the <italic>ACT1</italic> promoter restored the production of β-1,6-glucan with a structure similar to that of the parental strain (<xref ref-type="fig" rid="fig3">Figure 3g–i</xref>).</p><p>Therefore, in <italic>C. albicans,</italic> deletion of all <italic>KRE6</italic> homologous genes led to the absence of β-1,6-glucan production and structural alterations of the cell wall, showing that the β-1,6-glucan biosynthetic pathway is critical to the regulation of cell wall homeostasis.</p></sec><sec id="s2-6"><title><italic>KRE6</italic> regulation of cell wall architecture</title><p>The single deletions of <italic>KRE62</italic>, <italic>SKN1,</italic> and <italic>SKN2</italic> did not affect the growth of <italic>C. albicans</italic> in SD medium nor drug sensitivity (<xref ref-type="fig" rid="fig4">Figure 4</xref>), whereas the deletion of <italic>KRE6</italic> led to a significant increase in doubling time (×2.4, <xref ref-type="fig" rid="fig4">Figure 4a and b</xref>). The double <italic>kre6/skn1</italic>Δ/Δ mutant had the same growth rate as <italic>kre6</italic>Δ/Δ (<xref ref-type="fig" rid="fig4">Figure 4a and b</xref>). However, deletion of all genes of the <italic>KRE6</italic> homologs family (quadruple <italic>kre6/kre62/skn2/skn1</italic>Δ/Δ mutant) resulted in a stronger growth phenotype with a longer lag phase and a higher doubling time (×3.5 vs. parental strain). Cells of the quadruple <italic>kre6/kre62/skn2/skn1</italic>Δ/Δ mutant were bigger than the parental strain (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). In addition, the single <italic>kre6</italic>Δ/Δ and all multiple mutants aggregated in SD liquid medium and had increased sensitivity to the cell wall perturbing agents Congo Red, Calcofluor White, as well as to the chitin synthase inhibitor nikkomycin Z and the <italic>N</italic>-glycosylation inhibitor tunicamycin. No growth of the quadruple mutant was observed in the presence of either of these drugs. Surprisingly, caspofungin enhanced the growth of mutants bearing <italic>KRE6</italic> gene deletion (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). Among the single mutants, only <italic>skn1</italic>Δ/Δ was defective for filamentous growth; all multiple mutants also displayed defects in filamentous growth, and the severity of this phenotype was proportional to the number of <italic>KRE6</italic> homologous genes deleted (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). The reintegration of <italic>KRE6</italic> under P<italic><sub>ACT1</sub></italic> restored parental strain-like growth kinetics, filamentation, and drug resistance (<xref ref-type="fig" rid="fig4">Figure 4</xref>) and confirmed the above differences noted in the mutants of <italic>KRE6</italic> and <italic>SKN1</italic> (<xref ref-type="bibr" rid="bib59">Han et al., 2019b</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Phenotypic characterization of <italic>KRE6</italic> family mutants: growth kinetics, drug susceptibility, and filamentation.</title><p>(<bold>a</bold>) Kinetic curve of all strains grown in liquid synthetic dextrose (SD) medium, 30°C. Optical density at 620 nm was measured every 10 min during 80 hr by TECAN SUNRISE. Means and standard deviations were calculated from three independent experiments. (<bold>b</bold>) Doubling time of each strain was determined from three independent replicates. Statistical analyses were performed with one-way ANOVA with Tukey’s multiple comparisons test: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001; ns, nonsignificant. (<bold>c</bold>) Spotting test of tenfold serial dilution of yeast cells of all strains on SD medium, 30°C, 48 hr, with cell wall disturbing agents (CR, Congo Red; CFW, Calcofluor White) or drugs (nikkomycin, tunicamycin, caspofungin). These results are representative of three independent experiments. Pictures were taken with a Phenobooth (Singer Instruments). (<bold>d</bold>) Filamentation assay of all strains. Top row: growth in liquid SD medium at 30°C; middle panels: growth in liquid YNB medium + 2% GlcNAc, buffered at pH 7.2 at 37°C during 6 hr. Pictures were taken using an Olympus IX 83 microscope, ×40 objective. Bottom row: cells were grown on agar YNB + 2% GlcNAc, buffered at pH 7.2, at 37°C for 6 days.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw data for panels a and b.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Control PCR control of mutants obtained in this study.</title><p>(<bold>a</bold>) Principle of PCR check done in (b) and (c). P1 and P2 are PCR diagnostic primers. ORF = <italic>KRE6</italic>, <italic>KRE62</italic>, <italic>SKN2,</italic> or <italic>SKN1</italic>. Repair Templates contain either <italic>HygB</italic> or a <italic>SAT1-Flipper</italic> cassette for selection. FRT correspond to the scar after <italic>SAT1-Flipper</italic> cassette excision. (<bold>b</bold>) Table of expected PCR bands according to mutant. (<bold>c</bold>) PCR bands obtained.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>PDF file containing original gels PCR for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1c</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100569-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Original files for gels PCR analysis displayed in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1c</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100569-fig4-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Control PCR of the quadruple mutant complemented for <italic>KRE6 (kre6/kre62/skn2/skn1</italic>Δ/<italic>Δ</italic>+P<italic><sub>ACT</sub>-KRE6</italic>).</title><p><italic>KRE6</italic> was reintegrated at the <italic>RPS1</italic> locus under the control of <italic>ACT1</italic> promoter, using <italic>SAT1</italic> as a selection marker.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>PDF file containing original gel PCR for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100569-fig4-figsupp2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata2"><label>Figure 4—figure supplement 2—source data 2.</label><caption><title>Original files for gel PCR analysis displayed in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100569-fig4-figsupp2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Cell wall architecture, observed by transmission electron microscopy, showed that single <italic>skn1</italic>Δ/Δ, <italic>kre62</italic>Δ/Δ, and <italic>skn2</italic>Δ/Δ mutants presented a bilayered structure with a classical fibrillar outer layer similar to the parental strain (<xref ref-type="fig" rid="fig5">Figure 5</xref>). However, the outer layer of the <italic>skn1</italic>Δ/Δ and <italic>skn2</italic>Δ/Δ mutants was thicker than the WT (<italic>skn1</italic>Δ/Δ, 70 ± 12 nm; <italic>skn2</italic>Δ/Δ, 66 ± 12 nm vs. WT, 53 ± 10 nm). The cell wall of the <italic>kre6</italic>Δ/Δ and <italic>kre6/skn1</italic>Δ/Δ mutants had a heterogeneous and thicker inner layer (<italic>kre6</italic>Δ/Δ, 210 ± 89 nm; <italic>kre6/skn1</italic>Δ/Δ, 216 ± 68 nm vs. WT, 108 ± 23 nm) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). The external mannoprotein-rich fibrillar layer was absent in the quadruple <italic>kre6/kre62/skn2/skn1</italic>Δ/Δ mutant and the inner layer was thicker and of variable thickness (440 ± 158 nm vs. 108 ± 23 nm). A normal wall architecture was fully restored in the complemented strain.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Cell wall electron microscopy observations of <italic>KRE6</italic> simple and multiple mutants.</title><p>(<bold>a</bold>) Representative transmission electron microscopy images of the cell wall of each strains. After culture, cells were fixed and high-pressure frozen and freeze substituted with Spurr resin. Sections were cut and stained and then pictures were taken with a Tecnai Spirit 120Kv TEM microscope. Scale bar = 200 nm. (<bold>b</bold>) Measurement of the inner and outer cell wall layers of the mutants. Means and standard deviations are represented. 37–40 measurements were performed randomly on 7–13 cells. Statistical analyses were performed with one-way ANOVA with Tukey’s multiple comparisons test: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw data for panel b.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig5-v1.tif"/></fig><p>These results demonstrate that β-1,6-glucan has a pivotal role in determining the architectural arrangement of polysaccharides in the cell wall, which in turn influences growth, drug sensitivity, cell morphology, and filamentation.</p></sec><sec id="s2-7"><title>β-1,6-Glucan stimulates human peripheral blood mononuclear cells in vitro</title><p>The major cell wall polysaccharides of <italic>C. albicans,</italic> β-1,3-glucan, mannan, and chitin function as PAMPs, and their recognition by host PRRs trigger immune responses. Although β-1,6-glucan is one of the major constituent polysaccharides in the cell wall of <italic>C. albicans</italic>, its immunomodulatory potential has been understudied. We extracted β-1,6-glucan from the cell wall of the parental strain and used this to stimulate peripheral blood mononuclear cells (PBMCs) and neutrophils isolated from the whole blood samples of healthy human donors. As controls, PBMCs were stimulated with the AI fraction (composed of β-1,3-glucan, β-1,6-glucan, and chitin), as well as with the periodate-oxidized AI fraction (AI-OxP) devoid of β-1,6-glucan. A protein profiler was used to identify cytokines, chemokines, and acute-phase proteins differentially released by PBMCs and neutrophils stimulated with the three different cell wall fractions (AI, AI-OxP, and β-1,6-glucan) (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplements 2</xref> and <xref ref-type="fig" rid="fig6s3">3</xref>). Then, differentially stimulated cytokines, chemokines, and acute-phase proteins were quantified by ELISA. Fractions containing β-1,3-glucan (AI and AI-OxP fractions) induced the secretion of pro-inflammatory cytokines, including IL-6, IL-1β, and TNF-α, chemokines such as IL-8, MCP-1, MIP-1β, and RANTES, and the complement factor C5a (an acute-phase protein), but anti-inflammatory cytokine IL-10 was released in a relatively small amount (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). However, removal of β-1,6-glucan by periodate oxidation (AI-OxP) led to a significant decrease in the IL-8, IL-6, IL-1β, TNF-α, C5a, and IL-10 released, suggesting that their stimulation was in part β-1,6-glucan dependent. Although the response was much lower than that induced by the AI fraction and AI-OxP, β-1,6-glucan activated PBMCs and induced secretion of most cytokines and chemokines (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Both AI and AI-OxP fractions stimulated neutrophils secreted IL-8 at a similar level (<xref ref-type="fig" rid="fig6">Figure 6b</xref>) but purified β-1,6-glucan did not, suggesting that β-1,6-glucan and β-1,3-glucan stimulate innate immune cells in distinct ways.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Stimulation of peripheral blood mononuclear cells (PBMCs) and neutrophils in vitro by cell wall fractions and purified β-1,6-glucans from <italic>C. albicans</italic>.</title><p>Cytokines, chemokines, or acute-phase proteins (IL-8, MCP-1, IL-6, MIP-1β, IL-1β, TNF-α, RANTES, C5a, IL-10) concentrations in culture supernatants of PBMCs (<bold>a</bold>) and neutrophils (<bold>b</bold>) stimulated by cell wall fractions of <italic>C. albicans</italic> (AI-Fraction, AI-Fraction OxP, and β-1,6-glucan) at 25 µg/mL or LPS (positive control, 0.1 µg/mL). PBMCs and neutrophils were isolated from healthy human donors (n = 8). Three independent batches of each fractions were used. Means are represented and data were analyzed using nonparametric Friedman test with Dunn’s multiple comparisons: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001; ns, nonsignificant.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Raw data of panels a and b.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Stimulation of peripheral blood mononuclear cells (PBMCs) and neutrophils in vitro by β-1,6-glucan with different size from <italic>C. albicans</italic>.</title><p>Cytokines, chemokines, or acute-phase proteins (IL-8, MCP-1, IL-6, MIP-1β, IL-1β, TNF-α, RANTES, C5a, IL-10) concentrations in culture supernatants of PBMCs (<bold>a</bold>) or neutrophils (<bold>b</bold>) stimulated by different β-1,6-glucans from <italic>C. albicans</italic> at 25 µg/mL or LPS (positive control, 0.1 µg/mL). β-1,6-Glucans were isolated from cell wall alkali-insoluble (AI) fraction of <italic>C. albicans</italic> grown either at 37°C in synthetic dextrose (SD) medium (control, β-1,6-glucan size = 58 kDa), or in the presence of caspofungin at sublethal concentration 0.015 µg/mL (β-1,6-glucan size = 70 kDa) or in the presence of 2% lactate as sole carbon source (β-1,6-glucan size = 19 kDa). PBMCs and neutrophils were isolated from healthy human donors (n = 8). Three independent batches of the different fractions were used. Means are represented and data were analyzed using nonparametric Friedman test with Dunn’s multiple comparisons: ns, nonsignificant.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Raw data of panels a and b.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig6-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Human proteome profiler done with culture supernatant from peripheral blood mononuclear cells (PBMCs) stimulated with <italic>C</italic>. <italic>albicans</italic> cell wall fractions.</title><p>Left: membrane blots obtained after incubation with supernatants from PBMCs cultures stimulated by different <italic>C. albicans</italic> cell wall fractions: AI, AI-OxP, or β-1,6-glucans. Incubation with the culture medium was used as a control (top). Right: coordinate of each protein (cytokines, chemokines, acute-phase proteins) detected on the membranes. The experiment was performed once using a pool of 24 supernatants from the stimulation of PBMCs isolated from eight healthy donors, each stimulated with three independent batches of fractions.</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>PDF file containing original blots for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100569-fig6-figsupp2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s2sdata2"><label>Figure 6—figure supplement 2—source data 2.</label><caption><title>Original files for blots analysis displayed in <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100569-fig6-figsupp2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Human proteome profiler done with culture supernatant from neutrophils stimulated with <italic>C</italic>. <italic>albicans</italic> cell wall fractions.</title><p>Left: membrane blots obtained after incubation with supernatants from neutrophils cultures stimulated by different <italic>C. albicans</italic> cell wall fractions: AI, AI-OxP, or β-1,6-glucans; incubation with the culture medium was used as a control (top). Right: coordinate of each protein (cytokines, chemokines, acute-phase proteins) detected on the membranes. The experiment was performed once using a pool of 24 supernatants from the stimulation of neutrophils isolated from eight healthy donors, each stimulated with three independent batches of fractions.</p><p><supplementary-material id="fig6s3sdata1"><label>Figure 6—figure supplement 3—source data 1.</label><caption><title>PDF file containing original blots for <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100569-fig6-figsupp3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s3sdata2"><label>Figure 6—figure supplement 3—source data 2.</label><caption><title>Original files for blots analysis displayed in <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100569-fig6-figsupp3-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>β-1,6-Glucan from <italic>C</italic>. <italic>albicans</italic> activates complement system.</title><p>(<bold>a</bold>) Normal human serum (NHS) enhances the immunostimulatory capacity of β-1,6-glucan from <italic>C. albicans</italic>. Peripheral blood mononuclear cells (PBMCs) isolated from healthy human donors (n = 2) were stimulated with three independent batches of β-1,6-glucan at 25 µg/mL with (w/) or without (w/o) NHS (10%). Immune response was analyzed by measuring IL-8 released into the culture medium. Means are represented and data were analyzed with an unpaired parametric <italic>t</italic>-test: ****p&lt;0.0001. (<bold>b</bold>) Complement factor C3b binds to β-1,6-glucan purified from <italic>C. albicans</italic> cell wall. Three cell wall fractions (AI, AI-OxP, and β-1,6-glucan) from <italic>C. albicans</italic> were coated on microtiter plates at 50 µg, 25 µg, or 12.5 µg per well. Human normal serum, diluted in Gelatin-Veronal Buffer (GVB), was added to activate complement pathways. The amount of deposited C3b on each fraction (=level on complement activation) was determined by using anti-human C3b and peroxidase-conjugated anti-mouse IgG antibodies. 3,3’,5,5’-Tetramethylbenzidine (TMB) was used as the peroxidase substrate and the reaction was stopped with 4% H<sub>2</sub>SO<sub>4</sub> and optical density (OD) was measured at 450 nm. The experiment was done with three independent batches of each cell wall fractions. Blank value was subtracted from the values presented. Statistical analyses were performed with one-way ANOVA with Tukey’s multiple comparisons test: ****p&lt;0.0001.</p><p><supplementary-material id="fig6s4sdata1"><label>Figure 6—figure supplement 4—source data 1.</label><caption><title>Raw data of panels a and b.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100569-fig6-figsupp4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig6-figsupp4-v1.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>Exposure of β-1,6-glucans and β-1,3-glucans at the cell surface of <italic>C.</italic> <italic>albicans</italic> SC5314.</title><p>Cells were cultured in synthetic dextrose (SD) at 37°C. β-Glucan exposure was detected by a polyclonal rabbit anti-β-1,6-glucan serum (top panel) and or monoclonal anti-β-1,3-glucan antibody (bottom panel).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig6-figsupp5-v1.tif"/></fig></fig-group><p>Because the structure of cell wall β-1,6-glucan is dependent on stress as well as environmental conditions of growth, we investigated the structure–function immune response of β-1,6-glucan from <italic>C. albicans</italic>. Shorter β-1,6-glucan chains (19 kDa) were purified from the cell wall of <italic>C. albicans</italic> cell wall grown with lactate as carbon source and larger β-1,6-glucan chains (70 kDa) were purified from cell wall produced in the presence of caspofungin (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Both fractions stimulated PBMCs and led to cytokine/chemokine secretion at a level similar to the control β-1,6-glucan, suggesting that β-1,6-glucan size was not a significant factor influencing the stimulation of PBMCs (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Cell wall β-1,6-glucan is a conserved constituent in most of the major human fungal pathogens, including <italic>Candida</italic>, <italic>Cryptococcus</italic>, <italic>Pneumocystis</italic>, <italic>Histoplasma,</italic> and <italic>Malassezia</italic> species (<xref ref-type="bibr" rid="bib45">Garcia-Rubio et al., 2020</xref>; <xref ref-type="bibr" rid="bib112">Stalhberger et al., 2014</xref>; <xref ref-type="bibr" rid="bib69">Kottom et al., 2015</xref>). The cell wall of fungal pathogens is the target of several classes of antifungal drugs and is critical for immune recognition and activation, and therefore has been the subject of numerous investigations (<xref ref-type="bibr" rid="bib51">Gow et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Garcia-Rubio et al., 2020</xref>). However, this polysaccharide has been neglected, perhaps because its analysis requires bespoke methodologies. Here, we established new biochemical tools for quantitative and comparative analysis of cell wall β-1,6-glucan dynamics and structure in <italic>C. albicans</italic> and used them to demonstrate that this polysaccharide is instrumental in determining the gross architecture of the fungal wall and its immune reactivity.</p><p>In SD medium at 37°C, β-1,6-glucan represents 23% of the total cell wall, with an average size of 58 kDa (<xref ref-type="fig" rid="fig1">Figure 1</xref>). From our analytical data on <italic>C. albicans</italic> cell wall, we proposed an updated model underlining the true role of β-1,6-glucan as a major cell wall component (<xref ref-type="fig" rid="fig7">Figure 7a</xref>). NMR has demonstrated that the structure of β-1,6-glucan in the yeast cell wall is similar between species (<xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>; <xref ref-type="bibr" rid="bib112">Stalhberger et al., 2014</xref>), but there are variations in β-1,6-glucan content, chain length, and branching. <italic>Malassezia restricta</italic> contains long β-1,6-glucan chains, averaging 80 kDa, whilst in <italic>S. cerevisiae</italic> and <italic>C. albicans</italic> they are moderate in size (30–60 kDa). We showed here that modulating environmental conditions induce significant changes in both cell wall structure and content. As described previously, lactate used as the sole carbon source led to a thinner inner cell wall layer and greater exposure of β-1,3-glucan (<xref ref-type="bibr" rid="bib38">Ene et al., 2012</xref>; <xref ref-type="bibr" rid="bib5">Ballou et al., 2016</xref>). We observe here that lactate medium also led to a marked reduction in cell wall β-1,6-glucan content and chain length (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig7">Figure 7b</xref>). Our data showed that several factors related to host niches (morphology, temperature, salinity, pH, and presence of organic acids) and the presence of antifungals had a significant impact on the structure, size, and branching of β-1,6-glucan (<xref ref-type="fig" rid="fig7">Figure 7b</xref>). This dynamic nature of the β-1,6-glucan component of the wall (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) is as important as the regulation and structural diversity of chitin, mannan, and β-1,3-glucan (<xref ref-type="bibr" rid="bib53">Gow and Lenardon, 2023</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>β-1,6-Glucan in <italic>C</italic>. <italic>albicans</italic> is a major and dynamic cell wall polymer.</title><p>(<bold>a</bold>) Scheme of the cell wall of <italic>C. albicans</italic>. The proportion of each cell wall polymer was representative of the results obtained on <italic>C. albicans</italic> SC5314 grown in liquid synthetic dextrose (SD) medium at 37°C. (<bold>b</bold>) Scheme representing the dynamic of β-1,6-glucan under different environmental factors. (<bold>c</bold>) β-1,6-Glucan is a compensatory pathway for mannan elongation defect. (<bold>d</bold>) β-1,6-Glucan is a PAMP. (<bold>e</bold>) Scheme of the cell wall of <italic>KRE6</italic> family deficient mutant. Created with <ext-link ext-link-type="uri" xlink:href="https://biorender.com/j31b325">BioRender.com</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>A model for β-1,6-glucan biosynthetic pathway and putative role of Kre6 family members in this process in yeast.</title><p>The cellular location of β-1,6-glucan synthesis in yeast is still unknown. We assume that synthesis begins intracellularly with the polymerization of linear β-1,6-glucan chain (step 1), which requires a β-glucosyltransferase and UDP-glucose as a donor (<xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>; <xref ref-type="bibr" rid="bib118">Vink et al., 2004</xref>) and a putative acceptor (sugar, protein, lipid). Our data (<xref ref-type="fig" rid="fig3">Figure 3g</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>) suggest that Kre6 and its homologs (Kre62, Skn1, Skn2) act at this stage, but their function remains unknown. Two proposed hypotheses are (1) Kre6 family members are β-glucosyltransferases and (2) they have glycosylhydrolase and transglycosidase activity essential for polymerization. Step 2 is the branching of nascent β-1,6-glucan where glucosides and laminaribiosides are added to form side chains. The enzymes (β-glucosyltransferase or transglycosidase) involved in this branching remain unknown. According to our data, members of the Kre6 family are not involved in branching (<xref ref-type="fig" rid="fig3">Figure 3i</xref>). Next, the polysaccharide is secreted (step 3) and then cross-linked to β-1,3-glucans in the cell wall space by an unknown transglycosidase (step 4). The transfer of GPI-anchored proteins onto β-1,6-glucan (step 5), leading to the formation of the outer layer of the cell wall, appears to be driven by Dfg5/Dcw1 (<xref ref-type="bibr" rid="bib119">Vogt et al., 2020</xref>). The chronology between these two cross-links (steps 4 and 5) has not been established. Created with <ext-link ext-link-type="uri" xlink:href="https://biorender.com/q54j043">BioRender.com</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100569-fig7-figsupp1-v1.tif"/></fig></fig-group><p>The dynamic regulation of mannan biosynthesis leading to structural changes in the outer mannoprotein layer of <italic>C. albicans</italic> is also under-investigated. <italic>C. albicans</italic> evolves in different environments as a commensal or pathogen (<xref ref-type="bibr" rid="bib34">d’Enfert et al., 2021</xref>), mainly in the gut, oral cavity, genital tract, and blood. How fungal cell walls adapt to changing environments was recently been listed as one of the top five unanswered question in fungal cell surface research (<xref ref-type="bibr" rid="bib52">Gow et al., 2023</xref>). Our data demonstrate that in response to several environmental factors β-1,6-glucan and mannan productions are coupled. The in vivo importance of this novel dynamic process remains to be addressed but it could be critical in the articulation of host inflammatory responses (<xref ref-type="bibr" rid="bib32">de Assis et al., 2022</xref>; <xref ref-type="bibr" rid="bib26">Chen et al., 2022</xref>).</p><p>Immunolabeling with an anti-β-1,6-glucan serum demonstrated that this polymer is exposed at the cell surface and is therefore accessible to receptors that stimulate human immune cells (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5</xref>, <xref ref-type="fig" rid="fig6">Figure 6</xref>). Similarly in <italic>Pneumocystis carinii</italic>, β-1,6-glucans are exposed to the cell surface and stimulate mouse macrophages, leading to the release of TNF-α (<xref ref-type="bibr" rid="bib69">Kottom et al., 2015</xref>). Our immunological data indicate that β-1,6-glucan is a bona fide fungal cell wall PAMP that activates the human immune system (<xref ref-type="fig" rid="fig7">Figure 7d</xref>). Beads coated with pustulan (an insoluble linear form of β-1,6-glucan) activate neutrophils and induce massive ROS production and phagocytosis in a dectin-1-independent manner (<xref ref-type="bibr" rid="bib102">Rubin-Bejerano et al., 2007</xref>; <xref ref-type="bibr" rid="bib96">Palma et al., 2006</xref>). We observed that the absence of human serum in the culture medium led to a strong reduction in β-1,6-glucan-induced cytokine secretion from PBMCs and that β-1,6-glucan bind to C3b (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>). These data are in agreement with the binding of pustulan to C3b/C3d, as described previously (<xref ref-type="bibr" rid="bib102">Rubin-Bejerano et al., 2007</xref>; <xref ref-type="bibr" rid="bib96">Palma et al., 2006</xref>). This allows us to assume that the opsonization by complement component C3 could partially mediate the recognition of β-1,6-glucan by immune cells, but needs to be validated experimentally. We observed that the size of soluble β-1,6-glucan did not alter immune stimulation in vitro (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), whereas, despite its ability to bind soluble and particulate β-1,3-glucan polymers, Dectin-1 signaling is only activated by particulate β-1,3-glucans (<xref ref-type="bibr" rid="bib47">Goodridge et al., 2011</xref>). The relevance of fungal β-1,6-glucan to the global host immune response and mechanism of recognition remains to be investigated.</p><p>In <italic>C. albicans</italic>, β-1,3-glucan exposure is regulated by external signals such as hypoxia, carbon source, or iron deprivation via the upregulation of β-1,3-glucanase activities that lead to β-1,3-glucan masking and immune evasion (<xref ref-type="bibr" rid="bib32">de Assis et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Childers et al., 2020b</xref>; <xref ref-type="bibr" rid="bib128">Yang et al., 2022</xref>). Regulation of the mechanisms determining β-1,6-glucan exposure and the expression of secreted glucanases remain also unknown in <italic>C. albicans</italic>. The absence of β-1,6-glucan in the AI fraction led to a reduced inflammatory response (<xref ref-type="fig" rid="fig6">Figure 6</xref>), suggesting that an endo-β-1,3-glucanase, such as Eng1, may enable the release of cross-linked β-1,6-glucan from the cell surface, which could attenuate the host response by pruning β-1,6-glucans that are covalently bound to β-1,3-glucans from the surface (<xref ref-type="bibr" rid="bib128">Yang et al., 2022</xref>).</p><p>Cell wall organization in <italic>C. albicans</italic> depends on the cross-linking of all polymers that function as a dynamic flexible network (<xref ref-type="bibr" rid="bib51">Gow et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Garcia-Rubio et al., 2020</xref>). Their interconnectedness means that alteration in the synthesis of one polymer can lead to a compensatory change and cell wall remodeling. Our data provides one new example of this phenomenon, namely decrease in cell wall chitin content results in an increase in both β-1,3-glucans and β-1,6-glucans in the AS fraction of the wall. Chitin exists in the yeast cell wall in three forms: free (~40%), and cross-linked to β-1,3-glucan (40–45%) or β-1,6-glucan (15–20%) and cross-linked β-glucan-chitin forms the core fibrillar cell wall structure resistant to alkali solubilization (<xref ref-type="bibr" rid="bib51">Gow et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Cabib, 2009</xref>; <xref ref-type="bibr" rid="bib16">Cabib and Durán, 2005</xref>; <xref ref-type="bibr" rid="bib17">Cabib et al., 2007</xref>). Therefore, a decrease in the chitin content might reduce the formation of fibrillar structure, thereby releasing the β-glucan contents into the AS fraction. On the other hand, in the <italic>FKS1</italic> mutant or upon caspofungin treatment, cell wall chitin and β-glucan-chitin contents were increased, which could be attributed to an upregulated <italic>CRH1</italic> expression due to decreased β-1,3-glucan synthesis as in <italic>FKS1</italic> mutant (<xref ref-type="bibr" rid="bib115">Terashima et al., 2000</xref>) or due to caspofungin treatment. <italic>CRH</italic> family members are involved in the β-glucan-chitin cross-linking (<xref ref-type="bibr" rid="bib18">Cabib, 2009</xref>). Interestingly, defects in the expression of <italic>CHS1</italic> that encodes an essential chitin synthase required to construct the primary septum were also compensated by an increased content of cell wall β-1,6-glucan but not of β-1,3-glucan (<xref ref-type="fig" rid="fig3">Figure 3</xref>). This suggests that Chs1 has other functions beyond septum construction that had previously been suggested by loss of cell integrity and swelling of cells upon <italic>CHS1</italic> repression (<xref ref-type="bibr" rid="bib90">Munro et al., 2001</xref>). In <italic>S. cerevisiae</italic>, deletion of <italic>GAS1</italic>, the ortholog of <italic>PHR1</italic> and <italic>PHR2</italic>, led to a strong decrease in cross-linked β-1,6-glucan to β-1,3-glucan-chitin cell wall core (<xref ref-type="bibr" rid="bib3">Aimanianda et al., 2017</xref>). Deletions of <italic>PHR1</italic> and <italic>PHR2</italic>, holding a β-1,3-glucan remodeling activity, led to an increased chitin content (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) and a reduction in β-1,3-glucan branching (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). However, a decrease in β-1,6-glucan content and β-1,6-glucan size was only observed in the <italic>PHR2</italic> mutant (<xref ref-type="fig" rid="fig3">Figure 3</xref>). As <italic>PHR1</italic> and <italic>PHR2</italic> genes are strongly regulated by external pH, the compensatory differences we described may be explained by pH-dependent regulation of β-1,6-glucan synthesis (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>In <italic>C. albicans</italic>, the mannan moieties of glycoproteins are covalently cross-linked to the β-glucan-chitin core. Mutants defective in <italic>N</italic>-mannan elongation led to a marked increase in β-1,6-glucan content and size (<xref ref-type="fig" rid="fig3">Figure 3</xref>). In yeast, Och1 and Mnn9 are α-1,6-mannosyltransferases that are involved in initial steps of α-1,6-mannan polymerization in the Golgi. Members of the Mnn2 α-1,2 mannosyltransferases are required for the addition of the side chains of the α-1,6-mannan backbone (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>). Mutants in these genes led to defects in the outer fibrillar layer (<xref ref-type="bibr" rid="bib76">Lenardon et al., 2020</xref>; <xref ref-type="bibr" rid="bib111">Southard et al., 1999</xref>) and increased β-1,3-glucan exposure (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>; <xref ref-type="bibr" rid="bib127">Yadav et al., 2020</xref>). The quantification of β-1,6-glucan content in these <italic>N</italic>-mannan-deficient mutants had not been described previously in <italic>C. albicans</italic> (<xref ref-type="bibr" rid="bib56">Hall and Gow, 2013</xref>; <xref ref-type="bibr" rid="bib111">Southard et al., 1999</xref>) and underline the new finding that the regulation of mannan, β-glucans, and chitin synthesis is coordinated and coupled. Screening with K1 toxin killer revealed a hypersensitivity of the Sc<italic>mnn9</italic> mutant and an increase in β-1,6-glucan cell wall content (<xref ref-type="bibr" rid="bib95">Pagé et al., 2003</xref>), reinforcing the hypothesis that β-1,6-glucans play a compensatory role when <italic>N</italic>-mannosylation is compromised (<xref ref-type="fig" rid="fig7">Figure 7c</xref>). Thus, a defect in the fibrillar outer mannan layer led to an increase in the inner cell wall chitin and β-1,6-glucan contents (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), suggesting that their synthesis was regulated by a rescue mechanism associated with the reprogramming of specific transcriptional responses via the cell wall integrity (CWI) pathway (<xref ref-type="bibr" rid="bib27">Childers et al., 2020a</xref>). Defects in <italic>O</italic>-mannosylation also affected β-1,6-glucan synthesis, leading to shortened highly branched β-1,6-glucan chains, without significant changes in overall cell wall composition, suggesting a specific inhibition of the elongation of β-1,6-glucan chain and showing that size and branching of β-1,6-glucan can be regulated independently (<xref ref-type="fig" rid="fig7">Figure 7c</xref>).</p><p>Fine details of the biosynthetic pathway of yeast β-1,6-glucans are not clear. In <italic>S. cerevisiae</italic>, deletion of <italic>KRE5</italic> and <italic>ROT2</italic> led to a reduction in cell wall β-1,6-glucans (<xref ref-type="bibr" rid="bib109">Shahinian and Bussey, 2000</xref>). In <italic>C. albicans</italic>, this reduction is characterized by the presence of short seldom-branched β-1,6-glucan chains (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Although no difference was observed in the <italic>CWH41</italic> mutant, our data imply that canonical <italic>N</italic>-glycan processing in the ER is required for complete β-1,6-glucan synthesis (<xref ref-type="bibr" rid="bib95">Pagé et al., 2003</xref><italic>),</italic> and that Kre5p is not the β-1,6-glucan polymerase (<xref ref-type="bibr" rid="bib60">Herrero et al., 2004</xref>). Furthermore, our results confirm that the β-1,6-glucan biosynthetic pathway is similar in these phylogenetically distant yeasts, and that the <italic>N</italic>-glycosylation pathway is critical for β-1,6-glucan synthesis. Defects in early <italic>N</italic>-glycan synthesis at the ER level led to concomitant defects in β-1,6-glucan synthesis while defects in <italic>N</italic>-mannan elongation led to increased β-1,6-glucan synthesis. However, as Kre5, Rot2, and Cwh41 are part of the calnexin cycle involved in the control of N-glycoprotein folding in the ER, early N-glycan synthesis may have an indirect effect in ensuring the functionality of the enzymes rather than the synthesis of N-glycan moiety required for β-1,6-glucan synthesis. Our hypothesis is that this biosynthesis begins intracellularly. According to in vitro systems in <italic>S. cerevisiae</italic>, the initial step is the polymerization of a linear chain by a β-glucosyltransferase using UDP-glucose as the sugar donor (<xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>; <xref ref-type="bibr" rid="bib118">Vink et al., 2004</xref>) and probably an as yet unknown acceptor (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). The second step would be the addition of glucoside and laminaribioside as a side chain. Finally, after release into the cell wall, β-1,6-glucan will be cross-linked to the other cell wall polymers. Among the <italic>KRE</italic> genes, only <italic>KRE6</italic> may be directly involved in β-1,6-glucan synthesis. Kre6 and its homologs contain a β-glycosyl-hydrolase domain of the GH-16 family, which includes a large number of fungal enzymes such as Crh1 homologs that are involved in the cross-linking of chitin and β-1,3-glucan (<xref ref-type="bibr" rid="bib18">Cabib, 2009</xref>). In <italic>C. albicans</italic>, the quadruple deletion of <italic>KRE6</italic>, <italic>SKN1</italic>, <italic>SKN2,</italic> and <italic>KRE62</italic> led to the complete absence of β-1,6-glucan in the cell wall (<xref ref-type="fig" rid="fig3">Figures 3 and</xref> <xref ref-type="fig" rid="fig7">7e</xref>) but also in culture supernatants and in intracellular extracts (not shown), demonstrating a stop of β-1,6-glucan synthesis rather than miss-localization. The absence of β-1,6-glucan in the quadruple mutant led to global cell wall remodeling and the absence of the outer fibrillar <italic>N</italic>-mannan layer (<xref ref-type="fig" rid="fig5">Figures 5 and</xref> <xref ref-type="fig" rid="fig7">7e</xref>). Kre6 had the dominant role and its absence led to a hypersensitivity to cell wall-targeting antifungal drugs (<xref ref-type="bibr" rid="bib86">Mio et al., 1997</xref>; <xref ref-type="bibr" rid="bib59">Han et al., 2019b</xref>). One exception was observed for caspofungin, which enhanced the growth of all <italic>KRE6</italic> deleted mutants (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). Growth above the MIC (paradoxical growth) has been described at high caspofungin concentrations and is associated with high chitin content (<xref ref-type="bibr" rid="bib58">Han et al., 2019a</xref>; <xref ref-type="bibr" rid="bib103">Rueda et al., 2014</xref>) as observed in these mutants. Our data show that Kre6 is required for the production of normal amounts of β-1,6-glucan and that the remaining β-1,6-glucans present in <italic>kre6</italic>Δ/Δ was composed of short and highly branched chains. This suggests that the Kre6 family is required for the polymerization and/or elongation of β-1,6-glucan, but not glucan branching.</p><p>In <italic>S. cerevisiae</italic>, only two <italic>KRE6</italic> family members have been identified, Kre6 and Skn1, and their absence led to strong growth defects and hypersensitivity to cell wall perturbing agents – similar to what we observed here in <italic>C. albicans</italic> (<xref ref-type="bibr" rid="bib100">Roemer et al., 1993</xref>). In <italic>C. neoformans</italic>, among the six <italic>KRE6</italic> homologs, <italic>KRE6</italic> and <italic>SKN1</italic> are required for the production of cell wall β-1,6-glucan (<xref ref-type="bibr" rid="bib46">Gilbert et al., 2010</xref>), and although the <italic>KRE6</italic> family is essential for β-1,6-glucan synthesis, its biochemical function remains unknown. Kre6 homologs are type II membrane proteins with a GH-16 domain at the luminal C-terminus and an unfolded cytosolic <italic>N</italic>-terminal tail (<xref ref-type="bibr" rid="bib72">Kurita et al., 2011</xref>). Yeast Kre6 and Skn1 proteins have moderate similarity with diatom TGS (1,6-β-transglycosylase) proteins (<xref ref-type="bibr" rid="bib70">Kroth et al., 2008</xref>; <xref ref-type="bibr" rid="bib62">Huang et al., 2016</xref>) and can synthesize glucan from UDP-Glc (<xref ref-type="bibr" rid="bib63">Inukai et al., 2023</xref>). Kre6 homologs share structural similarities with β-glucanases and β-transglycosylases, arguing for a possible cell wall remodeling function. In <italic>S. cerevisiae</italic>, Kre6p has been localized in the endoplasmic reticulum, the plasma membrane, and secretory vesicle-like compartments (<xref ref-type="bibr" rid="bib109">Shahinian and Bussey, 2000</xref>; <xref ref-type="bibr" rid="bib72">Kurita et al., 2011</xref>; <xref ref-type="bibr" rid="bib73">Kurita et al., 2012</xref>), and the cytosol tail was shown to be essential for the correct cellular localization and β-1,6-glucan synthesis (<xref ref-type="bibr" rid="bib72">Kurita et al., 2011</xref>). Surprisingly, in <italic>C. albicans</italic> the cytosol tail is not essential (<xref ref-type="bibr" rid="bib59">Han et al., 2019b</xref>), suggesting some functional differences of this protein in these yeasts. In <italic>C. albicans</italic>, the double <italic>KRE6/SKN1</italic> mutant is avirulent in a mice model of candidiasis (<xref ref-type="bibr" rid="bib59">Han et al., 2019b</xref>), showing that the β-1,6-glucan biosynthetic pathway is a potential virulence target. However, the drugs jervine (steroidal alkaloid) and a pyridobenzimidazole derivate (D75-4590), which may target Kre6 and inhibit <italic>S. cerevisiae</italic> growth (<xref ref-type="bibr" rid="bib71">Kubo et al., 2022</xref>; <xref ref-type="bibr" rid="bib66">Kitamura et al., 2009</xref>), had no effect on <italic>C. albicans</italic> (<xref ref-type="bibr" rid="bib71">Kubo et al., 2022</xref>; <xref ref-type="bibr" rid="bib66">Kitamura et al., 2009</xref>), presumably representing species-specific differences in drug profiles. Kre6 family members are present in all fungal pathogens producing cell wall β-1,6-glucans, and further investigations are required to understand the enzyme activities and the diversity of structures related to the potential drug targeting of these proteins.</p><p>Overall, this work highlights the central role that β-1,6-glucan plays in orchestrating cell wall synthesis during growth and in response to stress and sets the focus for further work that can exploit this central role in mitigating fungal infections.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Strains and growth conditions</title><p>The <italic>C. albicans</italic> strains used in this study are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. The reference strain SC5314, used for all stress conditions, was grown overnight in 25 mL flasks, at 37°C, 180 rpm, in SD medium (2% glucose, 0.67% yeast nitrogen base with amino acids [YNB] [BD], pH 5.4). Overnight cultures were diluted to an OD<sub>600</sub> = 0.001, in 50 mL fresh SD medium, incubated at 37°C, 180 rpm, and then harvested either when reaching mid-exponential phase (OD<sub>600</sub> 3–5) or at stationary phase (OD<sub>600</sub> 11–12 after 30 hr). The following growth conditions were selected: hypha induction (SD containing 2% GlcNAc instead of 2% glucose, pH 7.2, no yeast form was observed in this medium), temperature (30°C), osmolarity (1 M NaCl), carbon source (SD containing 2% lactate [ChemCruz] instead of 2% glucose), oxygen limitation (hypoxia: 1% O<sub>2</sub>, 5% CO<sub>2</sub>, anaerobic chamber [Baker Ruskinn, I-CONIC, Bugbox M]), and oxidative stress (H<sub>2</sub>O<sub>2</sub> 1.5 mM, Prolabo). For studies of the effect of medium pH, SD medium was buffered with 100 mM MES (Sigma) at pH 4 or 5.4 or with MOPS (Sigma) at pH 7.5. For experiments on the effects of short-chain fatty acids (SCFAs), SD medium was supplemented with 100 mM MES and 50 mM acetate (Sigma) or 20 mM propionate (Sigma) or 15 mM butyrate (Sigma) and buffered to pH 5.4. Drugs were tested at sublethal concentrations: Calcofluor White (CFW, 400 µg/mL, Sigma-Aldrich), Congo Red (CR, 50 µg/mL, Sigma), tunicamycin (0.125 µg/mL, Sigma), nikkomycin (16 µg/mL, Sigma), and caspofungin (0.015 µg/mL, Sigma). Biofilm production was induced in SD medium at 37°C for 48 hr in six-well plates as previously described with some modifications (<xref ref-type="bibr" rid="bib98">Rai et al., 2023</xref>). Overnight cultures were diluted at OD<sub>600</sub> = 0.2 in six-well polystyrene plates (TPP) in 2 mL of minimal medium (SD: 2% glucose, 0.67% yeast nitrogen base without amino acids [BD], pH 5.4) supplemented by arginine 0.1 g/L, histidine 0.1 g/L, uridine 0.02 g/L, and methionine 0.2 g/L. The plates were incubated at 37°C, 60 min at 110 rpm for initial cell adhesion. Then, the plates were washed with 2 mL of fresh medium, and 4 mL of fresh medium was added. Plates were then sealed with Breathseal sealing membranes (Greiner Bio-one) and incubated at 37°C, 110 rpm. After 48 hr, supernatant culture was aspirated, the wells were gently washed with PBS, and biofilm was collected in PBS.</p><p>Cell wall mutant strains were grown at 30°C, 180 rpm, in SD medium supplemented with arginine (100 µg/mL), uridine (100 µg/mL), and histidine (20 µg/mL). The <italic>phr1</italic>Δ/Δ mutant was grown in SD buffered medium at pH 7.5 (with 100 mM MOPS) and the <italic>phr2</italic>Δ/Δ mutant at pH 5.5 (with 100 mM MES). The conditional mutant P<italic><sub>MRP1</sub>-CHS1/chs1</italic>Δ was first precultured in YNB with 2% maltose as a carbon source to allow the <italic>MRP1</italic> promoter expression and then it was grown, as all other mutants, in SD (carbon source glucose), under which condition the promoter is repressed.</p></sec><sec id="s4-2"><title>Cell wall fractionation</title><p>After growth culture, the fungal biomass was collected by centrifugation (5 min, 3300 × <italic>g</italic>), washed, and disrupted in 200 mM Tris-HCl pH 8 using a cell disruptor (FastPrep, MPbio, six cycles, 6 m/s, 60 s) with 0.3 mm glass beads (Braun). The cell wall was collected by centrifugation (5 min, 3300 × <italic>g</italic>), washed twice with 200 mM Tris-HCl, pH 8, then twice with milliQ water and freeze-dried. The wall polymers were then fractionated as previously described (<xref ref-type="bibr" rid="bib81">Liu et al., 2023</xref>). Briefly, noncovalently bound proteins were extracted by the following treatment: dried cell wall was treated twice in 50 mM Tris-HCl, 50 mM EDTA, pH 7.5, 2% SDS, 40 mM β-mercaptoethanol in boiling water for 10 min (10–20 mg of cell wall/mL). After centrifugation (10 min, 3300 × <italic>g</italic>), three volumes of ethanol were added to the supernatant and kept overnight at +4°C. The precipitate (SDS-β-ME fraction) was collected by centrifugation (10 min, 3300 × <italic>g</italic>) and dialyzed against water before freeze-drying. Other cell wall pellet was washed three times with 150 mM NaCl and extracted twice with a 1 M NaOH containing 1 mg/mL BH<sub>4</sub>Na (Sigma), at 10–20 mg of cell wall/mL at 65°C for 1 hr. After centrifugation (10 min, 3300 × <italic>g</italic>), the alkali-soluble extract (AS fraction, supernatant) was neutralized with acetic acid, extensively dialyzed against water, and freeze-dried. The alkali-insoluble fraction (AI fraction, pellet) was washed three times with distilled water and freeze-dried. Of note, the cell disruption was a key step to remove glycogen from cell wall extracts (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p></sec><sec id="s4-3"><title>Cell wall polymers quantification</title><p>Cell wall polymers of the three cell wall fractions (SDS-β-ME, AI, and AS fractions) were quantified as previously described (<xref ref-type="bibr" rid="bib81">Liu et al., 2023</xref>). Briefly, total neutral sugars were quantified by the phenol-sulfuric acid colorimetric assay using glucose as a standard (<xref ref-type="bibr" rid="bib36">DuBois et al., 1956</xref>). Proteins were quantified by colorimetry using the Pierce BCA Protein Assay Kit (Thermo Scientific) according to the manufacturer’s instructions. Monosaccharides, glucose and mannose, were identified and quantified by gas liquid chromatography (Perichrom) as their alditol acetates obtained after hydrolysis (4 N trifluoroacetic acid [TFA, Sigma], 100°C, 4 hr) (<xref ref-type="bibr" rid="bib106">Sawardeker et al., 1965</xref>). Glucosamine was quantified by HPAEC (Dionex, ICS-3000) on a CarboPAC-PA1 column (Thermo Scientific, 250 mm × 4.6 mm) after acid hydrolysis (6 M HCl, 6 hr, 100°C) using glucosamine as a standard. Samples were eluted at a flow rate of 1 mL/min with 18 mM NaOH for 15 min, then with a linear gradient to 300 mM sodium acetate (AcONa) in 100 mM NaOH for 20 min and finally under isocratic conditions with 300 mM AcONa in 100 mM NaOH for 5 min. The column was equilibrated for 20 min with the initial buffer before injection. Samples were detected on a pulsed electrochemical detector.</p></sec><sec id="s4-4"><title>Quantification of β-1,6-glucan in AI and AS fractions</title><p>To quantify β-1,6-glucan in the AI fraction, a colorimetric assay was used. Oxidation with periodate allows specific degradation of vicinal carbons bearing hydroxyl groups. In the AI fraction, only β-1,6-glucans were sensitive to this treatment, leading to the formation of aldehyde functions, which were quantified in the presence of 4-hydroxybenzhydrazide (PAHBAH) (Sigma) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Oxidation was carried out at 50°C for 6 hr on 100 µL of AI fraction (0.5 mg/mL) with 100 µL of 25 mM <italic>m</italic>-IO<sub>4</sub>Na (Sigma-Aldrich). Excess of reagent was quenched with 100 µL sodium sulfite 200 mM (Sigma). Then, 100 µL of reaction mixture were added to 900 µL of PAHBAH reagent (0.63 g sodium sulfite, 5 mL NaOH 5 M, 5 mL sodium citrate 0.5 M, 5 mL NaCl<sub>2</sub> 0.2 M qsp 100 mL milliQ water, 1 g PAHBAH) and placed in a boiling water bath for 10 min. The quantification of produced aldehyde was measured by the absorbance at 405 nm. Pustulan (linear β-1,6-glucan, Elicityl OligoTech) was used as a standard. The β-1,3-glucan content of the AI fraction was calculated as the total glucose content after subtraction of the amount of β-1,6-glucan.</p><p>The presence of mannan in the AS fraction prevents use of the colorimetric assay of β-1,6-glucan after periodate oxidation. β-1,3-Glucan and β-1,6-glucan of the AS fraction were therefore quantified by enzyme digestion. The AS fraction was digested with the endo-β-1,3-glucanase, LamA (from <italic>Thermotoga neapolitana</italic> expressed in <italic>Escherichia coli</italic>) (<xref ref-type="bibr" rid="bib129">Zverlov et al., 1997</xref>) or with an endo-β-1,6-glucanase (from <italic>Schizosaccharomyces pombe</italic> expressed in <italic>Pichia pastoris</italic>) (<xref ref-type="bibr" rid="bib37">Dueñas-Santero et al., 2010</xref>). Digestions were carried out at 37°C during 24 hr by treating 0.2 mg of AS fraction with 20 µL of LamA (specific activity: 10 µmol eq/min/µL) or 60 µL of the endo-β-1,6-glucanase (specific activity: 3.03 × 10<sup>–6</sup> µmol eq/min/µL), in 50 mM NaOAc, pH 6, in a final volume of 200 µL. Both enzymatic treatments released more than 95% of glucan. Products were quantified by the amount of released reducing sugars using the PAHBAH reagent (<xref ref-type="bibr" rid="bib42">Fontaine et al., 1997</xref>) and identified by HPAEC on a CarboPAC-PA1 column (Thermo Scientific). Soluble and purified β-1,6-glucans from <italic>C. albicans</italic> and a commercial source of laminarin (Sigma) were used as standards. Products from enzymatic digestion were eluted under the following gradient: isocratic step of 98% of eluent A (50 mM NaOH) and 2% of eluent B (500 mM AcONa in 50 mM NaOH) for 2 min, 2–15 min of a linear gradient of AcONa in 50 mM NaOH (2% B to 20% B), 15–20 min of a linear gradient (20% B to 43% B), 20–22 min of a linear gradient (43% B to 100% B), 22–25 min under isocratic conditions with 100% B. The column was equilibrated for 20 min with initial buffer before injection.</p></sec><sec id="s4-5"><title>Structural characterization of β-1,6-glucan</title><p>β-1,6-Glucan are branched by β-1,3-linked glucose or laminaribiose on the main chain (<xref ref-type="bibr" rid="bib64">Iorio et al., 2008</xref>; <xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>). Branching was estimated by enzymatic digestion by an endo-β-1,6-glucanase as previously described (<xref ref-type="bibr" rid="bib2">Aimanianda et al., 2009</xref>). A 0.1 mg sample of the AI fraction was digested for 48 hr at 37°C in a final volume of 100 µL with 30 µL of endo-β-1,6-glucanase in 50 mM sodium acetate, pH 6, 5 mM NaN<sub>3</sub>. Degradation products were analyzed by HPAEC on a CarboPAC-PA1 column as described above. Branching was estimated by the ratio of branched oligosaccharides on total degradation products, to which a coefficient of correction was applied. This coefficient (43.1) was calculated from a branching rate of 6.9% of purified β-1,6-glucan established by NMR (see below and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Branching of β-1,3-glucan was determined in the same way after digestion of the AI fraction with LamA.</p><p>The size of the β-1,6-glucan chain was estimated by gel filtration chromatography. First, β-1,6-glucans were released by incubation at 37°C for 48 hr of the AI fraction (0.5 mg) with LamA (100 µL) in 70 mM sodium acetate, pH 6, 5 mM NaN<sub>3</sub>, in a final volume of 700 µL. After 3 min centrifugation at 12,000 × <italic>g</italic>, the supernatant was concentrated under vacuum (SpeedVac concentrator). Then, the sample was submitted to a gel filtration on a Superdex 200 column (300 × 10 mm, Cytiva), eluted with ammonium acetate 150 mM, pH 4 at a flow rate of 0.2 mL/min. Samples were detected by a refractive index detector (Iota-2, Precision Instruments). The column was calibrated with dextran molecular weight standards (6, 10, 40, 70, and 500 kDa; Sigma-Aldrich, Pharmacia Fine Chemicals).</p></sec><sec id="s4-6"><title>Nuclear magnetic resonance (NMR)</title><p>NMR experiments were recorded at 318.15 K using a Bruker (Billerica, USA) 800 MHz Avance NEO spectrometer with an 18.8 Tesla magnetic field equipped with a cryogenically cooled triple resonance (<sup>1</sup>H,<sup>13</sup>C,<sup>15</sup>N) TCI probe. Spectra were recorded using TopSpin 4.2 (Bruker) and analyzed with CCPNMR Analysis 2.5.2 (<xref ref-type="bibr" rid="bib120">Vranken et al., 2005</xref>). <sup>1</sup>H and <sup>13</sup>C chemical shifts were referenced to external DSS (2,2-dimethyl-2-silapentane-5-sulfonate, sodium salt). After three cycles of exchange (dissolution/lyophilization) against D<sub>2</sub>O, 5 mg of purified polysaccharide were dissolved in 550 µL of D<sub>2</sub>O (99.99% 2 H, Eurisotop, Saclay, France) and placed in a 5 mm tube (Norell HT). Resonance assignment, glycosidic bonds identification, and J coupling determination were achieved following standard procedures from homonuclear <sup>1</sup>H 1D, 2D COSY (<xref ref-type="bibr" rid="bib4">Ancian et al., 1997</xref>), NOESY (<xref ref-type="bibr" rid="bib116">Thrippleton and Keeler, 2003</xref>) (150 ms mixing time), and natural abundance heteronuclear <sup>1</sup>H-<sup>13</sup>C experiments: edited HSQC (<xref ref-type="bibr" rid="bib125">Willker et al., 1993</xref>; <xref ref-type="bibr" rid="bib65">Kay et al., 1992</xref>), CLIP-HSQC (<xref ref-type="bibr" rid="bib39">Enthart et al., 2008</xref>), H2BC (<xref ref-type="bibr" rid="bib94">Nyberg et al., 2005</xref>), HMBC (<xref ref-type="bibr" rid="bib30">Cicero et al., 2001</xref>), and HSQC-TOCSY (<xref ref-type="bibr" rid="bib65">Kay et al., 1992</xref>) (100 ms mixing time). The anomeric configuration of monosaccharide residues was established from the corresponding chemical shifts and <sup>1</sup>JH<sub>1</sub>-C<sub>1</sub> coupling constants obtained from CLIP-HSQC spectra. Glycosidic bonds were identified using HMBC experiments and confirmed with NOESY data. <sup>3</sup>JH<sub>1</sub>-H<sub>2</sub> coupling constants were measured from <sup>1</sup>H 1D spectra. The relative amount of monosaccharide residues was estimated from the integrals on <sup>1</sup>H 1D spectra obtained at 333.15 K using a total recovery delay of 12 s.</p></sec><sec id="s4-7"><title>Transmission electron microscopy</title><p>Cells were grown as described above, and volumes of culture media equivalent to a quantity of cells equivalent to OD<sub>600nm</sub> = 1 were collected and centrifuged 5 min at 3300 × <italic>g</italic>. Cells were chemically fixed at room temperature in the dark for 1 hr with 2.5% glutaraldehyde (Sigma) in fresh culture media (10 mL), washed in 1× PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl<sub>2</sub>, pH 7.3), and centrifugated at low speed. The pellets were then resuspended in a droplet of 1× PHEM buffer and taken up into cellulose capillary tubes. For each strain, the capillaries were cut into 3 mm pieces, placed in 6 mm type A specimen carrier (side 0.2 mm) filled with hexadecen, covered by 6 mm type B (side flat), and frozen with a high-pressure freezing machine (EM ICE, Leica Microsystems) as previously described (<xref ref-type="bibr" rid="bib6">Baquero et al., 2021</xref>). The samples were then freeze-substituted in a mix of 1% OsO4, 5% H<sub>2</sub>O in pure acetone for 24 hr at –90°C, 12 hr at 5°C/hr at –30°C, 12 hr at –30°C, 3 hr at 10°C/h until 0°C and 1 hr at 0°C. All samples were washed in pure acetone and gradually infiltrated under agitation in low-viscosity Spurr resin/acetone mix from 30% to 100%, as previously described (<xref ref-type="bibr" rid="bib55">Hall et al., 2013</xref>). Samples were then embedded in pure Spurr resin (EMS), followed by polymerization for 48 hr at 60°C. Ultrathin sections (70 nm) were cut with a Leica Ultracut S microtome and stained with 4% uranyl acetate and then 3% lead citrate. Transmission electron microscopy (TEM) images were captured with a Tecnai Spirit 120 kV TEM equipped with a bottom-mounted Eagle 4k × 4k camera (FEI, USA). For statistical analysis, internal and external cell wall thickness have been measured (between 37 and 40 measurements, on 7–13 cells per condition) using TEM Imaging and Analysis software (TIA, FEI).</p></sec><sec id="s4-8"><title>Immunolabeling</title><p>Rabbit polyclonal antibodies were produced by ProteoGenix (Schiltigheim, France) using pustulan-conjugated BSA as the antigen. After 7–8 weeks of immunization, the resulting serum was used without antibodies purification. The specificity of serum was tested on pustulan, curdlan, and cell wall AI fractions from <italic>Aspergillus fumigatus</italic> (which did not contain β-1,6-glucan) and <italic>C. albicans</italic> by ELISA (not shown). For immunolabeling of β-1,6-glucans and β-1,3-glucans in the cell wall of <italic>C. albicans</italic>, cells were grown as described above. Then, 1 mL of culture was fixed at ambient temperature in the dark (1–2 hr) with paraformaldehyde 3.8% (PFA, Electron Microscopy Sciences). Cells were then centrifuged 3 min at 8000 × <italic>g</italic> and washed three times with 500 µL PBS. In each step, cells were resuspended vigorously to separate the cells and disperse aggregates. Then, cells were resuspended vigorously in 500 µL of PBS and 5% goat serum (Sigma) and then 20 µL were added to each well of a slide (Diagnostic Microscope Slides, 8-well 6 mm, Thermo Scientific) coated poly-<sc>l</sc>-lysine 0.1% and incubated 1 hr at ambient temperature to permit cell adhesion. Liquid was removed and PBS 1× and 5% goat serum was added again and incubated during 1 hr at ambient temperature. The liquid was aspirated and 20 µL of first antibody was added in PBS 1× and 5% goat serum overnight at 4°C (dilution 1/100 for polyclonal anti-β-1,6-glucan produced in rabbit, 1/250 for monoclonal anti-β-1,3-glucan [named 5H5] produced in mouse and kindly provided by N. Nifantiev) (<xref ref-type="bibr" rid="bib83">Matveev et al., 2019</xref>). Wells were washed three times with PBS 1× and 5% goat serum. The second antibody was then added in PBS 1× and 5% goat serum 1 hr at ambient temperature (dilution 1/200), Alexa Fluor 488 goat anti-mouse IgG [AF488, Molecular Probes] or fluorescein goat anti-rabbit IgG [FITC, Invitrogen]. Wells were washed three times with PBS and 5% (v/v) goat serum and once with PBS. Then, one drop of Fluoromount-G (Invitrogen) was added to each well, wells were covered with a coverslip No. 1.5 (Menzel-Gläser), and polymerization was done during 48 hr. Cells were observed on an EVOS FL microscope (Life Technologies), with a magnification ×100 objective with oil immersion.</p></sec><sec id="s4-9"><title>PBMC and neutrophil isolation, stimulation by parietal fractions, and cytokine quantification</title><p>Human PBMCs from healthy donors were isolated by a density-gradient separation of Ficoll 400 (Eurobio, France). Isolated PBMCs were re-suspended in RPMI 1640 + GlutaMAX medium (Gibco), supplemented by 20% normal human sera (NHS, Normal Human Serum-Pooled, Zenbio) and seeded in each well (100 µL containing 4 × 10<sup>6</sup> cells/mL) of 96-well microtiter plates (TPP). Cell wall fractions suspended in RPMI 1640 + GlutaMAX medium were then added at a final concentration of 25 µg/mL. LPS (Sigma, 0.1 µg/mL) was used as a positive control. After 24 hr incubation at 37°C in a 5% CO<sub>2</sub> chamber (Cytoperm 2, Thermo Fisher Scientific), the culture supernatants were collected and stored at –20°C until further analysis.</p><p>Neutrophils from healthy donors were isolated with EasySep Direct Human Neutrophil Isolation Kit (STEMCELL Technologies) according to the manufacturer’s instructions. Isolated neutrophils were re-suspended in RPMI 1640 + GlutaMAX medium (Gibco) and seeded in each well (100 µL containing 1 × 10<sup>6</sup> cells/mL) of 24-well microtiter plates (TPP). 200 µL of NHS at 3% diluted in RPMI 1640 + GlutaMAX medium were then added. Cell wall fractions suspended in RPMI 1640 + GlutaMAX medium were then added at a final concentration of 25 µg/mL. LPS (0.1 µg/mL) was used as a positive control. After 16 hr incubation at 37°C in a 5% CO<sub>2</sub> chamber (Cytoperm 2, Thermo Fisher Scientific), the culture supernatants were collected and stored at –20°C until further analysis.</p><p>Global cytokines, chemokines, and acute-phase proteins (total 36) present in the supernatants were detected with using Proteome Profiler Human Cytokines Array Kit (R&amp;D Systems) according to the manufacturer’s instructions. Then, the cytokines, chemokines, and acute-phase proteins of interest identified through protein profiler were quantified using DuoSet ELISA kits (R&amp;D Systems) according to the manufacturer’s instructions.</p><p>Native AI and periodate oxidized AI (AI-OxP) fractions and purified β-1,6-glucans from <italic>C. albicans</italic> were used. AI-OxP fraction was generated by the treatment of 40 mg of AI fraction with 100 mM <italic>m</italic>-IO<sub>4</sub>Na (4 mL), 3 days at 4°C. The reaction was stopped by the addition of 200 µL of glycerol, oxidized fraction was washed by centrifugation with water, reduced with BH<sub>4</sub>Na (10 mg/mL in 0.1 mM NaOH, overnight) then submitted to mild acid hydrolysis (AcOH 10% 100°C, 1 hr), and finally washed with water and freeze-dried. Purified β-1,6-glucans were produced by digesting the AI fraction (40 mg) with LamA as described above. LamA was removed by passing the sample through a C-18 SPE cartridge (Sep-Pak classic, Waters) eluted with 5% acetonitrile and 0.1% TFA. Then, samples were purified by gel filtration chromatography (Superdex 200, 60 cm × 16 cm, Cytiva) in ammonium acetate 150 mM, pH 4 at a flow rate of 0.5 mL/min. Samples were detected by a refractive index detector (Iota2, Precision Instruments) and dialyzed against water and then freeze-dried. The fractions were quantified by the phenol-sulfuric acid colorimetric assay as previously described.</p></sec><sec id="s4-10"><title>Complement activation</title><p>Complement activation was done as previously described (<xref ref-type="bibr" rid="bib126">Wong et al., 2020</xref>). Briefly, cell wall fraction from <italic>C. albicans</italic> – AI, AI-OxP, and purified β-1,6-glucans – were coated on 96-well microtiter plates (100 µL/well) at three different concentrations of 50 µg, 25 µg, and 12.5 µg per well in 50 mM bicarbonate buffer, pH 9.6, overnight at ambient temperature. Then, supernatants were discarded and wells were blocked with PBS 1×/BSA 1% for 1 hr at ambient temperature. Then, 8 µL of NHS and 92 µL of Gelatin-Veronal Buffer (GVB, 5 mM barbital, 145 mM NaCl, 0.1% gelatin, pH 7.4) supplemented by MgCl<sub>2</sub> (0.5 mM) and CaCl<sub>2</sub> (0.15 mM) were added, incubated for 1 hr, and then washed three times with PBS 1×/Tween-20 0.05%. Complement activation was measured by quantifying deposited C3b upon adding the wells with mouse monoclonal anti-human C3b antibody (MA1-82814, Thermo Fisher Scientific, diluted 1:1000) diluted in PBS 1×/BSA 1% and incubating 1 hr at ambient temperature, washing the wells with PBS 1×/Tween 20 0.05%, adding the wells with peroxidase-conjugated secondary anti-mouse IgG antibodies (Sigma-Aldrich, diluted 1:1000), and incubating for 1 hr at ambient temperature. After washing, 100 µL of substrate solution (TMB, BioFX; 100 µL/well) was added and the reaction was stopped with 50 µL of 4% H<sub>2</sub>SO<sub>4</sub>. The absorbance was read at 450 nm after subtraction of reference wavelength at 540 nm using microplate reader (Infinite m200 pro, TECAN).</p></sec><sec id="s4-11"><title>Generation of mutants by transient CRISPR/Cas9</title><p>Homozygous null mutants (<italic>kre6</italic>Δ/Δ<italic>; skn1</italic>Δ/Δ; <italic>kre62</italic>Δ/Δ; <italic>skn2</italic>Δ/Δ; <italic>kre6/skn1</italic>Δ/Δ; <italic>kre6/skn1/kre62/skn2</italic>Δ/Δ) were generated in <italic>C. albicans</italic> SC5314 using established transient CRISPR-Cas9 methods (<xref ref-type="bibr" rid="bib121">Vyas et al., 2015</xref>; <xref ref-type="bibr" rid="bib84">Min et al., 2016</xref>). An sgRNA cassette was constructed by PCR, first by synthesizing the SNR52 promoter (using primers SNR52/F and SNR52/R/GOI) and the sgRNA scaffold (with the primers sgRNA/F/GOI and sgRNA/R), using plasmid pV1093 as a template (<xref ref-type="bibr" rid="bib121">Vyas et al., 2015</xref>). These two products were fused by PCR, followed by nested PCR with primers SNR52/N and sgRNA/N. The <italic>CaCAS9</italic> cassette was amplified from the plasmid pV1093 with primers CaCas9/F and CaCas9/R. Repair templates (RT), which contained the <italic>SAT1</italic>-Flipper marker and harbored 80 bp homology to the 5’ and 3’ ends of the target gene, were amplified from pSFS2A (<xref ref-type="bibr" rid="bib99">Reuss et al., 2004</xref>). The RT containing the hygromycin resistance gene <italic>HygB</italic> was amplified from pCrispr-gRNA1/hygR, derived from plasmid pV1090 (<xref ref-type="bibr" rid="bib121">Vyas et al., 2015</xref>) as follows: a <italic>BspHI</italic> fragment carrying the <italic>HygB</italic> marker was cut from pYM70 (<xref ref-type="bibr" rid="bib7">Basso et al., 2010</xref>), the ends filled in with the Klenow enzyme and the fragment ligated into pV1090 digested with <italic>StuI</italic> and <italic>BglII</italic> and treated with the Klenow enzyme. PCR reactions to amplify sgRNA and CaCas9 were carried out using Phusion High-Fidelity DNA polymerase (NEB), and Q5 polymerase (NEB) was used for RT amplification, according to the manufacturer’s instructions. All PCR products were cleaned up and concentrated with NucleoSpin Gel and PCR Clean-up (Macherey-Nagel). PCR products (3 µg of CaCAS9 cassette, 1 µg of sgRNA cassette, and 3 µg of the relevant RT) were transformed into <italic>C. albicans</italic> SC5314 using the lithium acetate method (<xref ref-type="bibr" rid="bib105">Sanglard et al., 1996</xref>). Transformants were selected on YPD containing 150 µg/mL nourseothricin (Jena Bioscience) or YPD with 600 µg/mL hygromycin (Sigma). Disruption of both alleles of the target locus and integration of the RT were confirmed by PCR after DNA extraction (MasterPure Yeast DNA Purification Kit, Biosearch Technologies). The <italic>SAT1</italic> gene was removed with the flipper system. Briefly, the transformants were cultivated overnight in 3 mL YP with 2% maltose at 30°C. Then, the culture was diluted to 250 cells/mL in sterile water and 200 µL were plated on YPD with 25 µg/mL nourseothricin and incubated 1–2 days at 30°C. The smaller colonies were replicated on YPD vs. YPD + 150 µg/mL nourseothricin. Transformants that grew only YPD were checked by PCR using primers Flanking_F/GOI and Flanking_R/GOI. The primers used for the construction and PCR check of these mutants are described in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. Deletions were validated by PCR (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).</p><p>The quadruple mutant <italic>kre6/skn1/kre62/skn2</italic>Δ/Δ was complemented by integrating a StuI-linearized plasmid bearing the <italic>KRE6</italic> gene under the control of the constitutive promoter <italic>ACT1</italic> at the <italic>RPS1</italic> locus. This plasmid was obtained using the Gateway technology (Invitrogen) as described previously (<xref ref-type="bibr" rid="bib25">Chauvel et al., 2023</xref>). <italic>KRE6</italic> was PCR amplified on SC5314 genomic DNA with primers KRE6-FWD and KRE6-REV; the fragment was cloned in pDONR207 (<xref ref-type="bibr" rid="bib24">Chauvel et al., 2012</xref>) with the Invitrogen Gateway BP clonase, and then transferred to the destination vector CIp10-P<italic><sub>ACT1</sub>-SAT1</italic> (<xref ref-type="bibr" rid="bib25">Chauvel et al., 2023</xref>; <xref ref-type="bibr" rid="bib75">Legrand et al., 2018</xref>) using the Invitrogen Gateway LR clonase. Successful cloning into the destination vector was confirmed by sequencing. Transformants were selected on YPD + 100 µg/mL nourseothricin. Plasmid integration at the <italic>RPS1</italic> locus was checked by colony PCR using CIpUL and CIpSAT.</p></sec><sec id="s4-12"><title>Phenotypic analyses</title><p>Kinetic curves were generated in 96-well plate (TPP) in SD medium, 30°C, at initial OD<sub>620 nm</sub> = 0.01 using a Tecan Sunrise absorbance microplate reader. Optical density was measured every 10 min during 80 hr with Magellan Software. Doubling time was calculated from growth curves with GraphPad Prism software by generating a nonlinear regression (logistic curve) to determine the <italic>k</italic> coefficient, and then calculated as doubling time = ln(2)/k.</p><p>Spot test drug sensitivity assays were performed on complete SD medium agar plates containing either Congo Red (50 µg/mL), Calcofluor White (50 µg/mL), tunicamycin (1 µg/mL), nikkomycin (32 µg/mL), or caspofungin (0.5 µg/mL). Cells were precultured for 24 hr in SD medium liquid, 30°C, and then diluted to OD<sub>600 nm</sub> = 1 in sterile water, and then tenfold serially diluted. Samples of 5 µL of each concentration were spotted onto agar plates. Pictures of plates were taken after 24 hr, 48 hr, 72 hr and 6 days with a Phenobooth+Colony counter (Singer Instruments). To observe macroscopic filamentation, 5 µL (OD<sub>600 nm</sub> = 1) were spotted on YNB 2% GlcNAc, buffered at pH 7.2 with 100 mM MOPS agar, at 37°C, for 6 days. Pictures were taken using an iPhone camera.</p><p>To observe hyphal growth, cells were grown overnight in SD liquid 30°C, then diluted to OD<sub>600 nm</sub> = 0.2 in 1 mL of 24-well plate (TPP) and grown for 6 hr either in SD, 30°C (control, no filamentation) or in YNB 2% GlcNAc, buffed at pH 7.2 with 100 mM MOPS, at 37°C (inducing filamentation). Cells were then observed with an Olympus IX 83 microscope, and images were captured with a Hamamatsu ORCA Flash cooled CCD camera using the cellSens imaging software.</p></sec><sec id="s4-13"><title>Statistical analyses</title><p>GraphPad Prism 10 software was used for statistical analyses. Data were generated from at least three independent biological replicates and then expressed as means ± standard deviation. Specific tests are indicated in the figure legends. Normally distributed datasets (QQ plot or Shapiro–Wilk test) were compared with ordinary one-way ANOVA (Dunnett’s or Tukey’s multiple comparisons test) or two-tailed unpaired <italic>t</italic>-test. For immunology data, measurements were paired/dependant as the same donors were exposed to different cell wall fractions, thus we applied the nonparametric test for non-normally distributed data: Friedman test (with Dunn’s multiple comparisons test). p-values&lt;0.05 were considered significant and represented on graphs as follows: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001; ns: nonsignificant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Supervision, Methodology</p></fn><fn fn-type="con" id="con4"><p>Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con7"><p>Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Formal analysis, Supervision, Validation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources, Validation, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human blood samples were taken from healthy donors from Etablissement Français du Sang Trinité (Paris, France) with written and informed consent, as per the guidelines provided by the institutional ethics committee, Institut Pasteur (convention 12/EFS/023).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title><italic>C. albicans</italic> strains used in this study.</title></caption><media xlink:href="elife-100569-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Primers used in this study.</title></caption><media xlink:href="elife-100569-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-100569-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data supporting the findings of this study are available as source data files linked to the corresponding figure or figure supplement.</p></sec><ack id="ack"><title>Acknowledgements</title><p>CB is the recipient of a PhD fellowship from the Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID). We acknowledge support from the French Government’s Investissement d’Avenir program (Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]) and Institut Pasteur from Paris. VA and TF are supported by the Agence Nationale de la Recherche ANR-21-CE17-0032-01, FUNPOLYVAC grant. We thank Romain Laurian and Natacha Sertour for their advice for molecular biology, Cécile Gautier for her advice on Prism software and spotting assays, Catherine Comte, Lucia Oreus, and Jamal Boutchlhit for material availability, and Matt Edmondson for providing <italic>C. albicans</italic> strains. The authors thank Suzan Noble, Mathias Richard, and Neil Gow for the access to their deletion mutant collections. NG acknowledges support of Wellcome Trust Investigator, Collaborative, Equipment, Strategic and Biomedical Resource awards (101873, 200208, 215599, 224323). NG also thanks the MRC (MR/M026663/2) and the MRC Centre for Medical Mycology (MR/N006364/2) for support. This study/research was funded by the National Institute for Health and Care Research (NIHR) Exeter Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The 800-MHz NMR spectrometer of the Institut Pasteur was partially funded by the Région Ile de France (SESAME 2014 NMRCHR grant no. 4014526). CS is grateful for support for equipment from the French Government Programme Investissements d’Avenir France BioImaging (FBI, No. ANR-10-INSB-04-01).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aebi</surname><given-names>M</given-names></name><name><surname>Bernasconi</surname><given-names>R</given-names></name><name><surname>Clerc</surname><given-names>S</given-names></name><name><surname>Molinari</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>N-glycan structures: recognition and processing in the ER</article-title><source>Trends in Biochemical Sciences</source><volume>35</volume><fpage>74</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2009.10.001</pub-id><pub-id pub-id-type="pmid">19853458</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aimanianda</surname><given-names>V</given-names></name><name><surname>Clavaud</surname><given-names>C</given-names></name><name><surname>Simenel</surname><given-names>C</given-names></name><name><surname>Fontaine</surname><given-names>T</given-names></name><name><surname>Delepierre</surname><given-names>M</given-names></name><name><surname>Latgé</surname><given-names>J-P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cell wall beta-(1,6)-glucan of <italic>Saccharomyces cerevisiae</italic>: structural characterization and in situ synthesis</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>13401</fpage><lpage>13412</lpage><pub-id pub-id-type="doi">10.1074/jbc.M807667200</pub-id><pub-id pub-id-type="pmid">19279004</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aimanianda</surname><given-names>V</given-names></name><name><surname>Simenel</surname><given-names>C</given-names></name><name><surname>Garnaud</surname><given-names>C</given-names></name><name><surname>Clavaud</surname><given-names>C</given-names></name><name><surname>Tada</surname><given-names>R</given-names></name><name><surname>Barbin</surname><given-names>L</given-names></name><name><surname>Mouyna</surname><given-names>I</given-names></name><name><surname>Heddergott</surname><given-names>C</given-names></name><name><surname>Popolo</surname><given-names>L</given-names></name><name><surname>Ohya</surname><given-names>Y</given-names></name><name><surname>Delepierre</surname><given-names>M</given-names></name><name><surname>Latge</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The dual activity responsible for the elongation and branching of β-(1,3)-Glucan in the fungal cell wall</article-title><source>mBio</source><volume>8</volume><elocation-id>e00619</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00619-17</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ancian</surname><given-names>B</given-names></name><name><surname>Bourgeois</surname><given-names>I</given-names></name><name><surname>Dauphin</surname><given-names>JF</given-names></name><name><surname>Shaw</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Artifact-free pure absorption PFG-Enhanced DQF-COSY spectra including a gradient pulse in the evolution period</article-title><source>Journal of Magnetic Resonance</source><volume>125</volume><fpage>348</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1006/jmre.1997.1112</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballou</surname><given-names>ER</given-names></name><name><surname>Avelar</surname><given-names>GM</given-names></name><name><surname>Childers</surname><given-names>DS</given-names></name><name><surname>Mackie</surname><given-names>J</given-names></name><name><surname>Bain</surname><given-names>JM</given-names></name><name><surname>Wagener</surname><given-names>J</given-names></name><name><surname>Kastora</surname><given-names>SL</given-names></name><name><surname>Panea</surname><given-names>MD</given-names></name><name><surname>Hardison</surname><given-names>SE</given-names></name><name><surname>Walker</surname><given-names>LA</given-names></name><name><surname>Erwig</surname><given-names>LP</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>MacCallum</surname><given-names>DM</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lactate signalling regulates fungal β-glucan masking and immune evasion</article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>16238</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.238</pub-id><pub-id pub-id-type="pmid">27941860</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baquero</surname><given-names>DP</given-names></name><name><surname>Gazi</surname><given-names>AD</given-names></name><name><surname>Sachse</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Schmitt</surname><given-names>C</given-names></name><name><surname>Moya-Nilges</surname><given-names>M</given-names></name><name><surname>Schouten</surname><given-names>S</given-names></name><name><surname>Prangishvili</surname><given-names>D</given-names></name><name><surname>Krupovic</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A filamentous archaeal virus is enveloped inside the cell and released through pyramidal portals</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2105540118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2105540118</pub-id><pub-id pub-id-type="pmid">34341107</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>LR</given-names><suffix>Jr</suffix></name><name><surname>Bartiss</surname><given-names>A</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Gast</surname><given-names>CE</given-names></name><name><surname>Coelho</surname><given-names>PSR</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Transformation of Candida albicans with a synthetic hygromycin B resistance gene</article-title><source>Yeast</source><volume>27</volume><fpage>1039</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1002/yea.1813</pub-id><pub-id pub-id-type="pmid">20737428</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>PC</given-names></name><name><surname>Calderone</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Chitin synthesis in Candida albicans: comparison of yeast and hyphal forms</article-title><source>Journal of Bacteriology</source><volume>133</volume><fpage>1472</fpage><lpage>1477</lpage><pub-id pub-id-type="doi">10.1128/jb.133.3.1472-1477.1978</pub-id><pub-id pub-id-type="pmid">346576</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breinig</surname><given-names>F</given-names></name><name><surname>Tipper</surname><given-names>DJ</given-names></name><name><surname>Schmitt</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Kre1p, the plasma membrane receptor for the yeast K1 viral toxin</article-title><source>Cell</source><volume>108</volume><fpage>395</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(02)00634-7</pub-id><pub-id pub-id-type="pmid">11853673</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breinig</surname><given-names>F</given-names></name><name><surname>Schleinkofer</surname><given-names>K</given-names></name><name><surname>Schmitt</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Yeast Kre1p is GPI-anchored and involved in both cell wall assembly and architecture</article-title><source>Microbiology</source><volume>150</volume><fpage>3209</fpage><lpage>3218</lpage><pub-id pub-id-type="doi">10.1099/mic.0.27175-0</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JL</given-names></name><name><surname>Kossaczka</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>B</given-names></name><name><surname>Bussey</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A mutational analysis of killer toxin resistance in <italic>Saccharomyces cerevisiae</italic> identifies new genes involved in cell wall (1--&gt;6)-beta-glucan synthesis</article-title><source>Genetics</source><volume>133</volume><fpage>837</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1093/genetics/133.4.837</pub-id><pub-id pub-id-type="pmid">8462845</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Reid</surname><given-names>DM</given-names></name><name><surname>Willment</surname><given-names>JA</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Martinez-Pomares</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>SYC</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dectin-1 is a major beta-glucan receptor on macrophages</article-title><source>The Journal of Experimental Medicine</source><volume>196</volume><fpage>407</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1084/jem.20020470</pub-id><pub-id pub-id-type="pmid">12163569</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Fungal beta-glucans and mammalian immunity</article-title><source>Immunity</source><volume>19</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(03)00233-4</pub-id><pub-id pub-id-type="pmid">14499107</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Innate antifungal immunity: the key role of phagocytes</article-title><source>Annual Review of Immunology</source><volume>29</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-030409-101229</pub-id><pub-id pub-id-type="pmid">20936972</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Denning</surname><given-names>DW</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Levitz</surname><given-names>SM</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>White</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Hidden killers: human fungal infections</article-title><source>Science Translational Medicine</source><volume>4</volume><elocation-id>165rv13</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3004404</pub-id><pub-id pub-id-type="pmid">23253612</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabib</surname><given-names>E</given-names></name><name><surname>Durán</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Synthase III-dependent chitin is bound to different acceptors depending on location on the cell wall of budding yeast</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>9170</fpage><lpage>9179</lpage><pub-id pub-id-type="doi">10.1074/jbc.M414005200</pub-id><pub-id pub-id-type="pmid">15637060</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabib</surname><given-names>E</given-names></name><name><surname>Blanco</surname><given-names>N</given-names></name><name><surname>Grau</surname><given-names>C</given-names></name><name><surname>Rodríguez-Peña</surname><given-names>JM</given-names></name><name><surname>Arroyo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Crh1p and Crh2p are required for the cross-linking of chitin to beta(1-6)glucan in the <italic>Saccharomyces cerevisiae</italic> cell wall</article-title><source>Molecular Microbiology</source><volume>63</volume><fpage>921</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05565.x</pub-id><pub-id pub-id-type="pmid">17302808</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabib</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Two novel techniques for determination of polysaccharide cross-links show that Crh1p and Crh2p attach chitin to both beta(1-6)- and beta(1-3)glucan in the <italic>Saccharomyces cerevisiae</italic> cell wall</article-title><source>Eukaryotic Cell</source><volume>8</volume><fpage>1626</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1128/EC.00228-09</pub-id><pub-id pub-id-type="pmid">19734368</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="web"><person-group person-group-type="author"><collab>CAZy</collab></person-group><year iso-8601-date="2024">2024a</year><article-title>GT24</article-title><ext-link ext-link-type="uri" xlink:href="https://www.cazy.org/GT24.html">https://www.cazy.org/GT24.html</ext-link><date-in-citation iso-8601-date="2024-11-24">November 24, 2024</date-in-citation></element-citation></ref><ref id="bib20"><element-citation publication-type="web"><person-group person-group-type="author"><collab>CAZy</collab></person-group><year iso-8601-date="2024">2024b</year><article-title>GH16</article-title><ext-link ext-link-type="uri" xlink:href="http://www.cazy.org/GH16.html">http://www.cazy.org/GH16.html</ext-link><date-in-citation iso-8601-date="2024-11-24">November 24, 2024</date-in-citation></element-citation></ref><ref id="bib21"><element-citation publication-type="web"><person-group person-group-type="author"><collab>CGD</collab></person-group><year iso-8601-date="2024">2024</year><article-title>Candida Genome Database</article-title><ext-link ext-link-type="uri" xlink:href="http://www.candidagenome.org">http://www.candidagenome.org</ext-link><date-in-citation iso-8601-date="2024-11-27">November 27, 2024</date-in-citation></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaffin</surname><given-names>WL</given-names></name><name><surname>López-Ribot</surname><given-names>JL</given-names></name><name><surname>Casanova</surname><given-names>M</given-names></name><name><surname>Gozalbo</surname><given-names>D</given-names></name><name><surname>Martínez</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Cell wall and secreted proteins of Candida albicans: identification, function, and expression</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>62</volume><fpage>130</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1128/MMBR.62.1.130-180.1998</pub-id><pub-id pub-id-type="pmid">9529890</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>T</given-names></name><name><surname>Kinsman</surname><given-names>O</given-names></name><name><surname>Houston</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Chitin biosynthesis in Candida albicans grown in vitro and in vivo and its inhibition by nikkomycin Z</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>36</volume><fpage>1909</fpage><lpage>1914</lpage><pub-id pub-id-type="doi">10.1128/AAC.36.9.1909</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauvel</surname><given-names>M</given-names></name><name><surname>Nesseir</surname><given-names>A</given-names></name><name><surname>Cabral</surname><given-names>V</given-names></name><name><surname>Znaidi</surname><given-names>S</given-names></name><name><surname>Goyard</surname><given-names>S</given-names></name><name><surname>Bachellier-Bassi</surname><given-names>S</given-names></name><name><surname>Firon</surname><given-names>A</given-names></name><name><surname>Legrand</surname><given-names>M</given-names></name><name><surname>Diogo</surname><given-names>D</given-names></name><name><surname>Naulleau</surname><given-names>C</given-names></name><name><surname>Rossignol</surname><given-names>T</given-names></name><name><surname>d’Enfert</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A versatile overexpression strategy in the pathogenic yeast Candida albicans: identification of regulators of morphogenesis and fitness</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e45912</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0045912</pub-id><pub-id pub-id-type="pmid">23049891</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauvel</surname><given-names>M</given-names></name><name><surname>Bachellier-Bassi</surname><given-names>S</given-names></name><name><surname>Guérout</surname><given-names>A-M</given-names></name><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Maufrais</surname><given-names>C</given-names></name><name><surname>Permal</surname><given-names>E</given-names></name><name><surname>Da Fonseca</surname><given-names>JP</given-names></name><name><surname>Znaidi</surname><given-names>S</given-names></name><name><surname>Mazel</surname><given-names>D</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>d’Enfert</surname><given-names>C</given-names></name><name><surname>Legrand</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>High-throughput functional profiling of the human fungal pathogen Candida albicans genome</article-title><source>Research in Microbiology</source><volume>174</volume><elocation-id>104025</elocation-id><pub-id pub-id-type="doi">10.1016/j.resmic.2022.104025</pub-id><pub-id pub-id-type="pmid">36587858</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Wagner</surname><given-names>AS</given-names></name><name><surname>Reynolds</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>When is it appropriate to take off the mask? signaling pathways that regulate ß(1,3)-glucan exposure in <italic>Candida albicans</italic></article-title><source>Frontiers in Fungal Biology</source><volume>3</volume><elocation-id>842501</elocation-id><pub-id pub-id-type="doi">10.3389/ffunb.2022.842501</pub-id><pub-id pub-id-type="pmid">36908584</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childers</surname><given-names>DS</given-names></name><name><surname>Avelar</surname><given-names>GM</given-names></name><name><surname>Bain</surname><given-names>JM</given-names></name><name><surname>Larcombe</surname><given-names>DE</given-names></name><name><surname>Pradhan</surname><given-names>A</given-names></name><name><surname>Budge</surname><given-names>S</given-names></name><name><surname>Heaney</surname><given-names>H</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Impact of the environment upon the Candida albicans cell wall and resultant effects upon immune surveillance</article-title><source>Current Topics in Microbiology and Immunology</source><volume>425</volume><fpage>297</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1007/82_2019_182</pub-id><pub-id pub-id-type="pmid">31781866</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childers</surname><given-names>DS</given-names></name><name><surname>Avelar</surname><given-names>GM</given-names></name><name><surname>Bain</surname><given-names>JM</given-names></name><name><surname>Pradhan</surname><given-names>A</given-names></name><name><surname>Larcombe</surname><given-names>DE</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Erwig</surname><given-names>LP</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Epitope shaving promotes fungal immune evasion</article-title><source>mBio</source><volume>11</volume><elocation-id>e00984-20</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00984-20</pub-id><pub-id pub-id-type="pmid">32636248</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhury</surname><given-names>QJ</given-names></name><name><surname>Ambati</surname><given-names>S</given-names></name><name><surname>Link</surname><given-names>CD</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Lewis</surname><given-names>ZA</given-names></name><name><surname>Meagher</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Dectin-3-targeted antifungal liposomes efficiently bind and kill diverse fungal pathogens</article-title><source>Molecular Microbiology</source><volume>120</volume><fpage>723</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1111/mmi.15174</pub-id><pub-id pub-id-type="pmid">37800599</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicero</surname><given-names>DO</given-names></name><name><surname>Barbato</surname><given-names>G</given-names></name><name><surname>Bazzo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Sensitivity enhancement of a two-dimensional experiment for the measurement of heteronuclear long-range coupling constants, by a new scheme of coherence selection by gradients</article-title><source>Journal of Magnetic Resonance</source><volume>148</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1006/jmre.2000.2234</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dambuza</surname><given-names>IM</given-names></name><name><surname>Levitz</surname><given-names>SM</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fungal recognition and host defense mechanisms</article-title><source>Microbiology Spectrum</source><volume>5</volume><elocation-id>FUNK-0050-2016</elocation-id><pub-id pub-id-type="doi">10.1128/microbiolspec.FUNK-0050-2016</pub-id><pub-id pub-id-type="pmid">28752813</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Assis</surname><given-names>LJ</given-names></name><name><surname>Bain</surname><given-names>JM</given-names></name><name><surname>Liddle</surname><given-names>C</given-names></name><name><surname>Leaves</surname><given-names>I</given-names></name><name><surname>Hacker</surname><given-names>C</given-names></name><name><surname>Peres da Silva</surname><given-names>R</given-names></name><name><surname>Yuecel</surname><given-names>R</given-names></name><name><surname>Bebes</surname><given-names>A</given-names></name><name><surname>Stead</surname><given-names>D</given-names></name><name><surname>Childers</surname><given-names>DS</given-names></name><name><surname>Pradhan</surname><given-names>A</given-names></name><name><surname>Mackenzie</surname><given-names>K</given-names></name><name><surname>Lagree</surname><given-names>K</given-names></name><name><surname>Larcombe</surname><given-names>DE</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Avelar</surname><given-names>GM</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Erwig</surname><given-names>LP</given-names></name><name><surname>Mitchell</surname><given-names>AP</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Nature of β-1,3-glucan-exposing features on Candida albicans cell wall and their modulation</article-title><source>mBio</source><volume>13</volume><elocation-id>e02605</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.02605-22</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bernardis</surname><given-names>F</given-names></name><name><surname>Mühlschlegel</surname><given-names>FA</given-names></name><name><surname>Cassone</surname><given-names>A</given-names></name><name><surname>Fonzi</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The pH of the host niche controls gene expression in and virulence of Candida albicans</article-title><source>Infection and Immunity</source><volume>66</volume><fpage>3317</fpage><lpage>3325</lpage><pub-id pub-id-type="doi">10.1128/IAI.66.7.3317-3325.1998</pub-id><pub-id pub-id-type="pmid">9632601</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>d’Enfert</surname><given-names>C</given-names></name><name><surname>Kaune</surname><given-names>A-K</given-names></name><name><surname>Alaban</surname><given-names>L-R</given-names></name><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Cole</surname><given-names>N</given-names></name><name><surname>Delavy</surname><given-names>M</given-names></name><name><surname>Kosmala</surname><given-names>D</given-names></name><name><surname>Marsaux</surname><given-names>B</given-names></name><name><surname>Fróis-Martins</surname><given-names>R</given-names></name><name><surname>Morelli</surname><given-names>M</given-names></name><name><surname>Rosati</surname><given-names>D</given-names></name><name><surname>Valentine</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Emritloll</surname><given-names>Y</given-names></name><name><surname>Warn</surname><given-names>PA</given-names></name><name><surname>Bequet</surname><given-names>F</given-names></name><name><surname>Bougnoux</surname><given-names>M-E</given-names></name><name><surname>Bornes</surname><given-names>S</given-names></name><name><surname>Gresnigt</surname><given-names>MS</given-names></name><name><surname>Hube</surname><given-names>B</given-names></name><name><surname>Jacobsen</surname><given-names>ID</given-names></name><name><surname>Legrand</surname><given-names>M</given-names></name><name><surname>Leibundgut-Landmann</surname><given-names>S</given-names></name><name><surname>Manichanh</surname><given-names>C</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Queiroz</surname><given-names>K</given-names></name><name><surname>Roget</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>V</given-names></name><name><surname>Thoral</surname><given-names>C</given-names></name><name><surname>Van den Abbeele</surname><given-names>P</given-names></name><name><surname>Walker</surname><given-names>AW</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives</article-title><source>FEMS Microbiology Reviews</source><volume>45</volume><elocation-id>fuaa060</elocation-id><pub-id pub-id-type="doi">10.1093/femsre/fuaa060</pub-id><pub-id pub-id-type="pmid">33232448</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denning</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Global incidence and mortality of severe fungal disease</article-title><source>The Lancet. Infectious Diseases</source><volume>24</volume><fpage>e428</fpage><lpage>e438</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(23)00692-8</pub-id><pub-id pub-id-type="pmid">38224705</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DuBois</surname><given-names>M</given-names></name><name><surname>Gilles</surname><given-names>KA</given-names></name><name><surname>Hamilton</surname><given-names>JK</given-names></name><name><surname>Rebers</surname><given-names>PA</given-names></name><name><surname>Smith</surname><given-names>Fred</given-names></name></person-group><year iso-8601-date="1956">1956</year><article-title>Colorimetric method for determination of sugars and related substances</article-title><source>Analytical Chemistry</source><volume>28</volume><fpage>350</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1021/ac60111a017</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dueñas-Santero</surname><given-names>E</given-names></name><name><surname>Martín-Cuadrado</surname><given-names>AB</given-names></name><name><surname>Fontaine</surname><given-names>T</given-names></name><name><surname>Latgé</surname><given-names>J-P</given-names></name><name><surname>del Rey</surname><given-names>F</given-names></name><name><surname>Vázquez de Aldana</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Characterization of glycoside hydrolase family 5 proteins in <italic>Schizosaccharomyces pombe</italic></article-title><source>Eukaryotic Cell</source><volume>9</volume><fpage>1650</fpage><lpage>1660</lpage><pub-id pub-id-type="doi">10.1128/EC.00187-10</pub-id><pub-id pub-id-type="pmid">20852022</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ene</surname><given-names>IV</given-names></name><name><surname>Adya</surname><given-names>AK</given-names></name><name><surname>Wehmeier</surname><given-names>S</given-names></name><name><surname>Brand</surname><given-names>AC</given-names></name><name><surname>MacCallum</surname><given-names>DM</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen</article-title><source>Cellular Microbiology</source><volume>14</volume><fpage>1319</fpage><lpage>1335</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2012.01813.x</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enthart</surname><given-names>A</given-names></name><name><surname>Freudenberger</surname><given-names>JC</given-names></name><name><surname>Furrer</surname><given-names>J</given-names></name><name><surname>Kessler</surname><given-names>H</given-names></name><name><surname>Luy</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The CLIP/CLAP-HSQC: pure absorptive spectra for the measurement of one-bond couplings</article-title><source>Journal of Magnetic Resonance</source><volume>192</volume><fpage>314</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.jmr.2008.03.009</pub-id><pub-id pub-id-type="pmid">18411067</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erwig</surname><given-names>LP</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Interactions of fungal pathogens with phagocytes</article-title><source>Nature Reviews. Microbiology</source><volume>14</volume><fpage>163</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2015.21</pub-id><pub-id pub-id-type="pmid">26853116</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferwerda</surname><given-names>B</given-names></name><name><surname>Ferwerda</surname><given-names>G</given-names></name><name><surname>Plantinga</surname><given-names>TS</given-names></name><name><surname>Willment</surname><given-names>JA</given-names></name><name><surname>van Spriel</surname><given-names>AB</given-names></name><name><surname>Venselaar</surname><given-names>H</given-names></name><name><surname>Elbers</surname><given-names>CC</given-names></name><name><surname>Johnson</surname><given-names>MD</given-names></name><name><surname>Cambi</surname><given-names>A</given-names></name><name><surname>Huysamen</surname><given-names>C</given-names></name><name><surname>Jacobs</surname><given-names>L</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>Verheijen</surname><given-names>K</given-names></name><name><surname>Masthoff</surname><given-names>L</given-names></name><name><surname>Morré</surname><given-names>SA</given-names></name><name><surname>Vriend</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Perfect</surname><given-names>JR</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Adema</surname><given-names>GJ</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Human dectin-1 deficiency and mucocutaneous fungal infections</article-title><source>The New England Journal of Medicine</source><volume>361</volume><fpage>1760</fpage><lpage>1767</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0901053</pub-id><pub-id pub-id-type="pmid">19864674</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>T</given-names></name><name><surname>Hartland</surname><given-names>RP</given-names></name><name><surname>Beauvais</surname><given-names>A</given-names></name><name><surname>Diaquin</surname><given-names>M</given-names></name><name><surname>Latge</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Purification and Characterization of an Endo‐1,3‐β‐Glucanase from Aspergillus fumigatus</article-title><source>European Journal of Biochemistry</source><volume>243</volume><fpage>315</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1997.0315a.x</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonzi</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>PHR1 and PHR2 of Candida albicans encode putative glycosidases required for proper cross-linking of beta-1,3- and beta-1,6-glucans</article-title><source>Journal of Bacteriology</source><volume>181</volume><fpage>7070</fpage><lpage>7079</lpage><pub-id pub-id-type="doi">10.1128/JB.181.22.7070-7079.1999</pub-id><pub-id pub-id-type="pmid">10559174</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Free</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fungal cell wall organization and biosynthesis</article-title><source>Advances in Genetics</source><volume>81</volume><fpage>33</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-407677-8.00002-6</pub-id><pub-id pub-id-type="pmid">23419716</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Rubio</surname><given-names>R</given-names></name><name><surname>de Oliveira</surname><given-names>HC</given-names></name><name><surname>Rivera</surname><given-names>J</given-names></name><name><surname>Trevijano-Contador</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The fungal cell wall: candida, cryptococcus, and aspergillus species</article-title><source>Frontiers in Microbiology</source><volume>10</volume><elocation-id>2993</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.02993</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>NM</given-names></name><name><surname>Donlin</surname><given-names>MJ</given-names></name><name><surname>Gerik</surname><given-names>KJ</given-names></name><name><surname>Specht</surname><given-names>CA</given-names></name><name><surname>Djordjevic</surname><given-names>JT</given-names></name><name><surname>Wilson</surname><given-names>CF</given-names></name><name><surname>Sorrell</surname><given-names>TC</given-names></name><name><surname>Lodge</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>KRE genes are required for beta-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformans</article-title><source>Molecular Microbiology</source><volume>76</volume><fpage>517</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07119.x</pub-id><pub-id pub-id-type="pmid">20384682</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodridge</surname><given-names>HS</given-names></name><name><surname>Reyes</surname><given-names>CN</given-names></name><name><surname>Becker</surname><given-names>CA</given-names></name><name><surname>Katsumoto</surname><given-names>TR</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Bose</surname><given-names>N</given-names></name><name><surname>Chan</surname><given-names>ASH</given-names></name><name><surname>Magee</surname><given-names>AS</given-names></name><name><surname>Danielson</surname><given-names>ME</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name><name><surname>Vasilakos</surname><given-names>JP</given-names></name><name><surname>Underhill</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse.”</article-title><source>Nature</source><volume>472</volume><fpage>471</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1038/nature10071</pub-id><pub-id pub-id-type="pmid">21525931</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>NA</given-names></name><name><surname>Robbins</surname><given-names>PW</given-names></name><name><surname>Lester</surname><given-names>JW</given-names></name><name><surname>Brown</surname><given-names>AJ</given-names></name><name><surname>Fonzi</surname><given-names>WA</given-names></name><name><surname>Chapman</surname><given-names>T</given-names></name><name><surname>Kinsman</surname><given-names>OS</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans</article-title><source>PNAS</source><volume>91</volume><fpage>6216</fpage><lpage>6220</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.13.6216</pub-id><pub-id pub-id-type="pmid">8016141</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Candida albicans morphogenesis and host defence: discriminating invasion from colonization</article-title><source>Nature Reviews. Microbiology</source><volume>10</volume><fpage>112</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2711</pub-id><pub-id pub-id-type="pmid">22158429</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Hube</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Importance of the Candida albicans cell wall during commensalism and infection</article-title><source>Current Opinion in Microbiology</source><volume>15</volume><fpage>406</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2012.04.005</pub-id><pub-id pub-id-type="pmid">22609181</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Latge</surname><given-names>JP</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The fungal cell wall: structure, biosynthesis, and function</article-title><source>Microbiology Spectrum</source><volume>5</volume><elocation-id>FUNK-0035-2016</elocation-id><pub-id pub-id-type="doi">10.1128/microbiolspec.FUNK-0035-2016</pub-id><pub-id pub-id-type="pmid">28513415</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Casadevall</surname><given-names>A</given-names></name><name><surname>Fang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Top five unanswered questions in fungal cell surface research</article-title><source>Cell Surface</source><volume>10</volume><elocation-id>100114</elocation-id><pub-id pub-id-type="doi">10.1016/j.tcsw.2023.100114</pub-id><pub-id pub-id-type="pmid">38024560</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Lenardon</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Architecture of the dynamic fungal cell wall</article-title><source>Nature Reviews. Microbiology</source><volume>21</volume><fpage>248</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1038/s41579-022-00796-9</pub-id><pub-id pub-id-type="pmid">36266346</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graus</surname><given-names>MS</given-names></name><name><surname>Wester</surname><given-names>MJ</given-names></name><name><surname>Lowman</surname><given-names>DW</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Kruppa</surname><given-names>MD</given-names></name><name><surname>Martinez</surname><given-names>CM</given-names></name><name><surname>Young</surname><given-names>JM</given-names></name><name><surname>Pappas</surname><given-names>HC</given-names></name><name><surname>Lidke</surname><given-names>KA</given-names></name><name><surname>Neumann</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mannan molecular substructures control nanoscale glucan exposure in Candida</article-title><source>Cell Reports</source><volume>24</volume><fpage>2432</fpage><lpage>2442</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.088</pub-id><pub-id pub-id-type="pmid">30157435</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>RA</given-names></name><name><surname>Bates</surname><given-names>S</given-names></name><name><surname>Lenardon</surname><given-names>MD</given-names></name><name><surname>Maccallum</surname><given-names>DM</given-names></name><name><surname>Wagener</surname><given-names>J</given-names></name><name><surname>Lowman</surname><given-names>DW</given-names></name><name><surname>Kruppa</surname><given-names>MD</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Odds</surname><given-names>FC</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003276</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003276</pub-id><pub-id pub-id-type="pmid">23633946</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>RA</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mannosylation in Candida albicans: role in cell wall function and immune recognition</article-title><source>Molecular Microbiology</source><volume>90</volume><fpage>1147</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1111/mmi.12426</pub-id><pub-id pub-id-type="pmid">24125554</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dressed to impress: impact of environmental adaptation on the Candida albicans cell wall</article-title><source>Molecular Microbiology</source><volume>97</volume><fpage>7</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1111/mmi.13020</pub-id><pub-id pub-id-type="pmid">25846717</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Elevation of cell wall chitin via Ca<sup>2+</sup> -calcineurin-mediated PKC signaling pathway maintains the viability of Candida albicans in the absence of β-1,6-glucan synthesis</article-title><source>Molecular Microbiology</source><volume>112</volume><fpage>960</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1111/mmi.14335</pub-id><pub-id pub-id-type="pmid">31240791</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Qi</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Yao</surname><given-names>G</given-names></name><name><surname>Mu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Blocking β-1,6-glucan synthesis by deleting KRE6 and SKN1 attenuates the virulence of Candida albicans</article-title><source>Molecular Microbiology</source><volume>111</volume><fpage>604</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1111/mmi.14176</pub-id><pub-id pub-id-type="pmid">30507002</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrero</surname><given-names>AB</given-names></name><name><surname>Magnelli</surname><given-names>P</given-names></name><name><surname>Mansour</surname><given-names>MK</given-names></name><name><surname>Levitz</surname><given-names>SM</given-names></name><name><surname>Bussey</surname><given-names>H</given-names></name><name><surname>Abeijon</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties</article-title><source>Eukaryotic Cell</source><volume>3</volume><fpage>1423</fpage><lpage>1432</lpage><pub-id pub-id-type="doi">10.1128/EC.3.6.1423-1432.2004</pub-id><pub-id pub-id-type="pmid">15590817</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopke</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Hall</surname><given-names>RA</given-names></name><name><surname>Wheeler</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dynamic fungal cell wall architecture in stress adaptation and immune evasion</article-title><source>Trends in Microbiology</source><volume>26</volume><fpage>284</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2018.01.007</pub-id><pub-id pub-id-type="pmid">29452950</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Río Bártulos</surname><given-names>C</given-names></name><name><surname>Kroth</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Diatom vacuolar 1,6‐β‐transglycosylases can functionally complement the respective yeast mutants</article-title><source>Journal of Eukaryotic Microbiology</source><volume>63</volume><fpage>536</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1111/jeu.12298</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inukai</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>N</given-names></name><name><surname>Endo</surname><given-names>H</given-names></name><name><surname>Asakawa</surname><given-names>K</given-names></name><name><surname>Amano</surname><given-names>K</given-names></name><name><surname>Yasuda</surname><given-names>Y</given-names></name><name><surname>Cenci</surname><given-names>U</given-names></name><name><surname>Colleoni</surname><given-names>C</given-names></name><name><surname>Ball</surname><given-names>S</given-names></name><name><surname>Fujiwara</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Kre6 (yeast 1,6-β-transglycosylase) homolog, PhTGS, is essential for β-glucan synthesis in the haptophyte <italic>Pleurochrysis haptonemofera</italic></article-title><source>Frontiers in Bioengineering and Biotechnology</source><volume>11</volume><elocation-id>1259587</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2023.1259587</pub-id><pub-id pub-id-type="pmid">37790259</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iorio</surname><given-names>E</given-names></name><name><surname>Torosantucci</surname><given-names>A</given-names></name><name><surname>Bromuro</surname><given-names>C</given-names></name><name><surname>Chiani</surname><given-names>P</given-names></name><name><surname>Ferretti</surname><given-names>A</given-names></name><name><surname>Giannini</surname><given-names>M</given-names></name><name><surname>Cassone</surname><given-names>A</given-names></name><name><surname>Podo</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Candida albicans cell wall comprises a branched beta-D-(1--&gt;6)-glucan with beta-D-(1--&gt;3)-side chains</article-title><source>Carbohydrate Research</source><volume>343</volume><fpage>1050</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2008.02.020</pub-id><pub-id pub-id-type="pmid">18346722</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>LE</given-names></name><name><surname>Keifer</surname><given-names>P</given-names></name><name><surname>Saarinen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity</article-title><source>Journal of the American Chemical Society</source><volume>114</volume><fpage>10663</fpage><lpage>10665</lpage><pub-id pub-id-type="doi">10.1021/ja00052a088</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>A</given-names></name><name><surname>Someya</surname><given-names>K</given-names></name><name><surname>Hata</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>R</given-names></name><name><surname>Takemura</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>53</volume><fpage>670</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1128/AAC.00844-08</pub-id><pub-id pub-id-type="pmid">19015325</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klis</surname><given-names>FM</given-names></name><name><surname>Sosinska</surname><given-names>GJ</given-names></name><name><surname>de Groot</surname><given-names>PWJ</given-names></name><name><surname>Brul</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Covalently linked cell wall proteins of Candida albicans and their role in fitness and virulence</article-title><source>FEMS Yeast Research</source><volume>9</volume><fpage>1013</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1111/j.1567-1364.2009.00541.x</pub-id><pub-id pub-id-type="pmid">19624749</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kollár</surname><given-names>R</given-names></name><name><surname>Reinhold</surname><given-names>BB</given-names></name><name><surname>Petráková</surname><given-names>E</given-names></name><name><surname>Yeh</surname><given-names>HJ</given-names></name><name><surname>Ashwell</surname><given-names>G</given-names></name><name><surname>Drgonová</surname><given-names>J</given-names></name><name><surname>Kapteyn</surname><given-names>JC</given-names></name><name><surname>Klis</surname><given-names>FM</given-names></name><name><surname>Cabib</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Architecture of the yeast cell wall. Beta(1--&gt;6)-glucan interconnects mannoprotein, beta(1--&gt;)3-glucan, and chitin</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>17762</fpage><lpage>17775</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.28.17762</pub-id><pub-id pub-id-type="pmid">9211929</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kottom</surname><given-names>TJ</given-names></name><name><surname>Hebrink</surname><given-names>DM</given-names></name><name><surname>Jenson</surname><given-names>PE</given-names></name><name><surname>Gudmundsson</surname><given-names>G</given-names></name><name><surname>Limper</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Evidence for proinflammatory β-1,6 glucans in the pneumocystis carinii cell wall</article-title><source>Infection and Immunity</source><volume>83</volume><fpage>2816</fpage><lpage>2826</lpage><pub-id pub-id-type="doi">10.1128/IAI.00196-15</pub-id><pub-id pub-id-type="pmid">25916991</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroth</surname><given-names>PG</given-names></name><name><surname>Chiovitti</surname><given-names>A</given-names></name><name><surname>Gruber</surname><given-names>A</given-names></name><name><surname>Martin-Jezequel</surname><given-names>V</given-names></name><name><surname>Mock</surname><given-names>T</given-names></name><name><surname>Parker</surname><given-names>MS</given-names></name><name><surname>Stanley</surname><given-names>MS</given-names></name><name><surname>Kaplan</surname><given-names>A</given-names></name><name><surname>Caron</surname><given-names>L</given-names></name><name><surname>Weber</surname><given-names>T</given-names></name><name><surname>Maheswari</surname><given-names>U</given-names></name><name><surname>Armbrust</surname><given-names>EV</given-names></name><name><surname>Bowler</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A model for carbohydrate metabolism in the diatom phaeodactylum tricornutum deduced from comparative whole genome analysis</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e1426</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0001426</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>K</given-names></name><name><surname>Itto-Nakama</surname><given-names>K</given-names></name><name><surname>Ohnuki</surname><given-names>S</given-names></name><name><surname>Yashiroda</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>SC</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>Y</given-names></name><name><surname>Shimamoto</surname><given-names>Y</given-names></name><name><surname>Tominaga</surname><given-names>K-I</given-names></name><name><surname>Yamanaka</surname><given-names>D</given-names></name><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Takashima</surname><given-names>S</given-names></name><name><surname>Noda</surname><given-names>Y</given-names></name><name><surname>Boone</surname><given-names>C</given-names></name><name><surname>Ohya</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Jerveratrum-type steroidal alkaloids inhibit β-1,6-glucan biosynthesis in fungal cell walls</article-title><source>Microbiology Spectrum</source><volume>10</volume><elocation-id>e0087321</elocation-id><pub-id pub-id-type="doi">10.1128/spectrum.00873-21</pub-id><pub-id pub-id-type="pmid">35019680</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurita</surname><given-names>T</given-names></name><name><surname>Noda</surname><given-names>Y</given-names></name><name><surname>Takagi</surname><given-names>T</given-names></name><name><surname>Osumi</surname><given-names>M</given-names></name><name><surname>Yoda</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Kre6 protein essential for yeast cell wall β-1,6-glucan synthesis accumulates at sites of polarized growth</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><fpage>7429</fpage><lpage>7438</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.174060</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurita</surname><given-names>T</given-names></name><name><surname>Noda</surname><given-names>Y</given-names></name><name><surname>Yoda</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Action of multiple endoplasmic reticulum chaperon-like proteins is required for proper folding and polarized localization of kre6 protein essential in yeast cell wall β-1,6-glucan synthesis</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>17415</fpage><lpage>17424</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.321018</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Kubo</surname><given-names>K</given-names></name><name><surname>Abdelaziz</surname><given-names>JA</given-names></name><name><surname>Cunningham</surname><given-names>I</given-names></name><name><surname>de Silva Dantas</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Okada</surname><given-names>H</given-names></name><name><surname>Ohya</surname><given-names>Y</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Yeast species-specific, differential inhibition of β-1,3-glucan synthesis by poacic acid and caspofungin</article-title><source>Cell Surface</source><volume>3</volume><fpage>12</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.tcsw.2018.09.001</pub-id><pub-id pub-id-type="pmid">30370375</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legrand</surname><given-names>M</given-names></name><name><surname>Bachellier-Bassi</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Chaudhari</surname><given-names>Y</given-names></name><name><surname>Tournu</surname><given-names>H</given-names></name><name><surname>Arbogast</surname><given-names>L</given-names></name><name><surname>Boyer</surname><given-names>H</given-names></name><name><surname>Chauvel</surname><given-names>M</given-names></name><name><surname>Cabral</surname><given-names>V</given-names></name><name><surname>Maufrais</surname><given-names>C</given-names></name><name><surname>Nesseir</surname><given-names>A</given-names></name><name><surname>Maslanka</surname><given-names>I</given-names></name><name><surname>Permal</surname><given-names>E</given-names></name><name><surname>Rossignol</surname><given-names>T</given-names></name><name><surname>Walker</surname><given-names>LA</given-names></name><name><surname>Zeidler</surname><given-names>U</given-names></name><name><surname>Znaidi</surname><given-names>S</given-names></name><name><surname>Schoeters</surname><given-names>F</given-names></name><name><surname>Majgier</surname><given-names>C</given-names></name><name><surname>Julien</surname><given-names>RA</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Tichit</surname><given-names>M</given-names></name><name><surname>Bouchier</surname><given-names>C</given-names></name><name><surname>Van Dijck</surname><given-names>P</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>d’Enfert</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Generating genomic platforms to study Candida albicans pathogenesis</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>6935</fpage><lpage>6949</lpage><pub-id pub-id-type="doi">10.1093/nar/gky594</pub-id><pub-id pub-id-type="pmid">29982705</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenardon</surname><given-names>MD</given-names></name><name><surname>Sood</surname><given-names>P</given-names></name><name><surname>Dorfmueller</surname><given-names>HC</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Scalar nanostructure of the <italic>Candida albicans</italic> cell wall; a molecular, cellular and ultrastructural analysis and interpretation</article-title><source>Cell Surface</source><volume>6</volume><elocation-id>100047</elocation-id><pub-id pub-id-type="doi">10.1016/j.tcsw.2020.100047</pub-id><pub-id pub-id-type="pmid">33294751</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesage</surname><given-names>G</given-names></name><name><surname>Bussey</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cell wall assembly in <italic>Saccharomyces cerevisiae</italic></article-title><source>Microbiology and Molecular Biology Reviews</source><volume>70</volume><fpage>317</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00038-05</pub-id><pub-id pub-id-type="pmid">16760306</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levinson</surname><given-names>JN</given-names></name><name><surname>Shahinian</surname><given-names>S</given-names></name><name><surname>Sdicu</surname><given-names>AM</given-names></name><name><surname>Tessier</surname><given-names>DC</given-names></name><name><surname>Bussey</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Functional, comparative and cell biological analysis of <italic>Saccharomyces cerevisiae</italic> Kre5p</article-title><source>Yeast</source><volume>19</volume><fpage>1243</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1002/yea.908</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionakis</surname><given-names>MS</given-names></name><name><surname>Levitz</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Host control of fungal infections: lessons from basic studies and human cohorts</article-title><source>Annual Review of Immunology</source><volume>36</volume><fpage>157</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-042617-053318</pub-id><pub-id pub-id-type="pmid">29237128</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>LJ</given-names></name><name><surname>Chen</surname><given-names>SM</given-names></name><name><surname>Li</surname><given-names>LP</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>SQ</given-names></name><name><surname>Zhang</surname><given-names>JD</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>GT</given-names></name><name><surname>An</surname><given-names>MM</given-names></name><name><surname>Jiang</surname><given-names>YY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Bst1 is required for Candida albicans infecting host via facilitating cell wall anchorage of Glycosylphosphatidyl inositol anchored proteins</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>34854</elocation-id><pub-id pub-id-type="doi">10.1038/srep34854</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Valsecchi</surname><given-names>I</given-names></name><name><surname>Le Meur</surname><given-names>RA</given-names></name><name><surname>Simenel</surname><given-names>C</given-names></name><name><surname>Guijarro</surname><given-names>JI</given-names></name><name><surname>Comte</surname><given-names>C</given-names></name><name><surname>Muszkieta</surname><given-names>L</given-names></name><name><surname>Mouyna</surname><given-names>I</given-names></name><name><surname>Henrissat</surname><given-names>B</given-names></name><name><surname>Aimanianda</surname><given-names>V</given-names></name><name><surname>Latgé</surname><given-names>J-P</given-names></name><name><surname>Fontaine</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Conidium specific polysaccharides in aspergillus fumigatus</article-title><source>Journal of Fungi</source><volume>9</volume><elocation-id>155</elocation-id><pub-id pub-id-type="doi">10.3390/jof9020155</pub-id><pub-id pub-id-type="pmid">36836270</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marakalala</surname><given-names>MJ</given-names></name><name><surname>Vautier</surname><given-names>S</given-names></name><name><surname>Potrykus</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>LA</given-names></name><name><surname>Shepardson</surname><given-names>KM</given-names></name><name><surname>Hopke</surname><given-names>A</given-names></name><name><surname>Mora-Montes</surname><given-names>HM</given-names></name><name><surname>Kerrigan</surname><given-names>A</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Murray</surname><given-names>GI</given-names></name><name><surname>Maccallum</surname><given-names>DM</given-names></name><name><surname>Wheeler</surname><given-names>R</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Cramer</surname><given-names>RA</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003315</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003315</pub-id><pub-id pub-id-type="pmid">23637604</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matveev</surname><given-names>AL</given-names></name><name><surname>Krylov</surname><given-names>VB</given-names></name><name><surname>Khlusevich</surname><given-names>YA</given-names></name><name><surname>Baykov</surname><given-names>IK</given-names></name><name><surname>Yashunsky</surname><given-names>DV</given-names></name><name><surname>Emelyanova</surname><given-names>LA</given-names></name><name><surname>Tsvetkov</surname><given-names>YE</given-names></name><name><surname>Karelin</surname><given-names>AA</given-names></name><name><surname>Bardashova</surname><given-names>AV</given-names></name><name><surname>Wong</surname><given-names>SSW</given-names></name><name><surname>Aimanianda</surname><given-names>V</given-names></name><name><surname>Latgé</surname><given-names>J-P</given-names></name><name><surname>Tikunova</surname><given-names>NV</given-names></name><name><surname>Nifantiev</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Novel mouse monoclonal antibodies specifically recognizing β-(1→3)-D-glucan antigen</article-title><source>PLOS ONE</source><volume>14</volume><elocation-id>e0215535</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0215535</pub-id><pub-id pub-id-type="pmid">31022215</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>K</given-names></name><name><surname>Ichikawa</surname><given-names>Y</given-names></name><name><surname>Woolford</surname><given-names>CA</given-names></name><name><surname>Mitchell</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Candida albicans gene deletion with a transient CRISPR-Cas9 System</article-title><source>mSphere</source><volume>1</volume><elocation-id>e00130</elocation-id><pub-id pub-id-type="doi">10.1128/mSphere.00130-16</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mio</surname><given-names>T</given-names></name><name><surname>Yabe</surname><given-names>T</given-names></name><name><surname>Sudoh</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>Y</given-names></name><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Arisawa</surname><given-names>M</given-names></name><name><surname>Yamada-Okabe</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Role of three chitin synthase genes in the growth of Candida albicans</article-title><source>Journal of Bacteriology</source><volume>178</volume><fpage>2416</fpage><lpage>2419</lpage><pub-id pub-id-type="doi">10.1128/jb.178.8.2416-2419.1996</pub-id><pub-id pub-id-type="pmid">8636047</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mio</surname><given-names>T</given-names></name><name><surname>Yamada-Okabe</surname><given-names>T</given-names></name><name><surname>Yabe</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Arisawa</surname><given-names>M</given-names></name><name><surname>Yamada-Okabe</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Isolation of the Candida albicans homologs of <italic>Saccharomyces cerevisiae</italic> KRE6 and SKN1: expression and physiological function</article-title><source>Journal of Bacteriology</source><volume>179</volume><fpage>2363</fpage><lpage>2372</lpage><pub-id pub-id-type="doi">10.1128/jb.179.7.2363-2372.1997</pub-id><pub-id pub-id-type="pmid">9079924</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>R</given-names></name><name><surname>Minc</surname><given-names>N</given-names></name><name><surname>Peter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cells under pressure: how yeast cells respond to mechanical forces</article-title><source>Trends in Microbiology</source><volume>30</volume><fpage>495</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2021.11.006</pub-id><pub-id pub-id-type="pmid">35000797</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montijn</surname><given-names>RC</given-names></name><name><surname>Vink</surname><given-names>E</given-names></name><name><surname>Müller</surname><given-names>WH</given-names></name><name><surname>Verkleij</surname><given-names>AJ</given-names></name><name><surname>Van Den Ende</surname><given-names>H</given-names></name><name><surname>Henrissat</surname><given-names>B</given-names></name><name><surname>Klis</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Localization of synthesis of beta1,6-glucan in <italic>Saccharomyces cerevisiae</italic></article-title><source>Journal of Bacteriology</source><volume>181</volume><fpage>7414</fpage><lpage>7420</lpage><pub-id pub-id-type="doi">10.1128/JB.181.24.7414-7420.1999</pub-id><pub-id pub-id-type="pmid">10601196</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>Schofield</surname><given-names>DA</given-names></name><name><surname>Gooday</surname><given-names>GW</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Regulation of chitin synthesis during dimorphic growth of Candida albicans</article-title><source>Microbiology</source><volume>144</volume><fpage>391</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1099/00221287-144-2-391</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>Winter</surname><given-names>K</given-names></name><name><surname>Buchan</surname><given-names>A</given-names></name><name><surname>Henry</surname><given-names>K</given-names></name><name><surname>Becker</surname><given-names>JM</given-names></name><name><surname>Brown</surname><given-names>AJ</given-names></name><name><surname>Bulawa</surname><given-names>CE</given-names></name><name><surname>Gow</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity</article-title><source>Molecular Microbiology</source><volume>39</volume><fpage>1414</fpage><lpage>1426</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02347.x</pub-id><pub-id pub-id-type="pmid">11251855</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>Bates</surname><given-names>S</given-names></name><name><surname>Buurman</surname><given-names>ET</given-names></name><name><surname>Hughes</surname><given-names>HB</given-names></name><name><surname>Maccallum</surname><given-names>DM</given-names></name><name><surname>Bertram</surname><given-names>G</given-names></name><name><surname>Atrih</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>MAJ</given-names></name><name><surname>Bain</surname><given-names>JM</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name><name><surname>Hamilton</surname><given-names>S</given-names></name><name><surname>Westwater</surname><given-names>C</given-names></name><name><surname>Thomson</surname><given-names>LM</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Odds</surname><given-names>FC</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>1051</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.1074/jbc.M411413200</pub-id><pub-id pub-id-type="pmid">15519997</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>Bates</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>C</given-names></name><name><surname>Ferwerda</surname><given-names>G</given-names></name><name><surname>Hobson</surname><given-names>RP</given-names></name><name><surname>Bertram</surname><given-names>G</given-names></name><name><surname>Hughes</surname><given-names>HB</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>Jacobs</surname><given-names>L</given-names></name><name><surname>Buurman</surname><given-names>ET</given-names></name><name><surname>Gijzen</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Torensma</surname><given-names>R</given-names></name><name><surname>McKinnon</surname><given-names>A</given-names></name><name><surname>MacCallum</surname><given-names>DM</given-names></name><name><surname>Odds</surname><given-names>FC</given-names></name><name><surname>Van der Meer</surname><given-names>JWM</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors</article-title><source>The Journal of Clinical Investigation</source><volume>116</volume><fpage>1642</fpage><lpage>1650</lpage><pub-id pub-id-type="doi">10.1172/JCI27114</pub-id><pub-id pub-id-type="pmid">16710478</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Kullberg</surname><given-names>B-J</given-names></name><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune defence against Candida fungal infections</article-title><source>Nature Reviews. Immunology</source><volume>15</volume><fpage>630</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1038/nri3897</pub-id><pub-id pub-id-type="pmid">26388329</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyberg</surname><given-names>NT</given-names></name><name><surname>Duus</surname><given-names>JO</given-names></name><name><surname>Sørensen</surname><given-names>OW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Heteronuclear two-bond correlation: suppressing heteronuclear three-bond or higher NMR correlations while enhancing two-bond correlations even for vanishing 2J(CH)</article-title><source>Journal of the American Chemical Society</source><volume>127</volume><fpage>6154</fpage><lpage>6155</lpage><pub-id pub-id-type="doi">10.1021/ja050878w</pub-id><pub-id pub-id-type="pmid">15853304</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagé</surname><given-names>N</given-names></name><name><surname>Gérard-Vincent</surname><given-names>M</given-names></name><name><surname>Ménard</surname><given-names>P</given-names></name><name><surname>Beaulieu</surname><given-names>M</given-names></name><name><surname>Azuma</surname><given-names>M</given-names></name><name><surname>Dijkgraaf</surname><given-names>GJP</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Marcoux</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Dowse</surname><given-names>T</given-names></name><name><surname>Sdicu</surname><given-names>A-M</given-names></name><name><surname>Bussey</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A <italic>Saccharomyces cerevisiae</italic> genome-wide mutant screen for altered sensitivity to K1 killer toxin</article-title><source>Genetics</source><volume>163</volume><fpage>875</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1093/genetics/163.3.875</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palma</surname><given-names>AS</given-names></name><name><surname>Feizi</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Stoll</surname><given-names>MS</given-names></name><name><surname>Lawson</surname><given-names>AM</given-names></name><name><surname>Díaz-Rodríguez</surname><given-names>E</given-names></name><name><surname>Campanero-Rhodes</surname><given-names>MA</given-names></name><name><surname>Costa</surname><given-names>J</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Chai</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ligands for the beta-glucan receptor, Dectin-1, assigned using “designer” microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>5771</fpage><lpage>5779</lpage><pub-id pub-id-type="doi">10.1074/jbc.M511461200</pub-id><pub-id pub-id-type="pmid">16371356</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preechasuth</surname><given-names>K</given-names></name><name><surname>Anderson</surname><given-names>JC</given-names></name><name><surname>Peck</surname><given-names>SC</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Lenardon</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cell wall protection by the Candida albicans class I chitin synthases</article-title><source>Fungal Genetics and Biology</source><volume>82</volume><fpage>264</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2015.08.001</pub-id><pub-id pub-id-type="pmid">26257018</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>LS</given-names></name><name><surname>Chauvel</surname><given-names>M</given-names></name><name><surname>Permal</surname><given-names>E</given-names></name><name><surname>d’Enfert</surname><given-names>C</given-names></name><name><surname>Bachellier-Bassi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Transcript profiling reveals the role of PDB1, a subunit of the pyruvate dehydrogenase complex, in Candida albicans biofilm formation</article-title><source>Research in Microbiology</source><volume>174</volume><elocation-id>104014</elocation-id><pub-id pub-id-type="doi">10.1016/j.resmic.2022.104014</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuss</surname><given-names>O</given-names></name><name><surname>Vik</surname><given-names>A</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name><name><surname>Morschhäuser</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The SAT1 flipper, an optimized tool for gene disruption in Candida albicans</article-title><source>Gene</source><volume>341</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2004.06.021</pub-id><pub-id pub-id-type="pmid">15474295</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roemer</surname><given-names>T</given-names></name><name><surname>Delaney</surname><given-names>S</given-names></name><name><surname>Bussey</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>SKN1 and KRE6 define a pair of functional homologs encoding putative membrane proteins involved in beta-glucan synthesis</article-title><source>Molecular and Cellular Biology</source><volume>13</volume><fpage>4039</fpage><lpage>4048</lpage><pub-id pub-id-type="doi">10.1128/mcb.13.7.4039-4048.1993</pub-id><pub-id pub-id-type="pmid">8321211</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roncero</surname><given-names>C</given-names></name><name><surname>Durán</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Effect of Calcofluor white and Congo red on fungal cell wall morphogenesis: in vivo activation of chitin polymerization</article-title><source>Journal of Bacteriology</source><volume>163</volume><fpage>1180</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1128/jb.163.3.1180-1185.1985</pub-id><pub-id pub-id-type="pmid">3897187</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin-Bejerano</surname><given-names>I</given-names></name><name><surname>Abeijon</surname><given-names>C</given-names></name><name><surname>Magnelli</surname><given-names>P</given-names></name><name><surname>Grisafi</surname><given-names>P</given-names></name><name><surname>Fink</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Phagocytosis by human neutrophils is stimulated by a unique fungal cell wall component</article-title><source>Cell Host &amp; Microbe</source><volume>2</volume><fpage>55</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2007.06.002</pub-id><pub-id pub-id-type="pmid">18005717</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rueda</surname><given-names>C</given-names></name><name><surname>Cuenca-Estrella</surname><given-names>M</given-names></name><name><surname>Zaragoza</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>58</volume><fpage>1071</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1128/AAC.00946-13</pub-id><pub-id pub-id-type="pmid">24295973</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Herrera</surname><given-names>J</given-names></name><name><surname>Elorza</surname><given-names>MV</given-names></name><name><surname>Valentín</surname><given-names>E</given-names></name><name><surname>Sentandreu</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity</article-title><source>FEMS Yeast Research</source><volume>6</volume><fpage>14</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1111/j.1567-1364.2005.00017.x</pub-id><pub-id pub-id-type="pmid">16423067</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanglard</surname><given-names>D</given-names></name><name><surname>Ischer</surname><given-names>F</given-names></name><name><surname>Monod</surname><given-names>M</given-names></name><name><surname>Bille</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>40</volume><fpage>2300</fpage><lpage>2305</lpage><pub-id pub-id-type="doi">10.1128/AAC.40.10.2300</pub-id><pub-id pub-id-type="pmid">8891134</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawardeker</surname><given-names>JS</given-names></name><name><surname>Sloneker</surname><given-names>JH</given-names></name><name><surname>Jeanes</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography</article-title><source>Analytical Chemistry</source><volume>37</volume><fpage>1602</fpage><lpage>1604</lpage><pub-id pub-id-type="doi">10.1021/ac60231a048</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiavone</surname><given-names>M</given-names></name><name><surname>Vax</surname><given-names>A</given-names></name><name><surname>Formosa</surname><given-names>C</given-names></name><name><surname>Martin-Yken</surname><given-names>H</given-names></name><name><surname>Dague</surname><given-names>E</given-names></name><name><surname>François</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A combined chemical and enzymatic method to determine quantitatively the polysaccharide components in the cell wall of yeasts</article-title><source>FEMS Yeast Research</source><volume>14</volume><fpage>933</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1111/1567-1364.12182</pub-id><pub-id pub-id-type="pmid">25041403</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sem</surname><given-names>X</given-names></name><name><surname>Le</surname><given-names>GTT</given-names></name><name><surname>Tan</surname><given-names>ASM</given-names></name><name><surname>Tso</surname><given-names>G</given-names></name><name><surname>Yurieva</surname><given-names>M</given-names></name><name><surname>Liao</surname><given-names>WWP</given-names></name><name><surname>Lum</surname><given-names>J</given-names></name><name><surname>Srinivasan</surname><given-names>KG</given-names></name><name><surname>Poidinger</surname><given-names>M</given-names></name><name><surname>Zolezzi</surname><given-names>F</given-names></name><name><surname>Pavelka</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>β-glucan exposure on the fungal cell wall tightly correlates with competitive fitness of <italic>Candida</italic> Species in the mouse gastrointestinal tract</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>6</volume><elocation-id>186</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2016.00186</pub-id><pub-id pub-id-type="pmid">28066722</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahinian</surname><given-names>S</given-names></name><name><surname>Bussey</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>beta-1,6-Glucan synthesis in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular Microbiology</source><volume>35</volume><fpage>477</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.01713.x</pub-id><pub-id pub-id-type="pmid">10672173</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Chakrabarti</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Candidiasis and other emerging yeasts</article-title><source>Current Fungal Infection Reports</source><volume>17</volume><fpage>15</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1007/s12281-023-00455-3</pub-id><pub-id pub-id-type="pmid">36741271</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Southard</surname><given-names>SB</given-names></name><name><surname>Specht</surname><given-names>CA</given-names></name><name><surname>Mishra</surname><given-names>C</given-names></name><name><surname>Chen-Weiner</surname><given-names>J</given-names></name><name><surname>Robbins</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Molecular analysis of the Candida albicans homolog of <italic>Saccharomyces cerevisiae</italic> MNN9, required for glycosylation of cell wall mannoproteins</article-title><source>Journal of Bacteriology</source><volume>181</volume><fpage>7439</fpage><lpage>7448</lpage><pub-id pub-id-type="doi">10.1128/JB.181.24.7439-7448.1999</pub-id><pub-id pub-id-type="pmid">10601199</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stalhberger</surname><given-names>T</given-names></name><name><surname>Simenel</surname><given-names>C</given-names></name><name><surname>Clavaud</surname><given-names>C</given-names></name><name><surname>Eijsink</surname><given-names>VGH</given-names></name><name><surname>Jourdain</surname><given-names>R</given-names></name><name><surname>Delepierre</surname><given-names>M</given-names></name><name><surname>Latgé</surname><given-names>J-P</given-names></name><name><surname>Breton</surname><given-names>L</given-names></name><name><surname>Fontaine</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chemical organization of the cell wall polysaccharide core of Malassezia restricta</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>12647</fpage><lpage>12656</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.547034</pub-id><pub-id pub-id-type="pmid">24627479</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suwunnakorn</surname><given-names>S</given-names></name><name><surname>Wakabayashi</surname><given-names>H</given-names></name><name><surname>Kordalewska</surname><given-names>M</given-names></name><name><surname>Perlin</surname><given-names>DS</given-names></name><name><surname>Rustchenko</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title><italic>FKS2</italic> and <italic>FKS3</italic> genes of opportunistic human pathogen Candida albicans Influence Echinocandin Susceptibility</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>62</volume><elocation-id>e02299-17</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.02299-17</pub-id><pub-id pub-id-type="pmid">29358288</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Tsoni</surname><given-names>SV</given-names></name><name><surname>Willment</surname><given-names>JA</given-names></name><name><surname>Dennehy</surname><given-names>KM</given-names></name><name><surname>Rosas</surname><given-names>M</given-names></name><name><surname>Findon</surname><given-names>H</given-names></name><name><surname>Haynes</surname><given-names>K</given-names></name><name><surname>Steele</surname><given-names>C</given-names></name><name><surname>Botto</surname><given-names>M</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dectin-1 is required for beta-glucan recognition and control of fungal infection</article-title><source>Nature Immunology</source><volume>8</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1038/ni1408</pub-id><pub-id pub-id-type="pmid">17159984</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terashima</surname><given-names>H</given-names></name><name><surname>Yabuki</surname><given-names>N</given-names></name><name><surname>Arisawa</surname><given-names>M</given-names></name><name><surname>Hamada</surname><given-names>K</given-names></name><name><surname>Kitada</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Up-regulation of genes encoding glycosylphosphatidylinositol (GPI)-attached proteins in response to cell wall damage caused by disruption of FKS1 in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular &amp; General Genetics</source><volume>264</volume><fpage>64</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s004380000285</pub-id><pub-id pub-id-type="pmid">11016834</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thrippleton</surname><given-names>MJ</given-names></name><name><surname>Keeler</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Elimination of zero‐quantum interference in two‐dimensional NMR spectra</article-title><source>Angewandte Chemie International Edition</source><volume>42</volume><fpage>3938</fpage><lpage>3941</lpage><pub-id pub-id-type="doi">10.1002/anie.200351947</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname><given-names>CF</given-names></name><name><surname>Reichard</surname><given-names>U</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><name><surname>Zychlinsky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms</article-title><source>Cellular Microbiology</source><volume>8</volume><fpage>668</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00659.x</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vink</surname><given-names>E</given-names></name><name><surname>Rodriguez-Suarez</surname><given-names>RJ</given-names></name><name><surname>Gérard-Vincent</surname><given-names>M</given-names></name><name><surname>Ribas</surname><given-names>JC</given-names></name><name><surname>de Nobel</surname><given-names>H</given-names></name><name><surname>van den Ende</surname><given-names>H</given-names></name><name><surname>Durán</surname><given-names>A</given-names></name><name><surname>Klis</surname><given-names>FM</given-names></name><name><surname>Bussey</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>An in vitro assay for (1 --&gt; 6)-beta-D-glucan synthesis in <italic>Saccharomyces cerevisiae</italic></article-title><source>Yeast</source><volume>21</volume><fpage>1121</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1002/yea.1156</pub-id><pub-id pub-id-type="pmid">15484287</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>MS</given-names></name><name><surname>Schmitz</surname><given-names>GF</given-names></name><name><surname>Varón Silva</surname><given-names>D</given-names></name><name><surname>Mösch</surname><given-names>HU</given-names></name><name><surname>Essen</surname><given-names>LO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural base for the transfer of GPI-anchored glycoproteins into fungal cell walls</article-title><source>PNAS</source><volume>117</volume><fpage>22061</fpage><lpage>22067</lpage><pub-id pub-id-type="doi">10.1073/pnas.2010661117</pub-id><pub-id pub-id-type="pmid">32839341</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vranken</surname><given-names>WF</given-names></name><name><surname>Boucher</surname><given-names>W</given-names></name><name><surname>Stevens</surname><given-names>TJ</given-names></name><name><surname>Fogh</surname><given-names>RH</given-names></name><name><surname>Pajon</surname><given-names>A</given-names></name><name><surname>Llinas</surname><given-names>M</given-names></name><name><surname>Ulrich</surname><given-names>EL</given-names></name><name><surname>Markley</surname><given-names>JL</given-names></name><name><surname>Ionides</surname><given-names>J</given-names></name><name><surname>Laue</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The CCPN data model for NMR spectroscopy: development of a software pipeline</article-title><source>Proteins</source><volume>59</volume><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1002/prot.20449</pub-id><pub-id pub-id-type="pmid">15815974</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vyas</surname><given-names>VK</given-names></name><name><surname>Barrasa</surname><given-names>MI</given-names></name><name><surname>Fink</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A    <italic>Candida albicans</italic>    CRISPR system permits genetic engineering of essential genes and gene families</article-title><source>Science Advances</source><volume>1</volume><elocation-id>e1500248</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.1500248</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagener</surname><given-names>J</given-names></name><name><surname>Malireddi</surname><given-names>RKS</given-names></name><name><surname>Lenardon</surname><given-names>MD</given-names></name><name><surname>Köberle</surname><given-names>M</given-names></name><name><surname>Vautier</surname><given-names>S</given-names></name><name><surname>MacCallum</surname><given-names>DM</given-names></name><name><surname>Biedermann</surname><given-names>T</given-names></name><name><surname>Schaller</surname><given-names>M</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Kanneganti</surname><given-names>T-D</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1004050</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004050</pub-id><pub-id pub-id-type="pmid">24722226</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>LA</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Elevated chitin content reduces the susceptibility of Candida species to caspofungin</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>146</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1128/AAC.01486-12</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="web"><person-group person-group-type="author"><collab>WHO</collab></person-group><year iso-8601-date="2022">2022</year><article-title>WHO fungal priority pathogens list to guide research, development and public health action</article-title><ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications-detail-redirect/9789240060241">https://www.who.int/publications-detail-redirect/9789240060241</ext-link><date-in-citation iso-8601-date="2024-11-27">November 27, 2024</date-in-citation></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willker</surname><given-names>W</given-names></name><name><surname>Leibfritz</surname><given-names>D</given-names></name><name><surname>Kerssebaum</surname><given-names>R</given-names></name><name><surname>Bermel</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Gradient selection in inverse heteronuclear correlation spectroscopy</article-title><source>Magnetic Resonance in Chemistry</source><volume>31</volume><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1002/mrc.1260310315</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>SSW</given-names></name><name><surname>Daniel</surname><given-names>I</given-names></name><name><surname>Gangneux</surname><given-names>JP</given-names></name><name><surname>Jayapal</surname><given-names>JM</given-names></name><name><surname>Guegan</surname><given-names>H</given-names></name><name><surname>Dellière</surname><given-names>S</given-names></name><name><surname>Lalitha</surname><given-names>P</given-names></name><name><surname>Shende</surname><given-names>R</given-names></name><name><surname>Madan</surname><given-names>T</given-names></name><name><surname>Bayry</surname><given-names>J</given-names></name><name><surname>Guijarro</surname><given-names>JI</given-names></name><name><surname>Kuppamuthu</surname><given-names>D</given-names></name><name><surname>Aimanianda</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Differential interactions of serum and bronchoalveolar lavage fluid complement proteins with conidia of airborne fungal pathogen aspergillus fumigatus</article-title><source>Infection and Immunity</source><volume>88</volume><elocation-id>e00212</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00212-20</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>B</given-names></name><name><surname>Mora-Montes</surname><given-names>HM</given-names></name><name><surname>Wagener</surname><given-names>J</given-names></name><name><surname>Cunningham</surname><given-names>I</given-names></name><name><surname>West</surname><given-names>L</given-names></name><name><surname>Haynes</surname><given-names>K</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Gow</surname><given-names>NAR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Differences in fungal immune recognition by monocytes and macrophages: N-mannan can be a shield or activator of immune recognition</article-title><source>The Cell Surface</source><volume>6</volume><elocation-id>100042</elocation-id><pub-id pub-id-type="doi">10.1016/j.tcsw.2020.100042</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Solis</surname><given-names>NV</given-names></name><name><surname>Marshall</surname><given-names>M</given-names></name><name><surname>Garleb</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Swidergall</surname><given-names>M</given-names></name><name><surname>Pearlman</surname><given-names>E</given-names></name><name><surname>Filler</surname><given-names>SG</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Control of β-glucan exposure by the endo-1,3-glucanase Eng1 in Candida albicans modulates virulence</article-title><source>PLOS Pathogens</source><volume>18</volume><elocation-id>e1010192</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1010192</pub-id><pub-id pub-id-type="pmid">34995333</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zverlov</surname><given-names>VV</given-names></name><name><surname>Volkov</surname><given-names>IY</given-names></name><name><surname>Velikodvorskaya</surname><given-names>TV</given-names></name><name><surname>Schwarz</surname><given-names>WH</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Highly thermostable endo-1,3-β -glucanase (laminarinase) Lam A from Thermotoga neapolitana: nucleotide sequence of the gene and characterization of the recombinant gene product</article-title><source>Microbiology</source><volume>143</volume><fpage>1701</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1099/00221287-143-5-1701</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Yeast Nitrogen Base with amino acids (YNB)</td><td align="left" valign="bottom">BD</td><td align="left" valign="bottom">239210</td><td align="left" valign="bottom">Medium used in this study. See section ‘Strains and growth conditions’.</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Lactate</td><td align="left" valign="bottom">ChemCruz</td><td align="left" valign="bottom">sc-220120B</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">H<sub>2</sub>O<sub>2</sub></td><td align="left" valign="bottom">Prolabo</td><td align="left" valign="bottom">23612.294</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MES</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">M3058-100G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MOPS</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">M1254-1KG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Acetate</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">S2889-1KG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Propionate</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">P1880-100G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Butyrate</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">B5887-250MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Calcofluor white (CFW)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">910090-20mL</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Congo Red (CR)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">C6277-25G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tunicamycin</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">17765-5MG</td><td align="left" valign="bottom">From <italic>Streptomyces</italic> spp.</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Nikkomycin Z</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">N-8028</td><td align="left" valign="bottom">From <italic>Streptomyces tendae</italic></td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Caspofungin</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">SML0425-5MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Yeast Nitrogen Base without amino acids</td><td align="left" valign="bottom">BD</td><td align="left" valign="bottom">291940</td><td align="left" valign="bottom">Medium used in this study for biofilm production. See section ‘Strains and growth conditions’.</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Breathseal sealing membranes</td><td align="left" valign="bottom">Greiner Bio-one</td><td align="left" valign="bottom">676051</td><td align="left" valign="bottom">Used in this study for biofilm production. See section ‘Strains and growth conditions’.</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Pierce BCA Protein Assay Kit</td><td align="left" valign="bottom">Thermo Scientific</td><td align="left" valign="bottom">23225</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Trifluoroacetic acid (TFA)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">8.08260.0101</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hydrochloric acid (HCl)</td><td align="left" valign="bottom">Fisher</td><td align="left" valign="bottom">H/1200/PC15</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">4-Hydroxybenzhydrazide (PAHBAH)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">H9882-100G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium (meta)periodate (m-IO<sub>4</sub>Na)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">S1878-25G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium sulfite</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">S0505-250G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Biological sample</td><td align="left" valign="bottom">Pustulan</td><td align="left" valign="bottom">Elicityl OligoTech</td><td align="left" valign="bottom">GLU900-1g</td><td align="left" valign="bottom">From <italic>Lasallia pustulata</italic></td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">LamA</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9168619/">9168619</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">From <italic>Thermotoga neapolitana</italic> expressed in <italic>Escherichia coli</italic></td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Endo-β-1,6-glucanase</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20852022/">20852022</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">From <italic>Schizosaccharomyces pombe</italic> expressed in <italic>Pichia pastoris</italic></td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium azide (NaN<sub>3</sub>)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">S-8032</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">D<sub>2</sub>O</td><td align="left" valign="bottom">Eurisotop</td><td align="left" valign="bottom">17247446</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">CarboPAC-PA1 column</td><td align="left" valign="bottom">Thermo Scientific</td><td align="left" valign="bottom">035391</td><td align="left" valign="bottom">See sections ‘Cell wall polymers quantification’, ‘Quantification of β-1,6-glucan in AI and AS fractions,’ and ‘Structural characterization of β-1,6-glucan’.</td></tr><tr><td align="left" valign="bottom">Biological sample</td><td align="left" valign="bottom">Laminarin</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">L9634-5G</td><td align="left" valign="bottom">From <italic>Laminaria digitata</italic></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Superdex 200 column</td><td align="left" valign="bottom">Cytiva</td><td align="left" valign="bottom">28990944</td><td align="left" valign="bottom">See sections ‘Structural characterization of β-1,6-glucan’ and ‘PBMC and neutrophil isolation, stimulation by parietal fractions and cytokine quantification’.</td></tr><tr><td align="left" valign="bottom">Biological sample</td><td align="left" valign="bottom">Dextran 6 kDa</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">31388-25G</td><td align="left" valign="bottom">From <italic>Leuconostoc</italic> spp.</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dextran 10, 40, 70, and 500 kDa</td><td align="left" valign="bottom">Pharmacia Fine Chemicals</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Glutaraldehyde</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">G6257-100ML</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">6 mm type A and B specimen carriers</td><td align="left" valign="bottom">Leica</td><td align="left" valign="bottom">16770181 and 16770182</td><td align="left" valign="bottom">See section ‘Transmission electron microscopy’.</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Spurr resin</td><td align="left" valign="bottom">EMS</td><td align="left" valign="bottom">15000</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Polyclonal anti-β-1,6-glucan (rabbit polyclonal)</td><td align="left" valign="bottom">ProteoGenix</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Pustulan-conjugated BSA used as the antigen IF (1:100)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Curdlan</td><td align="left" valign="bottom">Wako</td><td align="left" valign="bottom">034-09901</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paraformaldehyde</td><td align="left" valign="bottom">Electron Microscopy Sciences</td><td align="left" valign="bottom">15714</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Biological sample</td><td align="left" valign="bottom">Goat serum</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">G9023</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Diagnostic Microscope Slides, 8-well 6 mm</td><td align="left" valign="bottom">Thermo Scientific</td><td align="left" valign="bottom">ER-301B-CE24</td><td align="left" valign="bottom">See section ‘Immunolabeling’.</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Poly-<sc>l</sc>-lysine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">P4707</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Monoclonal anti-β-1,3-glucan, named 5 H5 (mouse monoclonal)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31022215/">31022215</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">IF (1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">AlexaFluor 488 goat anti-mouse IgG (goat polyclonal)</td><td align="left" valign="bottom">Molecular Probes</td><td align="left" valign="bottom">A11029</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Fluorescein goat anti-rabbit IgG (goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">F2765</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fluoromount-G</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">00-4958-02</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ficoll 400</td><td align="left" valign="bottom">Eurobio</td><td align="left" valign="bottom">CMSMSL01-0U</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RPMI + GlutaMAX medium</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">61870044</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Biological sample</td><td align="left" valign="bottom">NHS</td><td align="left" valign="bottom">Zenbio</td><td align="left" valign="bottom">HSER-ABP100ML</td><td align="left" valign="bottom">From human pooled donor</td></tr><tr><td align="left" valign="bottom">Biological sample</td><td align="left" valign="bottom">LPS</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">L2630</td><td align="left" valign="bottom">From <italic>Escherichia coli</italic></td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">EasySep Direct Human Neutrophil Isolation Kit</td><td align="left" valign="bottom">STEMCELL Technologies</td><td align="left" valign="bottom">18001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Proteome Profiler Human Cytokines Array Kit</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">ARY005B</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">DuoSet ELISA kits</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">DY201, DY278, DY206, DY217B, DY208, DY2037, DY271, DY279, DY210</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BH<sub>4</sub>Na</td><td align="left" valign="bottom">Aldrich</td><td align="left" valign="bottom">213462-100G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Glycerol</td><td align="left" valign="bottom">Riedel-deHaën</td><td align="left" valign="bottom">15523</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">AcOH</td><td align="left" valign="bottom">Honeywell</td><td align="left" valign="bottom">27221-1L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Sep-Pak classic C18 cartridge</td><td align="left" valign="bottom">Waters</td><td align="left" valign="bottom">WAT051910</td><td align="left" valign="bottom">See section ‘PBMC and neutrophil isolation, stimulation by parietal fractions and cytokine quantification’.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">BSA</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A3059-100G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-human C3b (mouse monoclonal)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">MA1-82814</td><td align="left" valign="bottom">ELISA (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Peroxidase-conjugated secondary anti-mouse IgG (goat polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A4416</td><td align="left" valign="bottom">ELISA (1:1000)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TMB</td><td align="left" valign="bottom">BioFX</td><td align="left" valign="bottom">TMBW-1000-01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pV1093</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25977940/">25977940</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pSFS2A</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/5474295/">5474295</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pV1090</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25977940/">25977940</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pYM70</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20737428/">20737428</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Phusion High-Fidelity DNA polymerase</td><td align="left" valign="bottom">NEB</td><td align="left" valign="bottom">M0530S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Q5 polymerase</td><td align="left" valign="bottom">NEB</td><td align="left" valign="bottom">M0491S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NucleoSpin Gel and PCR Clean-up</td><td align="left" valign="bottom">Macherey-Nagel</td><td align="left" valign="bottom">740609.250</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Nourseothricin</td><td align="left" valign="bottom">Jena Biosciences</td><td align="left" valign="bottom">AB-102</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">MasterPure Yeast DNA Purification Kit</td><td align="left" valign="bottom">Biosearch Technologies</td><td align="left" valign="bottom">MPY80200</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">BP clonase</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">P/N 56480</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">LR clonase</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">P/N 56485</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">pDONR207</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23049891/">23049891</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Cip10-PACT1-SAT1</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29982705/">29982705</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom">SC5314</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/6394964/">6394964</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Clinical blood isolate</td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom">CAF2-1</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8349105/">8349105</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>URA3/ura3Δ::imm434</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom">CAI4</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8349105/">8349105</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ura3Δ::imm434/ura3Δ::imm434</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom">BWP17</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10074081/">10074081</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ura3Δ::imm434/ura3Δ::imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom">SN152</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15701792/">15701792</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ URA3/ura3Δ::imm434 IRO1/iro1Δ::imm434</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>cwh41Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17933909/">17933909</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as CAI4 but <italic>cwh41Δ::dp1200/cwh41Δ::dp1200 RPS1/rps1Δ::CIp10</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>rot2Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17933909/">17933909</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as CAI4 but <italic>rot2Δ::dp1200/rot2Δ::dp1200 RPS1/rps1Δ::CIp10</italic></td></tr><tr><td align="left" valign="bottom"><italic>Strain</italic></td><td align="left" valign="bottom"><italic>kre5Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20543849/">20543849</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>Same as SN152 but kre5Δ::leu2/kre5Δ::his1</italic></td></tr><tr><td align="left" valign="bottom"><italic>Strain</italic></td><td align="left" valign="bottom"><italic>kre6Δ/Δ</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>kre6Δ::HygB/kre6Δ::HygB</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>kre62Δ/Δ</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>kre62Δ::FRT/kre62Δ::FRT</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>skn2Δ/Δ</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">skn2Δ::FRT/skn2Δ::FRT</td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>skn1Δ/Δ</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>skn1Δ::FRT/skn1Δ::FRT</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>kre6/skn1Δ/Δ</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>kre6Δ::HygB/kre6Δ::HygB skn1Δ::FRT/skn1Δ::FRT</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>kre6/kre62/skn2/skn1Δ/Δ</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>kre6Δ::HygB/kre6Δ::HygB kre62Δ::FRT/kre62Δ::FRT skn2Δ::FRT/skn2Δ::FRT skn1Δ::FRT/skn1Δ::FRT</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>kre6/kre62/skn2/skn1Δ/Δ+P</italic><sub><italic>ACT1</italic></sub><italic>-KRE6</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>kre6Δ::HygB/kre6Δ::HygB kre62Δ::FRT/kre62Δ::FRT skn2Δ::FRT/skn2Δ::FRT skn1Δ::FRT/skn1Δ::FRT RPS1/RPS1::CIpSAT1-P</italic><sub><italic>ACT1</italic></sub><italic>-KRE6</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>kre1Δ/Δ</italic></td><td align="left" valign="bottom">Provided by Mathias Richard</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as BWP17 but <italic>kre1Δ::arg4/kre1Δ::his1</italic></td></tr><tr><td align="left" valign="bottom"><italic>Strain</italic></td><td align="left" valign="bottom"><italic>P</italic><sub><italic>MRP1</italic></sub><italic>-CHS1/chs1Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11251855/">11251855</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as CAI4 but <italic>chs1Δ::hisG/chs1Δ:pSK-URA3-P</italic><sub><italic>MRP1</italic></sub><italic>-CHS1</italic></td></tr><tr><td align="left" valign="bottom"><italic>Strain</italic></td><td align="left" valign="bottom"><italic>chs2Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8636047/">8636047</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as CAF2-1 but <italic>chs2Δ::hisG/chs2Δ::hisG-URA3-hisG</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>chs3Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7479842/">7479842</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as CAF2-1 but <italic>chs3-2::hisG/chs3-3::hisG-URA3-hisG</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>mnt1/mnt2Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15519997/">15519997</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as CAF2-1 but mnt1-<italic>mnt2Δ::hisG/mnt1-mnt2Δ::hisG-URA3-hisG</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>mnn2/22/21/23/24/26Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23633946/">23633946</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as CAF2-1 but <italic>mnn2Δ::dpl200/mnn2Δ::dpl200 mnn22Δ::dpl200/mnn2Δ::dpl200 mnn23Δ::dpl200/mnn23Δ::dpl200 mnn24Δ::dpl200/mnn24Δ::dpl200 mnn26Δ::dpl200/mnn26Δ::dpl200 mnn21Δ::dpl200/mnn21Δ::dpl200</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>mnn9Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10601199/">10601199</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as CAF2-1 <italic>mnn9Δ::hisG/mnn9Δ::hisG Δura3Δ::imm434/ura3Δ::imm434</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>och1Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20543849/">20543849</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as SN152 but <italic>och1Δ::leu2/och1Δ::his1</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>fks1Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30370375/">30370375</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">SC5314, but <italic>fks1/fks1Δ</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>phr1Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7823929/">7823929</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as BWP17 but <italic>phr1Δ::hisG/phr1Δ</italic></td></tr><tr><td align="left" valign="bottom">Strain</td><td align="left" valign="bottom"><italic>phr2Δ/Δ</italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9315654/">9315654</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Same as BWP17 but <italic>phr2Δ::hisG/phr2Δ::hisG-URA3-hisG</italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SNR52/F</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27340698/">27340698</ext-link></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">sgRNA/R</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27340698/">27340698</ext-link></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SNR52/N</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27340698/">27340698</ext-link></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">sgRNA/N</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27340698/">27340698</ext-link></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">CaCas9/F</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27340698/">27340698</ext-link></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">CaCas9/R</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27340698/">27340698</ext-link></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SNR52/R/SKN1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SNR52/R/SKN2</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SNR52/R/KRE62</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SNR52/R/KRE6</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">sgRNA/F/SKN1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">sgRNA/F/SKN2</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">sgRNA/F/KRE62</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">sgRNA/F/KRE6</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SAT1FLP/F/SKN1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SAT1FLP/F/SKN2</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SAT1FLP/F/KRE62</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">HygR/F/KRE6</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SAT1FLP/R/SKN1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SAT1FLP/R/SKN2</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">SAT1FLP/R/KRE62</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">hygR/R/KRE6</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">Flanking_F/SKN1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">Flanking_F/SKN2</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">Flanking_F/KRE62</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">Flanking_R/SKN1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">Flanking_R/SKN2</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">Flanking_R/KRE62</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">screenKre6/F</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">screenKre6/R</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">CIpUL</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">CIpSAT</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">KRE6-FWD</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="top">KRE6-REV</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See sequence in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref></td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100569.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brakhage</surname><given-names>Axel A</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Hans Knöll Institute</institution><country>Germany</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Fundamental</kwd></kwd-group></front-stub><body><p>The article will be of broad interest to fungal biologists and fungal immunologists seeking to understand the biosynthesis of the fungal cell wall, in particular of ß-1,6-glucan synthesis and the importance of this so far understudied constituent of the cell wall for cell wall integrity and immune response. The study is of <bold>fundamental</bold> significance and adds structural clarity to the genetic and biochemical basis of this difficult-to-analyze carbohydrate. It opens the potential for understanding its role in immune recognition and potentially as a drug target. Overall, the data is <bold>compelling</bold>, properly controlled, and analyzed.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100569.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The fungal cell wall is a very important structure for the physiology of a fungus but also for the interaction of pathogenic fungi with the host. Although a lot of knowledge on the fungal cell wall has been gained, there is lack of understanding of the meaning of ß-1,6-glucan in the cell wall. In the current manuscript, the authors studied in particular this carbohydrate in the important human-pathogenic fungus Candida albicans. The authors provide a comprehensive characterization of cell wall constituents under different environmental and physiological conditions, in particular of ß-1,6-glucan. Also, β-1,6-glucan biosynthesis was found to be likely a compensatory reaction when mannan elongation was defective. The absence of β-1,6-glucan resulted in a significantly sick growth phenotype and complete cell wall reorganization. The manuscript contains a detailed analysis of the genetic and biochemical basis of ß-1,6-glucan biosynthesis which is apparently in many aspects similar to yeast. Finally, the authors provide some initial studies on immune modulatory effects of ß-1,6-glucan.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100569.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors provide the first (to my knowledge) detailed characterization of cell wall b-1,6 glucan in the pathogen Candida albicans. The approaches range from biochemistry to genetics to immunology. The study provides fundamental information and will be a resource of exceptional value to the field going forward. Highlights include the construction of a mutant that lacks all b-1,6 glucan and the characterization of its cell wall composition and structure. Figure 5a is a feast for the eyes, showing that b-1,6 glucan is vital for the outer fibrillar layer of the cell wall. Also much appreciated was the summary figure, Figure 7, that presents the main findings in digestible form.</p><p>Strengths:</p><p>The work is highly significant for the fungal pathogen field especially, and more broadly for anyone studying fungi, antifungal drugs, or antifungal immune responses.</p><p>The manuscript is very readable, which is important because most readers will be cell wall nonspecialists.</p><p>The authors construct a key quadruple mutant, which is not trivial even with CRISPR methods, and validate it with a complemented strain. This aspect of the study sets the bar high.</p><p>The authors develop new and transferable methods for b-1,6 glucan analysis.</p><p>Weaknesses:</p><p>The one &quot;famous&quot; cell type that would have been interesting to include is the opaque cell. Please include it in the next paper!</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100569.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The cell wall of human fungal pathogens, such as Candida albicans, is crucial for structural support and modulating the host immune response. Although extensively studied in yeasts and molds, the structural composition has largely focused on the structural glucan b,1,3-glucan and the surface exposed mannans, while the fibrillar component β-1,6-glucan, a significant component of the well wall, has been largely overlooked. This comprehensive biochemical and immunological study by a highly experienced cell wall group provides a strong case for the importance of β-1,6-glucan contributing critically to cell wall integrity, filamentous growth, and cell wall stability resulting from defects in mannan elongation. Additionally, β-1,6-glucan responds to environmental stimuli and stresses, playing a key role in wall remodeling and immune response modulation, making it a potential critical factor for host-pathogen interactions.</p><p>Strengths:</p><p>Overall, this study is well designed and executed. It provides the first comprehensive assessment of β-1,6-glucan as a dynamic, albeit underappreciated, molecule. The role of β-1,6-glucan genetics and biochemistry has been explored in molds like Aspergillus fumigatus, but this work shines important light on its role in Candida albicans. This is important work that is of value to Medical Mycology, since β-1,6-glucan plays more than just a structural role in the wall. It may serve as a PAMP and a potential modulator of host-pathogen interactions.</p><p>Weaknesses:</p><p>In keeping with an important role in immune recognition, it was suggested that the manuscript rigor would benefit from a more physiological evaluation ex vivo and preferably in vivo, assessment on stimulating the immune system within in the cell wall and not just as a purified component. This is a critical outcome measure for this study and gets squarely at its importance for host-pathogen interactions, especially in response to environmental stimuli and drug exposure. The authors addressed this issue contextually and indicate that it will require a more detailed immunologic evaluation but is not in keeping with the intent of this foundational study.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100569.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bekirian</surname><given-names>Clara</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Valsecchi</surname><given-names>Isabel</given-names></name><role specific-use="author">Author</role><aff><institution>EA DYNAMYC 7380</institution><addr-line><named-content content-type="city">Créteil</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Bachellier-Bassi</surname><given-names>Sophie</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Scandola</surname><given-names>Cyril</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Guijarro</surname><given-names>J Inaki</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Chauvel</surname><given-names>Murielle</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Mourer</surname><given-names>Thierry</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Gow</surname><given-names>Neil</given-names></name><role specific-use="author">Author</role><aff><institution>University of Exeter</institution><addr-line><named-content content-type="city">Exeter</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Aimanianda Bopaiah</surname><given-names>Vishu Kumar</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>d'Enfert</surname><given-names>Christophe</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Fontaine</surname><given-names>Thierry</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>The fungal cell wall is a very important structure for the physiology of a fungus but also for the interaction of pathogenic fungi with the host. Although a lot of knowledge on the fungal cell wall has been gained, there is a lack of understanding of the meaning of ß-1,6-glucan in the cell wall. In the current manuscript, the authors studied in particular this carbohydrate in the important humanpathogenic fungus Candida albicans. The authors provide a comprehensive characterization of cell wall constituents under different environmental and physiological conditions, in particular of ß-1,6glucan. Also, β-1,6-glucan biosynthesis was found to be likely a compensatory reaction when mannan elongation was defective. The absence of β-1,6-glucan resulted in a significantly sick growth phenotype and complete cell wall reorganization. The manuscript contains a detailed analysis of the genetic and biochemical basis of ß-1,6-glucan biosynthesis which is apparently in many aspects similar to yeast. Finally, the authors provide some initial studies on the immune modulatory effects of ß-1,6-glucan.</p><p>Strengths:</p><p>The findings are very well documented, and the data are clear and obtained by sophisticated biochemical methods. It is impressive that the authors successfully optimized methods for the analyses and quantification of ß-1-6-glucan under different environmental conditions and in different mutant strains.</p><p>Weaknesses:</p><p>However, although already very interesting, at this stage there are some loose ends that need to be combined to strengthen the manuscript. For example, the immunological studies are rather preliminary and need at least some substantiation. Also, at this stage, the manuscript in some places remains a bit too descriptive and needs the elucidation of potential causalities.</p><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>The authors provide the first (to my knowledge) detailed characterization of cell wall b-1,6 glucan in the pathogen Candida albicans. The approaches range from biochemistry to genetics to immunology. The study provides fundamental information and will be a resource of exceptional value to the field going forward. Highlights include the construction of a mutant that lacks all b-1,6 glucan and the characterization of its cell wall composition and structure. Figure 5a is a feast for the eyes, showing that b-1,6 glucan is vital for the outer fibrillar layer of the cell wall. Also much appreciated was the summary figure, Figure 7, which presents the main findings in digestible form.</p><p>Strengths:</p><p>The work is highly significant for the fungal pathogen field especially, and more broadly for anyone studying fungi, antifungal drugs, or antifungal immune responses.</p><p>The manuscript is very readable, which is important because most readers will be cell wall nonspecialists.</p><p>The authors construct a key quadruple mutant, which is not trivial even with CRISPR methods, and validate it with a complemented strain. This aspect of the study sets the bar high. The authors develop new and transferable methods for b-1,6 glucan analysis.</p><p>Weaknesses:</p><p>The one &quot;famous&quot; cell type that would have been interesting to include is the opaque cell. This could be included in a future paper.</p><p><bold>Reviewer #3 (Public Review):</bold></p><p>Summary:</p><p>The cell wall of human fungal pathogens, such as Candida albicans, is crucial for structural support and modulating the host immune response. Although extensively studied in yeasts and molds, the structural composition has largely focused on the structural glucan b,1,3-glucan and the surface exposed mannans, while the fibrillar component β-1,6-glucan, a significant component of the well wall, has been largely overlooked. This comprehensive biochemical and immunological study by a highly experienced cell wall group provides a strong case for the importance of β-1,6-glucan contributing critically to cell wall integrity, filamentous growth, and cell wall stability resulting from defects in mannan elongation. Additionally, β-1,6-glucan responds to environmental stimuli and stresses, playing a key role in wall remodeling and immune response modulation, making it a potential critical factor for host-pathogen interactions.</p><p>Strengths:</p><p>Overall, this study is well-designed and executed. It provides the first comprehensive assessment of β-1,6-glucan as a dynamic, albeit underappreciated, molecule. The role of β-1,6-glucan genetics and biochemistry has been explored in molds like Aspergillus fumigatus, but this work shines an important light on its role in Candida albicans. This is important work that is of value to Medical Mycology, since β-1,6-glucan plays more than just a structural role in the wall. It may serve as a PAMP and a potential modulator of host-pathogen interactions. In keeping with this important role, the manuscript rigor would benefit from a more physiological evaluation ex vivo and preferably in vivo, assessment on stimulating the immune system within in the cell wall and not just as a purified component. This is a critical outcome measure for this study and gets squarely at its importance for host-pathogen interactions, especially in response to environmental stimuli and drug exposure.</p></disp-quote><p><bold>Response to reviewers (Public reviews):</bold></p><p>We thank all the three reviewers for their opinion on our work on <italic>Candida albicans</italic> β-1,6-glucan, which highlights the importance of this cell wall component in the biology of fungi. Here are our responses to their comments for public reviews:</p><p>(1) Indeed, the data presented for immunological studies is preliminary. It has been acknowledged by the reviewers that our analysis providing insights into the biosynthetic pathways involved in comprehensive in dealing with organization and dynamics of the β-1,6-glucan polymer in relation with other cell wall components and environmental conditions (temperature, stress, nutrient availability, etc.). However, we anticipated that there would be immediate curiosity as to what the immunological contribution of β-1,6 glucan and we therefore felt we needed to initiative these studies and include them. We therefore performed immunological studies to assess whether β-1,6-glucans act as a pathogen-associated molecular pattern (PAMP), and if so, what its immunostimulatory potential is. Our data clearly suggest that β-1,6-glucan is a PAMP, and consequently lead to several questions: (a) what are the host immune receptors involved in the recognition of this polysaccharide, and thereby the downstream signaling pathways, (b) how is β-1,6-glucan differentially recognized by the host when <italic>C. albicans</italic> switches from a commensal to an opportunistic pathogen, and (c) how does the host environment impact the exposure of this polysaccharide on the fungal surface. We believe addressing these questions is beyond the scope of the present manuscript and aim to present new data in future manuscript. Nonetheless, in the revised manuscript, suggest approaches that we can take to identify the receptor that could be involved in the recognition of β-1,6-glucan. Moreover, we have modified the discussion presenting it based on the data rather than being descriptive.</p><p>(2) It will be interesting to assess the organization of β-1,6-glucan and other cell wall components in the opaque cells. It is documented that the opaque cells are induced at acidic pH and in the presence of <italic>N</italic>-acetylglucosamine and CO2. Our data shows that pH has an impact on β-1,6-glucan, which suggests that there will be differential organization of this polysaccharide in the cell wall of opaque cells. As suggested by the reviewer, we will include analysis of opaque cells (and other <italic>C. albicans</italic> cell types) in future studies.</p><p>With the exception of these major new avenues for this research, our revision can address each of the comments provided by the reviewers.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>Although the study is very interesting, there are some loose ends that need to be combined to strengthen the manuscript. For example, the immunological studies are rather preliminary and need at least some substantiation. Also, at this stage, the manuscript in some places remains a bit too descriptive and needs the elucidation of potential causalities.</p><p>Specifically:</p><p>(1) As you showed, defects in chitin content led to a decrease in the cross-linking of β-glucans in the inner wall that corresponded to the effect of nikkomycin-treated C. albicans phenotype; conversely, an increase in chitin content led to more cross-linking of β-glucans as observed in the FKS1 mutant or in the presence of caspofungin. What is the mechanistic reason for these observations?</p></disp-quote><p>On one hand, yeast cell wall chitin occurs in three forms: free and covalently linked to β-1,3-glucan or β-1,6-glucan; crosslinked β-glucan-chitin forms core fibrillar structure resistant to alkali. A decrease in the chitin content, therefore, affect β-glucan-chitin crosslinking thereby making β-glucan alkali-soluble. On the other hand, a decrease in the β-glucan content, as in <italic>FKS1</italic> mutant or upon caspofungin treatment, results in increased cell wall chitin and β-glucan-chitin contents. A decrease in the β-1,3-glucan biosynthesis is associated with upregulation of <italic>CRH1</italic> involved in the β-glucan-chitin crosslinking, which explains an increased β-glucan-chitin content in the <italic>FKS1</italic> mutant or upon caspofungin treatment. We have included in this discussion in the revised manuscript (p14, lines 2-10).</p><disp-quote content-type="editor-comment"><p>(2) The β-1,6-glucan biosynthesis is stimulated via a compensatory pathway when there is a defect in O- and N-linked cell wall mannan biosynthesis. Why? causality? Hypothesis?</p></disp-quote><p>Two phenomena were observed related to β-1,6-glucan and mannan biosynthesis: (1) a defect in the elongation of N-mannan led to an increase in the β-1,6-glucan content; (2) a defect of O-mannan elongation resulted in the reduce size of β-1,6-glucan chains, however, increased their branching. These observations of our study suggest a global rescue program of the cell wall damage that could occur due to defect in one of the cell wall contents. We have discussed this in the revised manuscript (p14, last paragraph, p15 first paragraph). Moreover, β-1,3-glucan and chitin are synthesized by respective membrane bound synthases, and a defect in of their synthesis is compensated by the other. In line, although need to be validated for β-1,6-glucan, biosynthesis of mannan and β-1,6-glucan seem to initiate intracellularly. Therefore, possibility is that the defective mannan biosynthesis could be compensated by β-1,6-glucan biosynthesis, but need to be further validated experimentally.</p><disp-quote content-type="editor-comment"><p>(3) You showed that the removal of β-1,6-glucan by periodate oxidation (AI-OxP) led to a significant decrease in the IL-8, IL-6, IL-1β, TNF-α, C5a, and IL-10 released, suggesting that their stimulation was in part β-1,6-glucan dependent. What is the consequence of the stimulation, e.g. better phagocytosis, etc.? This needs some more experiments, otherwise the data is purely descriptive, as the conclusion. Also, what do you want to show with the activation of the complement system? Is ß1,6-glucan detected by complement receptors? I think this is really a loose end. I think it is necessary to provide more data on this observation, which I think lacks control with serum lacking complement, this should then be moved to the main manuscript.</p></disp-quote><p>In this study, our aim was to assess whether β-1,6-glucan acts as a pathogen-associated molecular pattern (PAMP) of <italic>C. albicans</italic>, and if yes, what is its immunostimulatory capacity/potential. Our data confirms that, indeed, β-1,6-glucan acts as a PAMP, and its removal significantly reduces the immunostimulatory capacity of the fibrillar core structure of the <italic>C. albicans</italic> cell wall. On the other hand, data provided in the revised manuscript (see updated Figure S14, discussion p13 lines 16-21) indicate that the human serum factors significantly enhance the immunostimulatory capacity of β1,6-glucan and that β-1,6-glucan interacts with the complement component C3b. However, addressing the role of β-1,6-glucan in phagocytosis using β-1,6-glucan deletion mutant will not be possible as the cell wall of this mutant is modified, and β-1,6-glucan is not the only cell wall component interacting with C3b. Alternate is to coat β-1,6-glucan on beads and use to study phagocytosis and identify immune receptors; however, these are beyond the scope of our present study/focus.</p><disp-quote content-type="editor-comment"><p>(4) Also, you suggested that β-1,6-glucan and β-1,3-glucan stimulate innate immune cells in distinct ways. Please provide more data on this interesting suggestion. You can block the dectin-1 receptor for example or use dectin-1 deficient macrophages from mice. The part on the immune stimulation needs to be optimized.</p></disp-quote><p>Stimulation of immune cells by pustulan (insoluble linear β-1,6-glucan) via a dectin-1independent pathway has been described previously (PMIDs: 18005717, 16371356) as discussed in the manuscript. Our preliminary data indicate that dectin-1 blocking on immune cells (using antidectin-1 antibodies) has no effect on the immunostimulatory potential of β-1,6-glucan, unlike AI and AI-OxP that showed significantly reduced cytokine secretion by the immune cells upon dectin-1 blocking. Deciphering the β-1,6-glucan recognition and its immunomodulatory pathways are underway, and will be the subject of our future study/manuscript.</p><disp-quote content-type="editor-comment"><p>(5) β-1,6-glucan and mannan productions are coupled. What is the hypothesis? Is it due to the necessity of mannan residues in ß-1,6-glucan biosynthesis enzymes from the ER? Can that be experimentally proven?</p></disp-quote><p>β-1,6-glucan and mannan synthesis should be coupled in two ways. First, as mentioned above (Response 2), defects in mannan elongation led to an alteration of β-1,6-glucan production. Second, early steps of N-glycosylation led to a strong reduction of β-1,6-glucan size and its cell wall content. However, we do not believe that the synthesis of N-glycan is required for the synthesis of an acceptor essential to β-1,6-glucan synthesis. Defect in N-mannan elongation led to a global cell wall remodeling as described above. Kre5, Rot2 and Cwh41 are part of the calnexin cycle involved in the control of N-glycoprotein folding in the ER, suggesting that some protein directly involved in the β-1,6-glucan synthesis required a folding quality control to be active. We modified our discussion, accordingly, highlighting these points (p14, last paragraph, p15 second paragraph).</p><disp-quote content-type="editor-comment"><p>(6) As PHR1 and PHR2 genes are strongly regulated by external pH, the compensatory differences described may be explained by pH-dependent regulation of β-1,6-glucan synthesis.' Please check. Also, could the pH regulation form the basis of e.g. differences you found for ß-1,6-glucan under different environmental conditions, i.e., growth on different carbon sources leads to different external pH values, as shown for many fungi?</p></disp-quote><p>We agree that environmental pH is dependent on carbon source and pH varies during growth curve. To test the effect of pH we buffered the medium with 100 mM MOPS or MES. Clearly, Fig. 2 and S1 show that the pH has an effect on the cell wall composition and polymer exposure as previously described (PMID:28542528). Here, we show that pH has an impact on the β-1,6-glucan size as well as its branching. However, in buffered medium, addition of organic acid (such as acetate, propionate, butyrate or lactate) had an impact on cell wall composition, showing that not only pH has an effect on cell wall composition. About <italic>phr1</italic>Δ/Δ and <italic>phr2</italic>Δ/Δ mutants, we believe that the difference in the cell wall composition observed between mutants is mainly due to the pH-dependent regulation, which we indicated in the discussion (p14, end of first paragraph).</p><disp-quote content-type="editor-comment"><p>Minor:</p><p>(1) In Figure 7B: dynamism should be replaced by dynamic and in term is rather in terms.</p></disp-quote><p>Modified as suggested.</p><disp-quote content-type="editor-comment"><p>(2) Replace molecular size with molecular mass when you give daltons.</p></disp-quote><p>Molecular size has been replaced by molecular weight, when presented as daltons.</p><disp-quote content-type="editor-comment"><p>(3) Page 7: for explanation, please add that nikkomycin is a chitin biosynthesis inhibitor.</p></disp-quote><p>As suggested, explained that nikkomycin is a chitin biosynthesis inhibitor.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>(1) I wondered if the increased chitin content of hyphae might reflect growth on the precursor GlcNAc. Have you tested hyphae that are induced in other ways? (2) Related to point 1, did you look at the relative abundance of yeast vs hyphae in the preparation? I wonder if yeast contamination might have reduced the extent of the composition changes observed.</p></disp-quote><p>We used GlcNAc as hyphae inducer as: (1) in presence of GlcNAc, hyphae are produced without any yeast contamination; in this condition, we observed an increase in the chitin content, as described, in hyphae (PMID:16423067); (2) we excluded using of serum, another condition inducing hyphal formation, as we could not control serum factors that may impact cell wall composition. We now indicate in the methods section that hyphae induced by GlcNAc were not contaminated by yeast (p17, line 3).</p><disp-quote content-type="editor-comment"><p>(3) I recommend rephrasing the first sentence of the Figure 2 legend: &quot;Cells were grown in liquid SD medium at 37oC at exponential phase under different growth conditions.&quot; The conditions varied extensively - stationary is not exponential; biofilm is probably not exponential. Also, the &quot;D&quot; in &quot;SD&quot; stands for dextrose, and the carbon source varied a good deal. Perhaps you could say: &quot;Cells were grown in liquid synthetic medium at 37oC under different growth conditions, as specified in Methods.&quot;</p></disp-quote><p>Sentences have been rephrased.</p><disp-quote content-type="editor-comment"><p>(4) Figure 7b has a typo: &quot;dependant&quot; for &quot;dependent&quot;.</p></disp-quote><p>Typo-error has been corrected.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>To explore the biochemical composition of the cell wall, the authors fractionated the wall component into three categories based on polymer properties and reticulations: sodium-dodecyl-sulphate-βmercaptoethanol (SDS-β-ME) extract, alkali-insoluble (AI), and alkali-soluble (AS) fractions, and they developed several independent methods to distinguish between β-1,3-glucans and β-1,6-glucans. The composition and surface exposure of fungal cell wall polymers is known to depend on environmental growth conditions. It was shown that the cell wall of C. albicans hyphae increased chitin content (10% vs. 3%) and decreased β-1,6-glucan (18% vs. 23%) and mannan (13% vs. 20%) compared to the yeast form, and the reduced β-1,6-glucan content was associated with a smaller β1,6-glucan size (43 vs. 58 kDa), suggesting that both the content and structure of β-1,6-glucan are regulated during growth and cellular morphogenesis. Similar behavior was observed when exposing cells to acid and neutral medium pH. The most significant cell wall alteration occurred in a lactatecontaining medium, which led to a sharp reduction in structural core polysaccharides: chitin (-43%), β-1,3-glucan (-48%), and β-1,6-glucan (-72%). This reduction aligns with the previously observed decreases in inner cell wall layer thickness. As expected, the authors found that modulating chitin content genetically (chs3Δ/Δ knockout mutant) led to an increase of both β-1,3-glucan and β-1,6glucan. An increase in chitin content following genetic alteration of FKS genes impacting glucan synthase or after exposure to the echinocandin caspofungin led to enhanced cross-linking of βglucans. A slight increase in the β-1,3-glucan branching was also observed in the mnt1/mnt2Δ/Δ double mutant, suggesting that β-1,6-glucan and mannan synthesis may be coupled.</p><p>- This effect is not that pronounced, and the relationship appears somewhat overstated and may reflect an indirect interaction. The authors should address accordingly.</p></disp-quote><p>We agree that this sentence was overstated. To make it clearer and less pronounced, we divided this sentence into to two with less pronounced statements (p8, line 34).</p><disp-quote content-type="editor-comment"><p>The genetics of β-1,6-glucan biosynthesis appear complex and a figure describing putative roles for specific genes would be beneficial. For example, KRE6 is a glucosyl hydrolase required for beta1,6-glucan biosynthesis.</p><p>- It would be valuable to better understand the overall biosynthetic process. Please elaborate more in a figure.</p></disp-quote><p>Although proteins/enzymatic activities directly involved in the β-1,6-glucan biosynthesis have not yet been identified, as suggested by this reviewer, we included a schematic representation of this process based on our hypothesis (Figure S15, and p15 lines 17-22 in revised manuscript), indicating the possible involvement of Kre6p.</p><disp-quote content-type="editor-comment"><p>The deletion of KRE6 homologs, essential for β-1,6-glucan biosynthesis, resulted in the absence of β-1,6-glucan production, and significant structural alterations of the cell wall. This result nicely confirms the important role of β-1,6-glucan in regulating cell wall homeostasis. The absence of β1,6-glucan was associated with increased (mutant v. WT) chitin content (9.5% vs. 2.5%) and highly branched β- β-1,6-glucan 1,3-glucan (48% vs. 20%). TEM ultrastructure studies nicely showed the change in cell wall overall architecture. From a drug discovery perspective, since the blockade of β1,6-glucan did not block growth, it may have more value as a potential virulence target. This would be valuable but needs to be assessed in animal model challenge competition experiments.</p><p>- The authors may want to elaborate more.</p></disp-quote><p>We agree and modified “antifungal target” as “potential virulence target”.</p><disp-quote content-type="editor-comment"><p>It is well known that β-1,3-glucan, mannan, and chitin function serve as PAMPs, which induce immune responses. The role of β-1,6-glucan as a PAMP is not well understood, and the authors provide evidence that different cell wall extracted fractions with enriched constituents induce immune responses invoking cytokines, chemokines, and acute phase proteins, as well as the complement system. While this data clearly shows that β-1,6-glucan is immunologically active and potentially important for host-pathogen interactions, the analysis is preliminary and falls short of making this case.</p><p>- This is a critical point in getting at the potential host signaling of β-1,6-glucan contained in the cell wall or shed by the cell (is this known?)</p><p>- This analysis would be bolstered significantly by examining stimulation relative to other cell wall components, and most importantly, whole cell modulation of β-1,6-glucan exposure for immune presentation, and not just unnatural concentrated extracts. This can be readily accomplished with the various mutants in hand, as well as after exposure to various antifungal agents echinocandins and nikkomycins (see Hohl et al. 2008 JID). Additional validation would benefit from animal model studies to examine in vivo immune modulation.</p></disp-quote><p>We agree with the reviewer. However, the main focus of our present work was to study the organization and dynamics of <italic>C. albicans</italic> cell wall β-1,6-glucan, and to explore its possible role as pathogen-associated molecular pattern (PAMP). Our study indicates that, indeed, β-1,6-glucan acts as a PAMP with immunostimulatory potential. As pointed by this reviewer, and similar to β-1,3glucans, the exposure of β-1,6-glucan is probably a key point in immune response. However, this investigation beyond the scope of this study, underway and will be presented in our future work.</p><disp-quote content-type="editor-comment"><p>- The Discussion would also benefit from an analysis of how β-1,6-glucan in Aspergillus fumigatus, which was largely elucidated by the same primary authors.</p></disp-quote><p>To our knowledge, β-1,6-glucan has never been identified, either by chemical analysis (PMID:10869365; PMID:36836270) or solid-state NMR (PMID:34732740), in the cell wall of <italic>A. fumigatus</italic>, although a homolog of <italic>KRE6</italic> is present in <italic>A. fumigatus</italic> but with unknown function.</p></body></sub-article></article>